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CHAPTER	  1.	  




Clinical	  practice	  guidelines	  (CPGs)	  are	  systematically	  developed	  statements	  to	  assist	  practitioners	  
in	   making	   decisions	   about	   appropriate	   health	   care	   in	   specific	   clinical	   circumstances	   [1].	   Their	  
purpose	  is	  to	  make	  explicit	  recommendations	  with	  a	  definite	  intent	  to	  influence	  what	  clinicians	  do.	  
Clinical	   practice	   guidelines	   currently	   represent	   the	   standard	   of	   care	   and	   a	   support	   for	   medical	  
practitioners	  for	  the	  management	  of	  different	  acute	  and	  chronic	  conditions	  in	  different	  period	  of	  
life	  from	  infancy	  to	  elderly.	  
The	  primary	  goal	  of	  CPGs	  in	  pediatrics	  is	  to	  improve	  the	  health	  of	  infants	  and	  children	  by	  ensuring	  
that	  they	  receive	  up-­‐to-­‐date,	  evidence-­‐based	  care.	  
However	   the	   process	   that	   leads	   from	   the	   identification	   of	   clinical	   problem	   to	   the	   delivery	   of	  
standard	  care	  to	  the	  target	  population	  is	  complex	  and	  time-­‐consuming.	  It	  includes	  many	  different	  
steps	   from	   the	   development	   of	   clinical	   recommendations	   to	   their	   dissemination	   and	   local	  
implementation	   (Figure	  1.1),	  and	  each	  of	   these	  steps	   is	  needed	   to	  ensure	  a	   rapid	  application	  of	  
evidence-­‐based	  recommendations.	  
In	   the	   last	   20	   years	   the	   number	   of	   this	   kind	   of	   CPGs	   is	   progressively	   increasing	   in	   international	  
literature,	   including	   in	   the	   field	   of	   pediatrics.	   However,	   the	   plethora	   of	   CPGs	   has	   been	  
accompanied	  by	  growing	  concern	  about	  differences	  among	  clinical	   recommendations	  and	  about	  
the	  quality	  of	  guidelines	  [2-­‐5].	  
	  
1.2 The	  quality	  of	  guidelines	  	  
	  
How	  does	  one	  define	  the	  quality	  of	  guidelines?	  A	  “good”	  guideline	  should	  be	  scientifically	  valid,	  
usable,	  reliable,	  and	  should	  improve	  the	  outcome	  of	  patients.	  However,	  it	   is	  rarely	  known	  how	  a	  
guideline	  performs	   in	   clinical	  practice.	   Evaluation	  of	  CPGs	   should	   include	  both	  methods	  used	   to	  
develop	   recommendations	   and	   applicability	   of	   recommendations	   (benefits,	   adverse	   effects	   and	  
costs)	  [6].	  
An	   international	   group	   of	   researchers,	   the	   Appraisal	   of	   Guidelines,	   Research	   and	   Evaluation	  
(AGREE)	  Collaboration,	  developed	  and	  validated	  a	  specific	  instrument	  to	  assess	  the	  quality	  of	  CPGs	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based	  on	  theoretical	  assumptions	  [7],	  in	  2010	  the	  same	  group	  of	  expert	  developed	  a	  new	  updated	  
version	  of	  this	  instrument	  [8].	  
A	   recent	   assessment	   of	   the	   quality	   of	   pediatric	   guidelines	   with	   the	   AGREE	   instrument	  
demonstrated	  better	  results	  for	  CPGs	  produced	  in	  the	  field	  of	  pediatrics	  than	  those	  addressed	  to	  
adult	   conditions	   [9].	   In	   addition,	   the	   endorsement	   of	   leading	   Institutions	   or	   Scientific	   Societies	  
such	   as	   the	   American	   Academy	   of	   Pediatrics	   or	   the	   registration	   in	   the	   National	   Guidelines	  
Clearinghouse	  represent	  a	  guarantee	  of	  quality	  in	  most	  of	  cases.	  
We	  previously	  used	  this	  instrument	  to	  assess	  the	  quality	  of	  guidelines	  on	  acute	  gastroenteritis	  in	  
children,	  and	  to	  identify	  weaknesses	  and	  strengths,	  with	  the	  ultimate	  aim	  of	  improving	  the	  quality	  
and	  applicability	  of	  guidelines	  produced	  in	  this	  filed	  [6].	  	  
According	   to	   the	   AGREE	   criteria,	   the	   overall	   quality	   of	   published	   CPGs	   devoted	   to	   acute	  
gastroenteritis	  was	  fair,	  and,	  among	  the	  nine	  documents	  included	  in	  the	  analysis,	  only	  three	  were	  
strongly	  recommended	  without	  any	  provisos	  or	  alteration.	  
Aims,	   target	   population,	   synthesis	   of	   evidence,	   formulation	   of	   recommendations	   and	   clarity	   of	  
presentation	  are	  points	  of	  strength.	  	  
The	   involvement	   of	   professionals	   and	   users	   in	   the	   steering	   group	   is	   a	   point	   of	   strength	   in	   the	  
development	  process,	  however	  in	  our	  analysis	  all	  the	  CPGs	  but	  two	  failed	  to	  provide	  information	  
about	  patients	  preferences/expectations	  and	  experiences.	  Patient’s	  dimension	  should	  be	  factored	  
into	   decisions	   regarding	   clinical	   care,	   and	   this	   is	   particularly	   true	   for	   common	   diseases	   such	   as	  
acute	  infectious	  diarrhea.	  
Other	  relevant	  weak	  issues	  are	  applicability,	  including	  identification	  of	  organizational	  barriers	  and	  
adherence	  parameters,	  and	  cost/efficacy	  analysis.	  
The	   AGREE	   is	   also	   used	   during	   the	   development	   of	   a	   new	   guidelines	   to	   draw	   the	   frame	   of	   the	  
document	  and	  to	  define	  the	  quality	  criteria	  on	  which	  a	  high-­‐quality	  CPGs	  should	  be	  built.	  	  
According	  to	  our	  data,	  the	  quality	  of	  CPGs	  for	  the	  management	  of	  acute	  gastroenteritis	  improved	  
during	   the	   time	  and	  mainly	   after	   the	  publication	  of	   the	  paper	  describing	   the	  AGREE-­‐instrument	  
and	   domains	   of	   improvement	   were	   those	   related	   to	  methodology	   and	   editorial	   independence.	  
This	  may	  suggest	  that	  compliance	  with	  validated	  criteria	  may	  contribute	  to	  development	  of	  high	  
quality	  guidelines.	  
	  
1.3 Implementation	  of	  guidelines	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High-­‐quality	  CPGs	  are	  a	  major	  tool	  to	  improve	  quality	  of	  care	  [10,	  11].	  However	  the	  development	  
of	   CPGs	   is	   not	   enough	   and	   pilot	   testing,	   capillary	   dissemination	   and	   local	   implementation	   are	  
critical	  steps	  to	  change	  clinical	  practice.	  
For	   many	   health	   conditions,	   there	   is	   a	   gap	   between	   what	   medical	   science	   has	   shown	   to	   be	  
effective	  practice	  and	  what	  is	  actually	  done	  [12].	  
Strong	   evidence	   reports	   that	   compliance	   with	   guideline	   recommendations	   is	   often	   poor	   in	  
different	   medical	   settings	   and	   a	   high	   rate	   of	   inappropriate	   medical	   interventions	   has	   been	  
reported	  for	  different	  clinical	  condition	  in	  pediatric	  age.	  
Two	  relevant	  papers	  published	  in	  the	  New	  England	  Journal	  of	  Medicine	  showed	  a	  poor	  adherence	  
to	  standard	  of	  care	  both	  in	  adults	  and	  pediatric	  population	  in	  United	  States	  [13,	  14].	  According	  to	  
these	  data,	  about	  half	  of	  patients	  receive	  evidenced-­‐based	  care,	  and	  a	  large	  proportion	  of	  patients	  
receive	   everyday	   low	   quality	   care,	   not-­‐recommended	   medications,	   unnecessary	   diagnostic	   and	  
medical	   interventions.	   This	   seems	   to	   be	   true	   for	   the	   management	   of	   both	   acute	   and	   chronic	  
conditions,	  and	  even	  in	  case	  of	  prevention	  strategies.	  
The	   deficits	   that	   the	   authors	   identified	   in	   adherence	   to	   recommended	   processes	   for	   basic	   care	  
pose	  serious	  threats	   to	  the	  health	  of	   the	  American	  public.	  A	  similar	  deficit	   in	   the	  quality	  of	  care	  
was	  reported	  in	  the	  management	  and	  prevention	  of	  pediatric	  diseases	  [14].	  
The	  authors	  of	  both	  papers	  concluded	  with	  a	  call	  for	  strategies	  to	  reduce	  the	  apparent	  deficits	  in	  
quality	  of	  delivered	  care.	  
Local	  implementation	  of	  CPGs	  and	  adherence	  to	  clinical	  recommendations	  has	  been	  demonstrated	  
effective	  in	  reducing	  inappropriate	  medical	  intervention	  and	  the	  number	  of	  visits,	  hospitalizations	  
and	  costs	  in	  children.	  
Implementation	  and	  dissemination	  strategies	  affect	  the	  probability	  of	  guidelines	  of	  being	  effective	  
[15].	  Implementation	  depends	  on	  acceptance	  of	  specific	  recommendations	  by	  physicians,	  and	  on	  
the	  applicability	  of	   indications	  and	  acceptance	  by	   customers.	  Only	   a	  minority	  of	  physicians	   fully	  
complies	  with	  guidelines.	  To	   increase	  compliance,	  experts	  recommend	  that	  guidelines	  should	  be	  
tested	  in	  local	  settings	  [16-­‐18].	  Although	  AGREE	  requires	  guideline	  committees	  to	  undertake	  pilot	  
testing	   before	   publication	   to	   ensure	   that	   the	   guideline	   can	   be	   put	   into	   practice,	   only	   few	  CPGs	  
usually	  report	  this	  point	  in	  the	  document.	  	  
In	   addition,	   the	   process	   of	   CPGs	   development	   should	   consider	   potential	   barriers	   to	  
implementation	  and	  provide	  monitoring	  criteria	  to	  assess	  guideline’s	  impact.	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1.4 Guidelines	  in	  pediatric	  infectious	  diseases	  
	  
The	   infectious	   diseases	   are	   the	  most	   common	   illnesses	   in	   infants	   and	   children.	   Respiratory	   and	  
gastrointestinal	   infections	   represent	   the	  major	   indication	   to	  medical	   visit,	   access	   to	   emergency	  
department	  and	  hospital	  admission	  in	  pediatric	  age	  worldwide.	  	  
The	  melting	   pot	   of	   pediatric	   infectious	   diseases	   includes	  many	   different	   conditions	   that	   ranges	  
from	  acute,	  self-­‐limiting	  and	  easy-­‐to-­‐mange	   illnesses	  (eg.	   flu-­‐like	   illness,	  acute	  gastroenteritis)	   to	  
severe	   or	   chronic	   and	   life-­‐threatening	   conditions	   such	   as	   HIV	   infection,	   tuberculosis	   or	  
opportunistic	   infections	   in	   at-­‐risk	   or	   immune-­‐compromised	   subjects.	   With	   few	   exceptions,	  
infectious	  diseases	  are	  curable	  if	  an	  accurate	  and	  rapid	  diagnosis	  is	  performed	  and	  the	  appropriate	  
treatment	   is	  provided.	   In	  addition,	  all	   these	  conditions,	   although	  with	  different	   rates,	  have	  high	  
social	  and	  economic	  burden.	  	  
Many	  different	  CPGs	  for	  the	  prevention	  and	  management	  of	  selected	   infectious	  conditions	  have	  
been	  produced	   and	   are	   continuously	   updated.	   The	   routine	   and	   correct	   application	  of	   evidence-­‐
based	  recommendations	  may	  potentially	  have	  a	  dramatic	  impact	  on	  the	  burden	  of	  all	  infections	  in	  
pediatric	   age,	   improving	   child	   health	   and	   reducing	   inappropriate	   interventions,	   adverse	   effects	  
and	  health-­‐care	  expenses.	  
For	  all	  these	  reasons,	  and	  from	  a	  methodological	  point	  of	  view	  the	  infectious	  diseases	  represents	  
an	  ideal	  setting	  to	  test	  the	  efficacy	  and	  applicability	  of	  CPGs.	  
	  
1.5	  Aims	  and	  overview	  of	  the	  thesis	  
	  
This	   thesis	   depicts	   the	   entire	   evidence-­‐based	   path	   that	   leads	   from	   the	   rigorous	   process	   of	  
guidelines	  development	  to	  the	  final	  step	  of	  local	  implementation	  of	  clinical	  recommendations.	  	  
The	  overall	  aims	  of	  this	  work	  are:	  
1) To	   describe	   the	   process	   guidelines	   development	   and	   assessment	   of	   quality	   of	   scientific	  
evidence	   for	   the	  management	   of	   specific	   infectious	   diseases	   in	   pediatric	   age	   (i.e.	   acute	  
gastroenteritis);	  
2) To	  describe	   the	  methodology	   for	   the	   identification	  of	   relevant	  outcome	  measures	   in	   the	  
field	  of	  pediatric	  infectious	  diseases;	  	  
3) To	   assess	   the	   appropriateness	   of	  medical	   interventions	   and	   quality	   of	   care	   delivered	   to	  
children	  with	  selected	  infectious	  diseases	  (i.e.	  acute	  gastroenteritis);	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4) To	  test	  the	  efficacy	  and	  effectiveness	  of	  different	  interventions	  for	  the	  implementation	  and	  
local	  tailoring	  of	  recommendations	  for	  the	  management	  of	  infectious	  diseases	  in	  children.	  
	  
To	  reach	  these	  objectives	  and	  describe	  the	  evidence-­‐based	  process	  the	  thesis	  reports	  the	  results	  
of	  different	  works	  organized	  as	  follows:	  	  
-­‐ The	  evaluation	  of	  the	  quality	  of	  scientific	  evidence	  on	  the	  acute	  gastroenteritis	  as	  basis	  for	  the	  
development	  of	  the	  new	  up-­‐dated	  European	  evidence-­‐based	  guidelines	  for	  the	  management	  
of	  acute	  gastroenteritis	   in	  children.	   In	  addition,	  the	  same	  process	   leaded	  the	  publications	  of	  
two	  reviews	  reporting	  the	  hospital	  management	  of	  children	  with	  acute	  diarrhea	  and	  exploring	  
the	   differences	   between	   evidence-­‐based	   recommendations	   and	   clinical	   practice	   in	   children	  
living	  in	  developed	  and	  developing	  areas	  (chapter	  2);	  
-­‐ The	   identification	  of	   relevant	  clinical	  outcomes	   for	   the	  production	  of	  a	  core-­‐outcome	  set	   to	  
standardize	  the	  evaluation	  of	  efficacy	  of	  different	  interventions	  aimed	  at	  reducing	  the	  impact	  
of	   infectious	   diseases	   (i.e.	   respiratory	   infections	   and	   acute	   diarrhea)	   and	   to	   drive	   future	  
clinical	  trials	  in	  the	  field	  (chapter	  3);	  
-­‐ The	   assessment	   of	   quality	   of	   care	   delivered	   to	   children	   hospitalized	   for	   acute	   intestinal	  
infections	   in	   Italian	   institutions	   through	   the	   design	   of	   a	   multicenter	   observational	   study	  
carried	  out	  in	  more	  than	  30	  pediatric	  wards	  (chapter	  4);	  
-­‐ The	  identification	  of	  effective	  interventions	  to	  promote	  the	  use	  of	  Lactobacillus	  GG	  to	  reduce	  
the	   duration	   of	   diarrhea	   in	   children	   admitted	   for	   acute	   gastroenteritis	   and	   local	  
implementation	  in	  a	  tertiary-­‐care	  children	  hospital	  in	  United	  States	  (chapter	  5);	  
-­‐ An	  intervention	  trial	  aimed	  at	  evaluating	  the	  impact	  of	  an	  e-­‐learning	  course	  on	  the	  knowledge	  
and	  clinical	  practice	  of	  pediatricians	  and	  family	  physicians	  in	  15	  European	  countries	  (chapter	  
6);	  
-­‐ A	  quality	  care	  improvement	  study	  aimed	  at	  reducing	  the	  incidence	  and	  severity	  of	  infectious	  
events,	  mainly	  central-­‐line	  associated	  blood	  stream	  infections	  in	  children	  with	  acute	  leukemia.	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Figure	  1.1	  Evidence-­‐based	  path:	  from	  the	  production	  to	  implementation	  of	  guidelines	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CHAPTER	  2.	  
PRODUCTION	  OF	  THE	  ESPGHAN/ESPID	  GUIDELINES	  FOR	  THE	  
MANAGEMENT	  OF	  ACUTE	  GASTROENTERITIS	  IN	  EUROPEAN	  CHILDREN	  
	  
	  
2.1 Acute	  gastroenteritis	  in	  childhood	  and	  the	  need	  for	  a	  European	  guideline	  
	  
Acute	   gastroenteritis	   (AGE)	   still	   represents	   a	   common	   cause	   of	  morbidity	   and	  mortality	   among	  
infants	  and	  children	  worldwide.	  In	  developing	  areas	  the	  rapid	  fluid	  loss	  related	  to	  acute	  diarrhea,	  
vomiting	  and	  fever,	  together	  with	  the	  difficult	  to	  oral	  rehydration	  and	  the	  limited	  access	  to	  clean	  
water	  and	  facilities,	  gives	  to	  AGE	  the	  second	  leading	  position	  among	  the	  causes	  of	  child	  death.	  
In	   industrialized	   countries,	   the	   disease	   is	   relatively	   mild	   and	   generally	   self-­‐limiting,	   but	  
nevertheless	  can	  have	  a	  major	  impact	  on	  the	  quality	  of	  life	  of	  infected	  children	  and	  their	  families.	  
In	   these	   areas,	   AGE	   represents	   a	  major	   cause	   of	   outpatient	   visits	   and	   hospital	   admissions	   and	  
consequently	  it	  has	  a	  substantial	  effect	  on	  health-­‐care	  expenses.	  
Before	  the	   large	  dissemination	  of	  rotavirus	  vaccines,	   in	  United	  States	  AGE	  determined	  about	  1.5	  
million	  outpatient	  visits	  and	  over	  200.000	  hospitalizations	  every	  year	  [1].	  
Several	  guidelines	  for	  the	  management	  of	  AGE	  in	  children	  are	  available.	  However,	  only	  a	  minority	  
of	  physicians	  fully	  complies	  with	  guidelines,	  and	  clinical	  recommendations	  are	  only	  slowly	  put	  into	  
practice	  [2-­‐5].	  More	  specifically,	  the	  adherence	  to	  standard	  of	  care	  for	  AGE	  in	  United	  States	  is	  far	  
from	  optimal,	  ranging	  from	  37%	  in	  outpatients	  setting	  [6]	  to	  69%	  in	  hospitalized	  children	  [7].	  	  
However,	  a	  higher	  compliance	  to	  guidelines	  recommendations	  for	  AGE	  can	  reduce	  the	  economic	  
burden	  of	  the	  illness	  [7]	  and	  improve	  the	  clinical	  outcomes,	  by	  shortening	  the	  duration	  of	  diarrhea	  
and	  enhancing	  weight	  gain	  [8].	  
The	  management	  of	  AGE	  essentially	   consists	  of	   the	   replacement	  of	   fluids	   lost	   through	  diarrheic	  
stools,	  vomiting	  and	  fever.	  However,	  rehydration	  therapy	  does	  not	  reduce	  the	  severity	  not	  even	  
the	  duration	  of	   intestinal	   symptoms	   [9].	  With	   the	  overall	   aim	  of	   reducing	   the	   clinical	   and	   social	  
burden	  of	  the	  illness,	  numerous	  anti-­‐diarrheal	  drugs	  with	  different	  mechanism	  of	  action	  have	  been	  
tested	  worldwide.	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Europe	  encompasses	  a	  large	  number	  of	  countries	  that	  differ	  in	  terms	  of	  tradition,	  culture,	  wealth	  
and	  health	  care	  systems.	  The	  management	  of	  AGE	  is	  significantly	  affected	  by	  all	  these	  social	  and	  
economic	  aspects	  and	  covers	  today	  a	  broad	  range	  of	  interventions.	  
All	  European	  children	  are	  expected	  to	  present	  at	  least	  1	  or	  2	  episodes	  of	  AGE	  every	  year	  below	  5	  
years	  of	  age.	  
In	   the	   attempt	   to	   reduce	   the	   intensity	   and	   duration	   of	   symptoms	   related	   to	   AGE,	   in	   several	  
countries,	  there	  is	  an	  excess	  of	  medical	  interventions	  that	  do	  not	  always	  result	  in	  clear	  beneficial	  
outcomes.	   New	   options	   in	   terms	   of	   diagnosis,	   nutritional	   interventions,	   drugs,	   and	   prevention	  
through	   the	  distribution	  of	   new	   vaccines	   against	   Rotavirus	   infection	   are	   becoming	   available.	   All	  
these	   interventions	   may	   influence	   the	   severity	   and	   duration	   of	   symptoms	   and	   the	   rate	   of	  
infection.	  
In	   2008	   a	   joint	   committee	   of	   experts	   belonging	   to	   the	   European	   Society	   for	   Pediatric	  
Gastroenterology,	  Hepatology	  and	  Nutrition	  (ESPGHAN)	  and	  to	  the	  European	  Society	  of	  Pediatric	  
Infectious	  Diseases	  (ESPID)	  developed	  two	  evidence-­‐based	  guidelines	  for	  the	  management	  of	  AGE	  
in	  European	  children	  [10]	  and	  for	  the	  use	  of	  vaccines	  against	  Rotavirus	  infection	  in	  children	  [11].	  
These	   documents	   were	   addressed	   to	   practitioners	   at	   all	   levels	   of	   health-­‐care,	   primary	   care	  
physicians,	  pediatricians	  and	  family	  physicians	  in	  Europe.	  
The	  collaboration	  between	  the	  Societies	  was	  triggered	  by	  the	  understanding	  that	  AGE	  is	  still	  today	  
a	  major	  pediatric	  health	  problem	  in	  all	  European	  countries.	  	  
These	  two	  documents	  represented	  a	  milestone	  for	  the	  care	  of	  European	  children	  with	  AGE	  in	  the	  
last	  5	  years	  and	  have	  had	  a	  major	  impact	  as	  judged	  by	  the	  number	  of	  citations	  (about	  300)	  and	  by	  
several	  papers	  addressing	  their	  quality	  and	  impact	  [12,	  13].	  	  
	  
2.2 Methodology	  for	  guidelines	  production	  
	  
As	  stated	  in	  the	  2008	  version,	  an	  update	  accounting	  for	  scientific	  evidence	  accumulated	  over	  the	  
last	  years	  was	  planned	  after	  5	  years	  since	  the	  publication	  of	  the	  guidelines.	  	  
This	   update	   used	   the	   same	   methodology	   reported	   in	   the	   previous	   version,	   however	   some	  
difference	  in	  the	  process	  were	  applied	  and	  specifically	  described	  below.	  	  
The	  process	  started	  with	  specifying	  clinical	  questions	  that	  define	  the	  target	  population	  for	  search	  
purposes	   defined	   as:	   previously	   healthy	   children	   5	   years	   of	   age	   or	   younger	   with	   clinically	  
  15 
diagnosed	  AGE	  (diarrhea	  and/or	  vomiting	  presumably	  of	  infectious	  origin),	  in-­‐	  or	  outpatients	  living	  
in	  geographic	  Europe.	  
However,	  since	  selecting	  evidence	  referred	  to	  this	  age	  group	  was	  not	  always	  possible	  in	  systematic	  
reviews,	  in	  some	  cases,	  the	  data	  obtained	  in	  individuals	  up	  to	  age	  18	  were	  included.	  Children	  with	  
at	  risk	  conditions,	  such	  as	  chronic	  disorders	  or	  immunodeficiency	  were	  not	  included.	  	  
The	  process	  continued	  through	  a	  rigorous	  review	  of	  available	  scientific	  data	  (focusing	  on	  the	  last	  5	  
years),	  the	  grading	  of	  evidence	  and	  the	  production	  of	  tables	  of	  evidence	  that	  are	  the	  prerequisite	  
for	  a	  state-­‐of-­‐the-­‐art	  evidence-­‐based	  document.	  
The	   authors	   of	   each	   section	   of	   the	   guidelines	   conducted	   a	   literature	   search	   using	   primarily	   the	  
MEDLINE	  and	  the	  Cochrane	  Library	  databases	  to	   identify	   relevant	   literature	   in	  English;	  however,	  
relevant	  papers	  in	  other	  languages	  were	  also	  considered	  in	  some	  instances.	  When	  data	  referring	  
to	  Europe	  were	  missing	  or	   limited,	  the	  search	  was	  extended	  to	  non-­‐European	  settings,	   including	  
developing	  countries.	  
In	   May	   2013,	   the	   guideline	   development	   group	   met	   in	   Milan	   to	   discuss	   the	   outcome	   of	   the	  
literature	  search	  and	  a	  first	  proposal	  of	  clinical	  recommendations.	  After	  a	  thorough	  discussion	  of	  
each	   statement/question,	   the	   strength	  of	   recommendations	   and	   the	   strength	  of	   the	   supporting	  
evidence	  were	  graded	  according	  to	  the	  Muir-­‐Gray	  &	  Cook	  methodology	  (Table	  2.1).	  
The	   present	   document	   differs	   from	   the	   2008	   guidelines	   in	   that	   we	   have	   rated	   the	   quality	   of	  
evidence	   and	   the	   weight	   of	   recommendations	   using	   the	   Grading	   of	   Recommendations,	  
Assessment,	   Development	   and	   Evaluations	   (GRADE)	   system,	   which	   has	   advantages	   over	   other	  
rating	   systems	   (Table	   2.2)	   [14].	   However,	   to	   reflect	   the	   changes	   that	   have	   occurred,	   we	   have	  
retained	  and	  revised	  the	  Muir-­‐Gray	  and	  Cook	  rating	  that	  we	  used	  five	  years	  ago	  [15,	  16].	  
The	   rationale	   for	  using	   the	  GRADE	   system	  was	  based	  on	   the	   fact	   that	   it	   is	   considered	   the	  most	  
effective	  method	   of	   connecting	   evidence	   to	   clinical	   recommendations	   and	   is	   increasingly	   being	  
applied	   by	   guideline	   development	   groups.	   In	   brief,	   the	   GRADE	   system	   offers	   four	   categories	   of	  
quality	   of	   evidence	   (high,	  moderate,	   low,	   and	   very	   low)	   and	   two	   categories	   of	   the	   strength	   of	  
recommendations	  (strong	  or	  weak)	  (Table	  2.2).	  	  
Recommendations	  were	  formulated	  and	  graded,	  and	  a	  consensus	  was	  reached.	  Any	  disagreement	  
was	  resolved	  by	  discussion	  until	  a	  consensus	  was	  reached.	  The	  draft	  of	  the	  guidelines	  was	  sent	  to	  
the	   group	  members	   for	   review	   and	   further	   comments.	   All	   critical	   feedback	   was	   discussed	   and	  
changes	  were	  incorporated	  as	  necessary.	  Finally,	  the	  guidelines	  were	  submitted	  for	  external	  peer	  
review	  and	  then	  approved	  by	  the	  ESPGHAN	  and	  ESPID	  Council.	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Table2.1.	   Strength	   of	   evidence	   and	   grade	   of	   recommendations	   in	   support	   of	   the	  
recommendations	   formulated	   in	   the	   2008	   ESPAGHAN/ESPID	  Guidelines	   for	   the	  Management	   of	  
AGE	  in	  Children	  in	  Europe	  
Strength	  of	  
evidence	  
I	   Strong	  evidence	  from	  ≥1	  systematic	  review(s)	  of	  well-­‐designed	  RCTs.	  
II	   Strong	  evidence	  from	  ≥1	  properly	  designed	  RCT(s)	  of	  appropriate	  size.	  
III	   Evidence	   from	  well-­‐designed	   trials	  without	   randomization,	   single	   group	  pre-­‐
post,	  cohort,	  time	  series,	  or	  matched	  case-­‐control	  studies.	  
IV	   Evidence	  from	  well-­‐designed	  trials,	  non-­‐experimental	  studies	   from	  >1	  center	  
or	  research	  group.	  
Va	   Opinion	  of	  respected	  authorities.	  
Vb	   Clinical	  evidence,	  descriptive	  studies,	  or	  reports	  of	  expert	  committees.	  
Grade	  of	  
recommendation	  
A	   Supported	  by	  level	  I	  evidence,	  highly	  recommended.	  
B	   Supported	  by	  level	  II	  evidence,	  recommended.	  
C	   Supported	  by	  level	  III	  evidence,	  recommended.	  








Further	  research	  is	  unlikely	  to	  change	  our	  confidence	  in	  the	  estimate	  
of	  effect.	  	  
Moderate	  
quality	  
Further	   research	   is	   likely	   to	   have	   an	   important	   impact	   on	   our	  
confidence	  in	  the	  estimate	  of	  effect	  and	  may	  change	  the	  estimate.	  	  
Low	  
quality	  
Further	   research	   is	   very	   likely	   to	   have	   an	   important	   impact	   on	   our	  








When	   the	   desirable	   effects	   of	   an	   intervention	   clearly	   outweigh	   the	  
undesirable	  effects,	  or	  they	  clearly	  do	  not.	  	  
Weak	  
When	  the	  trade-­‐offs	  are	  less	  certain	  (either	  because	  of	  the	  low	  quality	  
of	   evidence	   or	   because	   the	   evidence	   suggests	   that	   desirable	   and	  
undesirable	  effects	  are	  closely	  balanced).	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2.3 Major	   changes	   in	   the	   recommendations	   for	   the	  management	   of	   childhood	   diarrhea:	   2014	  
guidelines	  update	  
	  
Acute	  gastroenteritis	  still	  has	  a	  major	  impact	  in	  developed	  countries.	  The	  guidelines	  produced	  by	  
ESPGHAN	   and	   ESPID	   Societies	   in	   2008	   drove	   the	   clinical	   practice	   all	   around	   Europe,	   in	   the	   last	  
years.	   The	   management	   of	   AGE	   didn’t	   change	   dramatically,	   however	   an	   update	   of	   data	   on	  
epidemiology,	   diagnostic	   workup	   and	   treatment	   was	   needed	   and	   scheduled	   5	   years	   after	   the	  
publication	  of	  the	  first	  document.	  The	  continuous	  up-­‐to-­‐date	  of	  evidence	  is	  a	  necessary	  process	  to	  
improve	  clinical	  practice.	  Major	  changes	  between	  2008	  and	  2014	  versions	  of	  ESPGHAN	  guidelines	  
are	  reported	  in	  Table	  2.3.	  
	  
Epidemiology	  
This	  new	  version	  of	  guidelines	  reported	  new	  data	  on	  the	  epidemiology	  that	  slightly	  changed	  in	  the	  
last	  times.	  Rotavirus	  is	  still	  the	  most	  common	  cause	  of	  AGE	  in	  children	  in	  all	  European	  countries,	  
with	  an	   incidence	  as	  high	  as	  1.33-­‐4.96	  cases/100	  person	  year.	  Hospitalization	  rates	   for	   rotavirus	  
gastroenteritis	  ranged	  from	  7%	  to	  81%	  in	  various	  countries.	  This	  rate	  had	  a	  major	  impact	  on	  costs	  
[17].	  Rotavirus	  serotype	  predominance	  appears	  to	  change	  on	  a	  seasonal	  basis	  within	  each	  country	  
and	  may	  even	  differ	  between	  regions	  of	  the	  same	  country.	  
It’s	   well	   known	   that	   beginning	   from	   the	   2006	   two	   oral	   live	   rotavirus	   vaccines,	   Rotarix®	   and	  
RotaTeq®	  have	  been	  licensed	  in	  Europe	  after	  the	  demonstration	  of	  their	  good	  safety	  and	  efficacy	  
profiles	  in	  large	  clinical	  trials	  [18,	  19].	  
Vaccination	  coverage	   in	  European	  countries	   is	   still	   low,	  and	   to	  date	  only	   few	  countries	   (Finland,	  
Austria	  and	  Belgium)	  reported	  a	  coverage	  higher	  than	  90%	  [20].	  However,	  some	  changes	   in	  AGE	  
epidemiology	   have	   been	   reported	   in	   countries	   where	   a	   rigorous	   implementation	   campaign	   of	  
rotavirus	   vaccination	   has	   been	   promoted	   by	   the	   national	   institutions.	   In	   fact,	   the	   proportion	   of	  
new	  (G12)	  or	  selected	  (G2P4)	  strains	   increased	   in	  countries	  after	  the	   introduction	  of	  vaccination	  
[21,	  22].	  
Norovirus,	  generally	  considered	  the	  second	  leading	  agent	  of	  AGE,	  is	  fast	  becoming	  a	  leading	  cause	  
of	  medically	   attended	  gastroenteritis	   in	   countries	  with	  high	   rotavirus	   vaccine	   coverage	   [23,	   24].	  
Noroviruses	  represent	  10-­‐15%	  of	  causes	  of	  hospitalizations	  for	  AGE	  in	  European	  children.	  
In	  addition	  changes	  in	  bacterial	  and	  protozoal	  AGE	  have	  been	  reported	  in	  different	  countries	  with	  
a	  reduction	  in	  Salmonella	  and	  Campylobacter	  and	  a	  rapid	  increase	  of	  Clostridium	  difficile	  infection	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in	   selected	   settings,	   such	   as	   in	  United	   States	  where	   it	   has	   been	   related	   to	   community-­‐acquired	  
acute	  diarrhea	  even	  in	  low-­‐risk	  pediatric	  populations	  [25,	  26].	  	  
	  
Diagnostic	  work-­‐up	  
In	  otherwise	  healthy	  children	  with	  AGE,	  investigations	  are	  generally	  not	  needed.	  
Dehydration	  reflects	  severity	  of	  illness	  and	  should	  be	  monitored	  by	  established	  score	  systems.	  	  
Since	  2008,	  a	  number	  of	  studies	  were	  conducted	  in	  children	  1	  to	  36	  months	  with	  AGE	  to	  validate	  
the	  Clinical	  Dehydration	  Scale	  (CDS)	  [27].	  The	  scale	  consists	  of	  4	  clinical	  items:	  general	  appearance,	  
eyes,	  mucous	  membranes	  and	   tears.	   Each	   item	   is	   rated	   from	  0	   to	  2,	   and	   the	   total	   score	   ranges	  
between	   0	   and	   8.	   The	   final	   three	   categories	   were:	   no	   dehydration	   (CDS	   score:	   0),	   some	  
dehydration	  (CDS	  score:	  1-­‐4),	  and	  moderate/severe	  dehydration	  (CDS	  score:	  5-­‐8)	  [28].	  	  
Successively	   this	   scale	  was	   validated	   in	   several	   clinical	   studies	   and	   it	  was	   found	   to	   be	   useful	   in	  
predicting	  the	  need	  for	  intravenous	  rehydration	  [29,	  30],	  weight	  gain	  [30],	  need	  for	  blood	  test	  [30,	  
31],	  need	  for	  hospitalization	  [30],	  the	  length	  of	  stay	  in	  hospital	  and	  in	  the	  ED	  [29,	  31].	  In	  addition,	  a	  
fairly	  good	  inter-­‐observer	  reliability	  was	  reported	  for	  CDS	  [30,	  32].	  	  
	  
Diet	  and	  oral	  rehydration	  	  
Oral	   rehydration	  with	  hypo-­‐osmolar	  solution	   is	   the	  major	   treatment	  and	  should	  start	  as	  soon	  as	  
possible.	  The	  so-­‐called	  ESPGHAN	  oral	  rehydration	  solution	  containing	  60	  mmol	  Na+	  is	  still	  the	  first	  
treatment	   choice	   for	   European	   children.	   In	   breast-­‐fed	   infants,	   breastfeeding	   should	   not	   be	  
interrupted	   during	   AGE	   episode.	   Regular	   feeding	   should	   continue	   with	   no	   dietary	   changes	  
including	  milk.	   Recent	  data	  based	  on	  a	  Cochrane	   systematic	   review	   suggest	   that	   in	   the	  hospital	  
setting,	   in	  non-­‐breast-­‐fed	   infants	  and	  young	  children	  with	  severe	  AGE,	   lactose-­‐free	   feeds	  can	  be	  
considered	  in	  the	  management	  of	  gastroenteritis	  to	  reduce	  the	  duration	  of	  diarrheal	  episodes	  of	  
about	  18	  hours	  [28,	  33].	  
	  
Hospital	  management	  
This	  version	  of	  European	  guidelines	  includes	  a	  completely	  new	  section	  on	  hospital	  management	  of	  
children	   with	   severe	   AGE.	   Hospitalization	   should	   generally	   be	   reserved	   for	   children	   requiring	  
enteral/parenteral	  rehydration;	  most	  cases	  may	  be	  managed	  in	  an	  outpatients	  setting.	  
Despite	  the	  high	  number	  of	  hospitalization	  for	  AGE	  registered	  in	  all	  countries,	  yet	  a	  standardized	  
rehydration	  scheme	  is	  not	  available.	  The	  guidelines	  provided	  an	  accurate	  and	  updated	  protocol	  for	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the	   intravenous	   rehydration	   treatment	   [28].	   In	   the	   last	   years	   rapid	   rehydration	   regimens	   have	  
been	  proposed	  with	  the	  aim	  of	  reducing	  hospital	  stay	  and	  health-­‐care	  expenses.	   In	  any	  case	  the	  
level	  of	  evidence	  in	  support	  is	  still	  very	  low,	  and	  further	  studies	  in	  that	  field	  are	  needed	  to	  better	  
define	  the	  ideal	  modality	  of	  rehydration	  
Rehydration	  therapy	  through	  nasogastric	  tube	  is	  better	  than	  intravenous	  rehydration,	  in	  children	  
with	  moderate-­‐severe	  dehydration	  base	  on	  meta-­‐analysis	  results	  [34,	  35].	  
Intravenous	  rehydration	  is	  rarely	  needed;	  guidelines	  recommend	  intravenous	  rehydration	  in	  case	  
of	  severe	  dehydration	  and/or	  in	  case	  of	  oral	  rehydration	  failure.	  
Despite	  the	  lack	  of	  evidence	  of	  efficacy,	  in	  the	  last	  years	  a	  rapid	  rehydration	  scheme	  (40-­‐60ml/kg	  
normal	   saline	  bolus	  over	  60	  minutes)	  has	  been	  gradually	   incorporated	   into	  clinical	  practice	  with	  
the	  aim	   to	  obtain	   	   a	   reduction	  of	   	   symptoms,	   an	   improvement	  of	   appetite,	   and	  a	   	   reduction	  of	  	  
hospital	   stay	   and	  of	   global	   costs	   of	  AGE.	   	   A	   survey	  of	  North	  American	  physicians,	   specialized	   in	  
pediatric	  emergency,	  found	  that	  several	  regimens	  are	  used	  [36].	  
Ultrarapid	   rehydration	   proposed	   either	   by	   enteric	   or	   intravenous	   route	   demonstrated	   no	  
difference	   in	   clinical	   outcomes,	   however	   reduced	   rehydration	   times	   are	   associated	   with	   high	  
readmission	  rates	  and	  side	  effects.	  
	  
Antiemetics	  and	  Anti-­‐diarrheal	  drugs	  
Active	   therapy	  may	  reduce	  the	  duration	  and	  severity	  of	  diarrhea.	  Effective	   interventions	   include	  
administration	  of	  specific	  probiotics	  such	  as	  Lactobacillus	  GG	  or	  Saccharomyces	  boulardii	  or	  anti-­‐
diarrheal	   drugs	   such	   as	  Diosmectite	   (an	   absorbent	   clay)	   or	  Racecadotril	   (an	   antisecretory	  drug).	  
Anti-­‐infectious	  drugs	  should	  be	  given	  in	  exceptional	  cases	  being	  viruses	  the	  leading	  cause	  of	  AGE.	  
Since	   vomiting	   is	   still	   a	   major	   indication	   to	   emergency	   department	   consultation	   and	   hospital	  
admission	  and	   represents	   the	  most	   scaring	  AGE-­‐related	  symptoms	   from	  physicians	  and	   families,	  
stopping	  vomiting	  is	  one	  of	  the	  main	  issues	  in	  the	  management	  of	  AGE.	  
Antiemetics	  may	  reduce	  the	  need	  of	  intravenous	  rehydration	  because	  of	  vomiting	  and	  the	  number	  
of	  hospital	  admission.	  The	  use	  of	  Ondansetron	   is	   supported	  by	  strong	  evidence	  of	  efficacy	   [37	   -­‐	  
39],	  but	  its	  routine	  use	  requires	  safety	  clearance	  given	  the	  warning	  about	  severe	  cardiac	  effects. 
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Table	  2.3	  Summary	  of	  major	  changes	  in	  guidelines	  recommendations	  –	  2014	  update.	  
	  
 
	   	  
ISSUE	   2008	   2014	  
Definition	  of	  AGE	   No	  change	  
Etiology	   RV,	  Norovirus	  
Changes	  in	  countries	  where	  
RV	  vaccination	  as	  been	  implemented	  
Dehydration	  scores	  
No	  recommendation	  
Gorelick	  and	  Steiner	  scales	  suggested	  
Clinical	  Dehydration	  Scale	  
Nutritional	  intervention	   Not	  recommended	  
Lactose	  free	  diet	  to	  be	  considered	  in	  
children	  hospitalized	  for	  severe	  AGE	  
Oral	  rehydration	   Hypo-­‐osmolar	  ORS	  recommended	   Hypo-­‐osmolar	  ORS	  recommended	  
Enteral	  rehydration	   To	  be	  considered	  in	  selected	  cases	   Superior	  to	  IV	  rehydration	  
Intravenous	  rehydration	   -­‐	   Rapid	  rehydration	  recommended	  
PHARMACOLOGICAL	  TREATMENT	  
Antiemetics	   Not	  recommended	  
Ondansetron	  to	  be	  considered	  
in	  selected	  cases	  after	  safety	  release	  
Antibiotics	   Not	  routinely	  recommended	   Not	  routinely	  recommended	  
Probiotics	   To	  be	  considered	  in	  addition	  to	  ORS	  
To	  be	  considered	  in	  addition	  to	  ORS	  
New	  evidence	  in	  support	  
Racecadotril	   To	  be	  considered	  in	  addition	  to	  ORS	  
To	  be	  considered	  in	  addition	  to	  ORS	  
New	  evidence	  in	  support	  
Smectite	   To	  be	  considered	  in	  addition	  to	  ORS	  	  
To	  be	  considered	  in	  addition	  to	  ORS	  
New	  evidence	  in	  support	  
Zinc	   Not	  recommended	   Not	  recommended	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  used	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  produce	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  evidence-­‐based	  guidelines	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reference:	  
	  
4. Coordinators:	  Susanna	  Esposito	  and	  Alberto	  Villani	  
Stearing	  Committee:	  Elena	  Chiappini,	  Maurizio	  de	  Martino,	  Luisa	  Galli,	  Alfredo	  Guarino,	  Laura	  
Lancella,	  Andrea	  Lo	  Vecchio,	  Nicola	  Principi.	  	  
Multidisciplinary	  panel:	  	  F	  Bernardi,	  E	  Bertazzoni	  Minelli,	  F	  Blasi,	  M	  Bocchino,	  S	  Bosis,	  E	  
Castagnola,	  E	  Chiappini,	  D	  Ciofi,	  D	  Cirillo,	  L	  Codecasa,	  M	  de	  Martino,	  A	  Di	  Comite,	  G	  Di	  Mauro,	  S	  	  
Esposito,	  M	  Faccini,	  F	  Festini,	  C	  Gabiano,	  L	  Galli,	  S	  Garazzino,	  A	  Guarino,	  L	  Lancella,	  G	  Losurdo,	  A	  
Lo	  Vecchio,	  G	  Marseglia,	  A	  Mattelli,	  G	  Migliori,	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CHAPTER	  3.	  
THE	  IDENTIFICATION	  OF	  RELEVANT	  CLINICAL	  OUTCOMES	  
IN	  INFECTIOUS	  DISEASES	  
	  
	  
3.1 The	  Consensus	  Group	  on	  Outcome	  Measures	  Made	  in	  Pediatric	  Enteral	  Nutrition:	  COMMENT	  
Initiative	  
	  
A	  standard	  definition	  of	  outcomes	  measures	  is	  a	  essential	  point	  in	  the	  evidence-­‐based	  process	  to	  
1)	  accurately	  assess	   the	  efficacy	  of	   interventions;	  2)	   compare	   results	  of	  different	   studies	  and/or	  
different	  interventions;	  3)	  monitor	  process	  in	  the	  time	  and	  assess	  the	  effect	  of	  changes	  in	  practice.	  	  
The	  change	  in	  definition	  of	  outcomes	  and	  in	  the	  way	  of	  measuring	   it	  may	  significantly	  affect	  the	  
evaluation	  of	  results.	  
In	  many	  fields	  of	  medicine	  a	  high	  heterogeneity	  in	  definitions	  has	  been	  reported;	  one	  example	  has	  
been	   reported	   in	   a	   recent	   systematic	   review	   of	   138	   RCTs	   studying	   the	   effects	   of	   different	  
interventions	   applied	   to	   children	   with	   acute	   diarrhea.	   In	   this	   review	   Johnston	   and	   colleagues	  
found	  that	  64	  different	  definitions	  of	  diarrhea,	  69	  definitions	  of	  diarrhea	  resolution	  and	  46	  unique	  
primary	  outcomes	  were	  used	  [1].	  
The	   key	   question	   is:	   How	   can	   we	   consider	   an	   intervention	   effective	   and	   appropriate	   if	   the	  
definition	   of	   illness	   and	   healing,	   and	   the	   way	   choose	   to	   measure	   them	   are	   not	   reliable	   and	  
standardized?	   Only	   the	   use	   of	   standardized	   definitions	   of	   illness,	   severity	   and	   healing	   or	  
compliance	   and	   poor	   outcomes	   can	   lead	   to	   reliable	   and	   comparable	   results,	   and	   consequently	  
allow	  an	  active	  monitoring	  of	  processes	  in	  the	  time.	  	  
In	  addition,	  in	  many	  cases	  researches	  focus	  on	  indices	  that	  may	  not	  be	  relevant	  to	  child	  health	  or	  
quality	  of	  life.	  
	  
Nutrition	  in	  infancy	  and	  childhood	  markedly	  influence	  relevant	  functional	  and	  health	  outcomes	  on	  
a	  short-­‐	  and	  long-­‐term	  basis	  [2,	  3].	  During	  infancy,	  nutritional	  habits	  must	  meet	  the	  physiological	  
nutrient	  requirements	  and	  support	  healthy	  growth	  and	  normal	  development.	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Many	  different	  nutritional	   interventions	  have	  been	  proposed	  and	  tested	  to	   improve	  or	  optimize	  
child	  development.	  Also	  the	  ESPGHAN	  provided	  guidance	  documents	  and	  promoted	  clinical	  trials	  
to	  develop	  recommendations	  on	  the	  efficacy	  and	  benefits	  of	  many	  nutritional	   interventions	  and	  
innovations;	   however	   conclusions	   still	   remain	   uncertain	   and	   controversial	   in	   many	   fields,	   for	  
example	  the	  addition	  of	  compounds	  with	  proposed	  probiotic	  and	  prebiotic	  effects	  to	  infant	  foods	  
that	  has	  been	  recently	  highlighted	  by	  the	  ESPGHAN	  Committee	  on	  Nutrition	  [4].	  
There	  is	  still	  no	  agreement	  within	  the	  scientific	  community	  about	  how	  to	  best	  define	  and	  measure	  
outcomes	  used	  in	  nutrition	  trials	  conducted	  in	  infants	  and	  young	  children	  [5].	  	  
The	   use	   of	   inappropriate	   outcome	   measures	   and/or	   their	   definitions	   may	   result	   in	   misleading	  
information	   on	   the	   relevance	   of	   the	   outcome	   measure	   for	   infant	   health.	   It	   also	   may	   result	   in	  
overestimation,	  underestimation	  or	  failure	  to	  reveal	  potential	  benefits	  of	  the	  intervention	  [5].	  	  
Moved	  by	  these	  features,	  in	  2012,	  a	  group	  constituted	  by	  members	  of	  the	  Committee	  of	  Nutrition	  
of	   the	   ESPGHAN,	   the	   Early	   Nutrition	   Academy	   and	   the	   Child	   Health	   Foundation	   promoted	   an	  
initiative	   named	   Consensus	   Group	   on	   Outcome	   Measures	   Made	   in	   Pediatric	   Enteral	   Nutrition	  
Clinical	  Trials	  (COMMENT).	  The	  main	  objectives	  of	  this	  initiative	  are	  to:	  
1) To	   agree	   upon	   a	   range	   of	   outcome	  measures	   relevant	   to	   nutrition	   trials	   in	   children	   below	   3	  
years	  of	  age;	  
2) To	  agree	  upon	  an	  updated	  ‘core	  data	  set’	  that	  should	  generally	  be	  recorded	  in	  nutrition	  trials	  in	  
infants	  and	  young	  children,	  and	  	  
3) To	  provide	  guidance	  on	  the	  use	  of	  surrogate	  markers	  in	  pediatric	  nutrition	  research.	  
With	  the	   final	  aim	  of	  driving	  the	   future	  research	   in	   the	   filed	  of	  pediatric	  nutrition	  and	  provide	  a	  
standard	  core	  outcome	  set	  for	  the	  development	  of	  future	  clinical	  trails	  in	  that	  filed.	  	  
In	   details	   the	   participants	   discussed	   these	   objectives	   and	   agreed	   to	   set	   up	   six	   minor	   working	  
groups	  whose	  coordinators	  and	  objectives	  are	  reported	  in	  Table	  3.1.	  
Table	  3.1	  COMMENT	  Working	  Groups	  with	  respective	  coordinators	  and	  field	  of	  work	  
Working	  Group	  -­‐	  Topic	   Coordinator	  
Growth	   Prof.	  Kim	  Fleischer	  Michaelsen	  
Acute	  diarrhea	   Prof.	  Hania	  Szajewska	  
Atopic	  dermatitis	  and	  cows’	  milk	  protein	  allergy	   Prof.	  Christophe	  Dupont	  
Respiratory	  Infections	   Prof.	  Alfredo	  Guarino	  
‘Gut	  comfort’	  (e.g.	  colic,	  constipation,	  bloating)	   Prof.	  Marc	  Benninga	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Review	  of	  core	  data	  set	   Prof.	  Bert	  Koletzko	  
	  
The	  methodology	   used	   to	   define	   the	  most	   appropriate	   outcome	  measures	   in	   different	   fields	   of	  
infant	  medicine	  was	  based	  on	  the	  following	  steps:	  
1. Isolation	  and	  comparison	  of	   the	  outcomes	  currently	  reported	   in	   literature	   for	  each	  topic.	  
To	  reach	  the	  first	  goal	  a	  systematic	  search	  in	  MEDLINE,	  EMBASE	  and	  the	  Cochrane	  Library	  
was	   performed	   by	   using	   appropriate	   search	   terms	   and	   filters	   according	   to	   each	   specific	  
topic;	  
2. Determination	  of	  which	  outcomes	  to	  measure	  in	  clinical	  trials.	  Since	  the	  best	  strategy	  for	  
selecting	   outcomes	   for	   clinical	   trials	   in	   children	   is	   currently	   not	   known	   [6],	   the	   working	  
groups	  chose	  the	  Delphi	  technique.	  This	  is	  a	  structured	  method	  for	  reaching	  consensus	  in	  
which	   opinions	   are	   sought	   from	   individuals	   and	   the	   collated	   results	   are	   fed	   back	   to	   the	  
group	  as	  a	  whole	  to	  generate	  further	  discussion	  and	  finally	  reach	  an	  agreement	  [7,	  8].The	  
Delphi	  method’s	  main	  advantage	  is	  anonymity,	  which	  allows	  for	  freedom	  of	  expression	  and	  
also	   protects	   from	   any	   individual	   dominating	   a	   discussion,	   as	   can	   happen	   during	   a	  
discussion	  or	  face-­‐to-­‐face	  debate	  [8];	  
3. Identification	  of	  outcomes	  of	  highest	  relevance	  in	  clinical	  trials	  from	  different	  perspectives	  
(ie.	   clinicians/researchers,	   patients	   or	   their	   families,	   representatives	   from	   industry	   and	  
regulatory	  people);	  
4. Definition	  of	  a	  core	  outcome	  set	  to	  be	  used	  for	  future	  trials	  in	  the	  field	  of	  interest.	  
	  
	  
3.2 Results	  of	  the	  COMMENT	  working	  group	  on	  respiratory	  infections	  	  
	  
The	  Working	  Group	  on	  respiratory	  infections	  was	  coordinated	  by	  Prof.	  Alfredo	  Guarino	  and	  aimed	  
at	  defining	  criteria	  for	  assessing	  key	  outcomes	  in	  pediatric	  nutrition	  trials	  in	  the	  field	  of	  respiratory	  
infections.	  	  
We	   critically	   reviewed	   clinical	   trials	   studying	   the	   impact	   of	   nutritional	   interventions	   on	   upper	  
(URTI)	   and	   lower	   (LRTI)	   respiratory	   tract	   infections.	   We	   focused	   on	   definitions,	   key	   outcomes,	  
settings	   and	   confounding	   factors.	   A	   standardized	   table	   of	   evidence	   including	   author,	   year	   of	  
publication	  and	   journal,	   type	  of	   trial,	   target	  population,	   intervention,	  control,	  primary	  outcomes	  
and	   definitions	   of	   respiratory	   illness,	   clinical	   outcomes	   and	   the	   assessment	   of	   biomarkers	   to	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measure	  the	  effects	  of	  nutritional	  interventions	  on	  respiratory	  outcomes	  was	  prepared.	  In	  papers	  
including	  respiratory	  and	  non	  respiratory	  clinical	  outcomes,	  only	  data	  related	  to	  respiratory	  clinical	  
features	  and	  related	  definitions	  were	  reported	  in	  the	  table	  of	  evidence.	  
The	   electronic	   and	   bibliographic	   research	   identified	   107	   suitable	   references.	   After	   abstract	  
screening	   and	   application	   of	   study	   inclusion	   criteria,	   50	   papers	   were	   included,	   46	   focusing	   on	  
prevention	  of	  respiratory	  episodes	  and	  4	  on	  treatment.	  
Trials	   included	   in	  our	  analysis	  were	  published	  between	  1991	  and	  2012	   (21%	  between	  1991	  and	  
1999	  and	  79%	  between	  2000	  and	  2012).	  
	  
Interventions	  
The	   nutritional	   interventions	   applied	   in	   the	   analyzed	   studies	   were	   broad	   and	   included	   infant	  
formulas	   and	   yogurt	   (enriched	   with	   various	   prebiotics	   or	   probiotics	   and/or	   micronutrients),	  
vitamins	  and	  micronutrients	  supplementation	  and	  other	  interventions.	  
	  
Definitions	  
A	  specific	  segmental	  definition	  of	  upper	  or	  lower	  respiratory	  tract	  infections	  was	  reported	  in	  45/50	  
(90%)	   trials.	   In	   5	   trials,	   no	   definition	   of	   respiratory	   infections	   was	   reported.	   In	   15	   of	   the	   50	  
analyzed	   trials,	   the	   definitions	   of	   URTI,	   LRTI	   and	   acute	   otitis	   media	   were	   based	   on	   a	   specific	  
diagnosis	   made	   by	   a	   pediatrician	   (rhinitis,	   laryngitis,	   tracheitis,	   pharyngitis,	   sinusitis,	   otitis,	  
common	  cold/influenza).	  In	  30	  trials,	  the	  definition	  of	  URTI	  or	  LRTI	  was	  based	  on	  clinical	  symptoms	  
reported	   by	   families	   or	   field	   workers	   (runny	   nose,	   cough,	   sore	   throat).	   Lower	   respiratory	   tract	  
infections	  included	  pneumonia,	  bronchitis,	  wheezing	  and	  bronchiolitis.	  The	  specific	  diagnosis	  was	  
usually	  made	   based	   on	   cough,	   abnormal	   respiratory	   rate	   according	   to	   age,	   crepitation	   to	   chest	  
auscultation	  and	  chest	  indrawing,	  and	  was	  supported	  by	  radiographic	  findings	  in	  some	  cases.	  	  
In	  some	  trials,	  other	  systemic	  symptoms	  and	  signs	  such	  as	  fever,	  headache,	  restlessness,	  shortness	  
of	  breath	  and	  acute	  ear	  pain,	  were	  added	  to	  the	  respiratory	  features	  to	  further	  support	  diagnosis.	  
Fever	  was	  reported	  in	  22	  out	  of	  50	  trials	  reported	  as	  a	  feature	  associated	  to	  URTI	  or	  LRTI	  although	  
a	   specific	   definition	   of	   fever	  was	   provided	   only	   in	   8	   papers	   (36%)	   and	   the	   cut-­‐off	   temperature	  
values	   varied,	   with	   a	   rectal	   temperature	   >38°C	   being	   the	   most	   common	   definition.	   The	  
temperatures	  were	  usually	  reported	  by	  parents	  or	  field	  workers,	  and	  the	  duration	  of	  each	  episode	  
was	  recorded	  in	  days	  (rather	  than	  hours).	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The	  most	  relevant	  result	   is	  the	  huge	  heterogeneity	   in	  definitions	  used	  in	  trials.	  Overall	  we	  found	  
13	  different	  definitions	  of	  LRTI,	  5	  of	  URTI	  and	  3	  of	  fever.	  	  
	  
Outcomes	  	  
Incidence,	  prevalence	  and	  duration	  of	   specific	   respiratory	   symptoms	   (eg.	   cough	  with	  or	  without	  
fever)	  were	  the	  main	  outcomes	  in	  prevention	  trials.	  Duration	  of	  symptoms	  or	  hospitalization,	  and	  
symptom-­‐free	  periods	  were	  the	  main	  outcomes	  in	  the	  only	  4	  trials	  on	  treatment.	  
Some	  trials	   included	  quantitation	  of	  antibiotic	  prescriptions,	  absence	   from	  daycare	  or	  school,	  or	  
medical	  visits	  as	  surrogate	  end-­‐points,	  even	  if	  in	  no	  case	  a	  specific	  definition	  was	  provided.	  
In	   addition,	   in	   many	   trials	   the	   “definition”	   of	   diseases,	   as	   well	   as	   the	   diagnosis	   of	   respiratory	  
infection,	   was	   committed	   to	   field	   workers	   of	   even	   to	   family	   members;	   this	   evaluation	   might	  
significantly	  affect	  the	  reliability	  of	  the	  results.	  
	  
Conclusion	  and	  further	  research	  steps	  
Considering	   the	   current	   scenario	   and	   the	   relevant	   heterogeneity	   reported,	   a	   straightforward	  
definition	   of	   outcome	  measures	   seems	   to	   be	   needed	   to	   ensure	   a	  more	   reliable	   and	   consistent	  
reporting	  of	  data.	  
We	  hypothesized	  to	  differentiate	  outcomes	  into	  two	  categories:	  “direct”	  and	  “indirect”	  outcomes.	  
The	   “direct	   outcomes”	   would	   be	   aimed	   at	   assessing	   the	   efficacy	   of	   a	   selected	   intervention	   on	  
respiratory	  diseases.	  These	  outcomes,	  including	  the	  incidence	  or	  the	  severity	  of	  selected	  infections	  
(otitis,	   URTI,	   pneumonia),	   should	   be	   measured	   by	   well-­‐trained	   personnel	   (eg.	   physicians)	   who	  
make	  a	  specific	  diagnosis.	  In	  that	  case	  definitions	  should	  be	  based	  on	  updated	  guidelines.	  	  
On	   the	   other	   side,	   the	   “indirect	   outcomes”,	   such	   as	   the	   number	   of	   performed	   chest-­‐X-­‐ray,	  
working-­‐day	   loss,	   medical	   visits	   and	   interventions	   or	   hospitalization,	   may	   provide	   a	   reliable	  
estimate	  of	  the	  burden	  of	  respiratory	  diseases	  on	  health-­‐care.	  These	  simple,	  easy-­‐to-­‐measure	  end-­‐
points	  may	   be	  monitored	   by	   field	  workers	   or,	   even,	   family	  members	   (if	   trained),	   bypassing	   the	  
need	  to	  use	  difficult	  or	  complex	  diagnostic	  criteria,	  or	  validated	  scores.	  
The	  article	  by	  Guarino	  et	  al.	  [9]	  here	  attached	  reports	  in	  details	  the	  finding	  of	  this	  first	  phase	  of	  the	  
Working	  Group.	  However,	  based	  on	  the	  above	  reported	  approach	  the	  Working	  Group	  developed	  a	  
questionnaire	   reporting	   the	   main	   outcome	   measures	   distinguished	   in	   direct	   and	   indirect	  
outcomes.	  To	  complete	  the	  phase	  4,	  the	  questionnaire	  has	  been	  circulated	  among	  1)	  the	  authors	  
of	   previously	   published	   trials	   on	   the	   use	   of	   nutritional	   intervention	   aimed	   at	   prevent	   or	   treat	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respiratory	   infections,	  2)	  expert	  of	   the	  ESPGHAN	  Society,	  3)	  experts	  of	   the	  ESPID	  Society	  and	  4)	  
participants	  to	  international	  congress	  on	  gastroenterology	  and	  infectious	  diseases	  with	  the	  aim	  of	  
grading	  the	  3	  most	  relevant	  outcomes	  for	  each	  category	  (direct	  and	  indirect	  outcomes).	  
	  
	  
3.3 Results	  of	  the	  COMMENT	  working	  group	  on	  acute	  diarrhea	  
	  
The	  Working	  Group	  on	  acute	  diarrhea	  was	  coordinated	  by	  Prof.	  Hania	  Szajewska.	  
For	   the	   first	   phase	  of	   the	   project	   the	   group	   referred	   to	   the	   review	  performed	  by	   Johnston	   and	  
colleagues	   [1],	   and	   begins	   from	   that	   point	   to	   identify	   the	   definitions	   of	   diarrhea,	   resolutions,	  
scores	  and	  markers.	  
Once	   identified	   the	   outcomes	   reported	   in	   literature,	   the	   group	   developed	   an	   electronic	  
questionnaire	  with	  two	  open-­‐ended	  questions	  to	  identify	  potential	  outcomes	  and	  distributed	  it	  to	  
clinicians/researchers,	   industry	   representatives	   and	  members	   of	   regulatory	   bodies.	  Members	   of	  
ESPGHAN	   and	   ESPID	   were	   invited	   to	   participate	   in	   the	   electronic	   Delphi	   survey,	   along	   with	  
representatives	  from	  industry,	  regulatory	  people	  and	  researchers.	  The	  responders	  were	  asked	  to	  
consider	  which	  outcomes	   should	  be	  measured	   in	   clinical	   trials	   related	   to	  acute	  diarrhea	   in	  both	  
inpatient	  and	  outpatient	  settings.	  A	  similar,	  simplified	  questionnaire	  was	  developed	  for	  parents.	  
Parents	   of	   children	   admitted	   to	   the	   hospital	   due	   to	   acute	   diarrhea	   in	   Belgium,	   Italy,	   Israel	   and	  
Poland	  were	  invited	  to	  participate	  in	  the	  first	  round	  of	  the	  Delphi	  survey	  of	  parents.	  
A	  second	  phase	  included	  the	  definition	  of	  a	  short	  list	  of	  clinically	  relevant	  outcomes	  selected	  from	  
those	  listed	  by	  at	  least	  10%	  of	  participants	  in	  phase	  1.	  	  
This	  list	  was	  proposed	  to	  the	  evaluation	  and	  responders	  were	  asked	  to	  consider	  which	  outcomes	  
should	   be	  measured	   in	   clinical	   trials	   related	   to	   acute	   diarrhea	   in	   both	   inpatient	   and	   outpatient	  
settings.	  Two	  types	  of	  question	  were	  created	  for	  this	  part—one	  ranking	  each	  outcome	  on	  a	  scale	  
of	  0	  (unimportant)	  to	  4	  (very	  important)	  and	  the	  other	  asking	  responders	  to	  select	  the	  five	  most	  
important	  outcomes	  in	  their	  opinion	  [8].	  
	  
Clinical	  questionnaire	  	  
A	  total	  of	  64	  responders,	   including	  ESPGHAN	  members,	  ESPID	  members,	   researchers,	   regulatory	  
body	  members	  and	  industry	  representatives,	  completed	  the	  2	  phases	  
In	   the	   outpatient	   setting,	   the	   need	   for	   hospitalization,	   diarrhea	   duration	   and	   dehydration	  were	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clearly	  considered	  to	  be	  the	  most	   important	  outcomes	  of	  treatment.	   In	  the	   inpatient	  setting,	  on	  
the	   other	   hand,	   hospital	   stay,	   diarrhea	   duration,	   dehydration	   and	   the	   use	   of	   intravenous	  
rehydration	  therapy	  were	  seen	  as	  the	  most	  relevant	  outcomes	  to	  be	  included	  considered.	  	  
	  
Parents’	  questionnaire	  	  
Thirty-­‐two	  parents	  from	  Italy,	  Belgium,	  Israel	  and	  Poland	  took	  part	  to	  the	  phase	  2.	  
It	  was	  found	  that	  the	  most	  comforting	  aspects	  of	  treatment	  included	  the	  child	  behaving	  normally,	  
seeming	  healthy	  and	  being	  willing	  to	  eat	  and	  drink,	  improvement	  of	  diarrhea	  and	  the	  medical	  visit,	  
consultation	  and	  reassurance.	  The	  most	  worrisome	  aspects	  of	  treatment	  included	  bloody	  diarrhea,	  
fever	  and	  the	  child’s	  worsening	  condition.	  	  
	  
Conclusions	  and	  further	  research	  steps	  
So	  far,	  the	  Working	  Group	  on	  acute	  diarrhea	  has	  completed	  three	  out	  of	  four	  steps	  of	  the	  project.	  	  
Once	  again	  a	  huge	  heterogeneity	  in	  reporting	  clinical	  outcomes	  was	  emerged	  in	  this	  filed	  as	  well	  
as	  for	  respiratory	  infections.	  To	  date	  the	  identification	  of	  outcomes	  related	  to	  acute	  diarrhea	  are	  
reported	  and	  the	  decision	  about	  the	  methodology	  for	  determining	  which	  outcomes	  to	  measure	  in	  
clinical	  trials	  has	  been	  taken.	  The	  latter	  steps	  have	  been	  reported	  in	  the	  paper	  by	  Karas	  et	  al	  [8].	  To	  
complete	   the	   project,	   the	   working	   group	   needs	   to	   determine	   the	   outcome	   core	   set.	   It	   would	  
additionally	  be	  very	  useful	  to	  ascertain	  the	  impact	  of	  this	  core	  outcome	  set	  creation	  and	  monitor	  





	   	  




1. Johnston	   BC,	   Shamseer	   L,	   da	   Costa	   BR	   et	   al.	  Measurement	   issues	   in	   trials	   of	   pediatric	   acute	  
diarrheal	  diseases:	  a	  systematic	  review.	  Pediatrics	  2010;126:e222–	  e231.	  	  
2. Koletzko	  B,	  Aggett	  PJ,	  Bindels	   JG	  et	  al.	  Growth,	  development	  and	  differentiation:	  a	   functional	  
food	  sci-­‐	  ence	  approach.	  Br	  J	  Nutr	  1998;80(suppl	  1):	  S5–S45.	  
3. Koletzko	  B,	  Decsi	  T,	  Molnar	  D	  et	  al.	  Early	  Nutrition	  Programming	  and	  Health	  Outcomes	  in	  Later	  
Life:	  Obesity	  and	  Beyond.	  Advances	  in	  Experimental	  Medi-­‐	  cine	  and	  Biology.	  Springer,	  2009,	  vol	  
646:1–	  196.	  	  
4. Braegger	  C,	  Chmielewska	  A,	  Decsi	  T	  et	  al;	  ESPGHAN	  Commit-­‐	  tee	  on	  Nutrition:	  Supplementation	  
of	   infant	   formula	  with	  probiotics	  and/or	  prebiotics:	  a	  systematic	   review	  and	  comment	  by	   the	  
ESPGHAN	  committee	  on	  nutrition.	  J	  Pediatr	  Gastroenterol	  Nutr	  2011;52:238–250	  
5. Koletzko	  B,	   Szajewska	  H,	  Ashwell	  M	  et	   al;	   Early	  Nutrition	  Academy	  and	  European	  Society	   for	  
Paediatric	   Gastroenterology,	   Hepatology	   and	   Nutrition	   Committee	   on	   Nutrition	   –	   Consensus	  
Group	   on	   Outcome	   Measures	   Made	   in	   Paediatric	   Enteral	   Nutrition	   Clinical	   Trials.	  
Documentation	   of	   functional	   and	   clinical	   effects	   of	   infant	   nutrition:	   setting	   the	   scene	   for	  
COMMENT.	  Ann	  Nutr	  Metab.	  2012;60(4):222-­‐32.	  
6. Sinha	   I,	   Jones	  L,	  Smyth	  RL,	  et	  al.	  A	  systematic	   review	  of	   studies	   that	  aim	  to	  determine	  which	  
outcomes	  to	  measure	  in	  clinical	  trials	  in	  children.	  PLoS	  Med	  2008;29:5–96.	  	  
7. Dalkey	   N.	   The	   Delphi	   method:	   an	   experimental	   study	   of	   group	   opinion.	   Santa	   Monica,	  
California:	  Rand,	  1969.	  	  
8. Karas	  J,	  Ashkenazi	  S,	  Guarino	  A,	  et	  al.	  A	  core	  outcome	  set	  for	  clinical	  trials	  in	  acute	  diarrhoea.	  
Arch	  Dis	  Child	  2014;0:1–5.	  
9. Guarino	  A,	  Bruzzese	  E,	  Lo	  Vecchio	  A,	  Dagan	  R,	  Tsolia	  M.	  Definitions	  and	  Outcomes	  of	  Nutritional	  
Interventions	  in	  Children	  with	  Respiratory	  Infections:	  The	  Approach	  of	  the	  COMMENT	  Initiative.	  
Ann	  NutrMetab.	  2013	  Nov	  28;63(3):248-­‐255.	  
	   	  
  73 
3.5 Publications	  
1. Guarino	  A,	  Bruzzese	  E,	  Lo	  Vecchio	  A,	  Dagan	  R,	  Tsolia	  M.	  
Definitions	  and	  Outcomes	  of	  Nutritional	  Interventions	  in	  Children	  with	  Respiratory	  Infections:	  
The	  Approach	  of	  the	  COMMENT	  Initiative.	  
Ann	  NutrMetab.	  2013	  Nov	  28;63(3):248-­‐255.	  
	  
2. Karas	  J,	  Ashkenazi	  S,	  Guarino	  A,	  Lo	  Vecchio	  A,	  Shamir	  R,	  Vandenplas	  Y,	  Szajewska	  H.	  on	  behalf	  
of	  the	  Consensus	  Group	  on	  Outcome	  Measures	  Made	  in	  Paediatric	  Enteral	  Nutrition	  Clinical	  
Trials	  (COMMENT).	  
A	  core	  outcome	  set	  for	  clinical	  trials	  in	  acute	  diarrhoea.	  
Arch	  Dis	  Child	  2014;100(4):359-­‐63.	  
	  
	   	  
  74 
 
  75 
 
  76 
 
  77 
 
  78 
 
  79 
 
  80 
 




  82 
 
  83 
 
  84 
 
  85 
 
  86 
 
  87 
 
  88 
CHAPTER	  4.	  
ADHERENCE	  TO	  EUROPEAN	  GUIDELINES	  FOR	  ACUTE	  GASTROENTERITIS	  
	  
	  
4.1	  Rationale	  and	  adherence	  to	  guidelines	  for	  acute	  gastroenteritis	  	  
	  
Acute	  gastroenteritis	  (AGE)	  still	   is	  a	  major	  cause	  of	  medical	  visit	  and	  hospitalization	  in	  developed	  
countries	  being	  responsible	  for	  about	  1.5	  million	  outpatient	  visits	  and	  220.000	  hospitalizations	  per	  
year	  in	  USA,	  before	  introduction	  of	  Rotavirus	  vaccination	  [1].	  In	  European	  children,	  the	  estimated	  
annual	   incidence	  of	  AGE	   ranges	   from	  4%	   in	   Sweden	   to	  17%	   in	  Germany	   [2].	   In	   Italy,	  where	   the	  
annual	   incidence	   of	   AGE	   ranges	   between	   4.5%	   and	   19,6%	   according	   to	   age	   [2,3],	   the	   rate	   of	  
hospital	  admission	  for	  AGE	  is	  about	  0.8%	  in	  pediatric	  population	  [3].	  	  
In	   addition	   to	   its	   high	   incidence,	   the	   burden	   of	   AGE	   seems	   to	   be	   related	   to	   inappropriate	  
management	   that	   results	   in	   an	   excess	   of	   hospitalizations,	   changes	   in	   diet	   and	   misuse	   of	   anti-­‐
diarrheal	  drugs.	  AGE	   is	  a	  self-­‐limiting,	  usually	  mild	  disease,	  whose	  management	   is	   in	  most	  cases	  
simple	  and	  based	  on	  consistent	  and	  straightforward	  recommendations.	  According	  to	  most	  recent	  
available	   guidelines	   [4–6]	   its	   management	   basically	   consists	   in	   the	   replacement	   of	   fluids	   lost	  
through	  diarrheic	   stools,	   vomiting	   and	   fever.	   Anti-­‐diarrheal	   drugs,	   changes	   in	   diet	   or	   laboratory	  
investigations	   are	   not	   routinely	   needed.	   In	   addition	   to	   treatment	   recommendations,	   selected	  
guidelines	   also	   report	   indications	   to	   hospital	   admission	   for	   AGE.	   However,	   those	  
recommendations	  are	  usually	  based	  on	  experts	  opinion.	  
A	  good	  compliance	  to	  guidelines	  recommendations	  for	  AGE	  may	  improve	  child	  clinical	  outcomes,	  
specifically	  duration	  of	  diarrhea	  and	  weight	  gain	  [7]	  and	  reduce	  its	  economic	  burden	  [8].	  
However,	   a	   low	   adherence	   to	   guidelines	   recommendations	   for	   AGE	   has	   been	   reported	   both	   in	  
developed	  [8,9]	  and	  developing	  countries	  [10].	  Adherence	  to	  standard	  of	  care	  for	  AGE	   in	  United	  
States	   is	   far	   from	   optimal,	   ranging	   from	   37%	   in	   outpatients	   setting	   [9]	   to	   69%	   in	   hospitalized	  
children	  [8].	  In	  Italy	  only	  3%	  of	  primary-­‐care	  pediatricians	  is	  fully	  compliant	  to	  the	  evidence-­‐based	  
recommendations,	  but	  compliance	  increases	  to	  65%	  after	  a	  start	  course	  on	  guidelines	  for	  AGE	  [7].	  
Up	   to	   30%	   of	   inappropriate	   hospital	   admissions	   has	   been	   reported	   for	   other	   common	   acute	  
illnesses	  in	  children	  (such	  as	  Influenza–like	  illness)	  [11],	  but,	  to	  date,	  no	  specific	  data	  are	  available	  
on	  AGE	  in	  childhood	  in	  Europe.	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It	  should	  be	  noted	  that	  the	  National	  Health	  Care	  System	  in	  Italy	  is	  based	  on	  Family	  Pediatricians,	  
who	  are	  in	  charge	  of	  the	  health	  of	  all	  children.	  There	  is	  no	  fee	  for	  a	  medical	  visit	  in	  primary	  care,	  
similarly	  there	  is	  no	  fee	  for	  hospital	  admission	  for	  children.	  	  
	  
The	   aim	  of	   this	   study	  was	   to	   estimate	   the	   rate	   of	   inappropriate	   hospital	   admissions	   for	   AGE	   in	  
children	  ≤5	  years	  and	  to	  assess	  physician’s	  compliance	  with	  guidelines	  recommendations	  for	  the	  
management	  of	  children	  admitted	  for	  AGE.	  
	  
4.2	  Methodology	  	  
	  
We	   carried	   out	   a	   prospective	   multicenter	   observational	   study	   in	   collaboration	   with	   the	  
Accreditation	   and	  Quality	   Improvement	  Working	  Group	   of	   the	   Italian	   Society	   of	   Pediatrics.	   This	  
national	  working	  group	   involves	  126	  hospitals	   admitting	   children	  and	   is	   aimed	  at	   improving	   the	  
quality	   of	   health	   care	   delivered	   to	   children	   by	   the	   implementation	   of	   evidence-­‐based	   and	  
standardized	  practice.	  
All	  centers	  involved	  in	  this	  Pediatric	  Network	  received	  an	  invitation	  to	  take	  part	  to	  this	  prospective	  
study	  and	  the	  instructions	  for	  patient	  enrolment;	  hospitals	  that	  agreed	  to	  participate	  were	  invited	  
to	  register	  at	  least	  5	  cases	  <5	  years	  from	  November	  1st	  2011	  to	  June	  30th	  2012.	  AGE	  was	  defined	  
according	  to	  EPSGHAN/ESPID	  guidelines	  as	  a	  decrease	  in	  the	  consistency	  of	  stools	  (loose	  or	  liquid)	  
and/or	  an	  increase	  in	  the	  frequency	  of	  evacuations	  (typically	  >3	  in	  24	  hours),	  with	  or	  without	  fever	  
or	  vomiting	  [5].	  
Data	  were	  recorded	  by	  one	  operator	  for	  each	  hospital	  at	  child	  discharge	  and	  loaded	  into	  electronic	  
Case	   Report	   Form	   (CRF)	   available	   on	   the	   pediatric	   network	   website	  
(http://networkpediatrico.sip.it/).	   The	   CRF	   included	   45	   multiple-­‐choice	   questions	   grouped	   in	   5	  
domains	   (personal	   and	   family	   data,	   clinical	   features,	   home	  management,	   reasons	   for	   admission	  
and	  hospital	  management)	  (Table	  4.1).	  In	  addition,	  the	  presence	  of	  underlying	  chronic	  conditions	  
and/or	   concomitant	   acute	   illnesses	   were	   recorded	   in	   the	   CRF	   in	   order	   to	   provide	   a	   correct	  
interpretation	  of	  outcomes	  according	  to	  patients	  risk	  factors.	  	  	  
	  
Table	  4.1.	  	  Data	  reported	  in	  the	  CRF	  according	  to	  each	  field	  	  
Fields	  and	  contents	  of	  the	  online	  questionnaire	  
Personal	  and	  family	  data	  
General	   characteristic	   had	   to	   be	   acquired	   by	   the	   pediatrician,	   comprehending	   both	   personal	   data	   of	   the	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patients	  (Gender,	  Birth	  Date)	  and	  family	  information	  (Father	  and	  Mother’s	  Job,	  Country	  of	  origin	  of	  parents)	  	  
Home	  management	  
Pediatricians	  were	  asked	  to	  give	   information	  on	  children’s	  history,	  especially	  about	  diet	  (free,	  breast	  milk,	  
milk-­‐formula,	  mixed	  feeding)	  and	  the	  presence	  of	  any	  chronic	  diseases	  or	  concomitant	  acute	  illnesses.	  They	  
were	  also	  asked	  if	  oral	  rehydration	  therapy	  on	  patients	  was	  already	  attempted	  by	  parents,	  and	  if	  any	  anti-­‐
diarrheal	  drugs	  or	  antibiotics	  was	  taken.	  	  	  
Reasons	  for	  admission	  
Every	   single	   registered	   case	   had	   to	   be	   justified	   by	   the	   pediatrician	   pointing	   out	   the	   main	   reasons	   for	  
admission.	   They	   could	   choose	  more	   than	   one	   between:	   severe	   clinical	   conditions	   (to	   be	   specified	   in	   the	  
following	   field),	   inability	   of	   the	  parents	   to	  manage	   the	   child	   according	   to	  physician’s	   opinion	   and	  explicit	  
request	  by	  family.	  
Clinical	  features	  
Children	   clinical	   condition	   at	   admission	   was	   reported.	   Pediatricians	   had	   to	   specify	   child	   weight	   and	   the	  
number	  of	  diarrheal	   (1-­‐3;3-­‐5;5-­‐7;>7)	  and	  vomiting	   (1-­‐3;	  3-­‐5;>5)	  episodes	  per	  day,	  characteristics	  of	   stools	  
(semi-­‐liquid,	   watery,	   soft,	   bloody),	   presence	   of	   abdominal	   pain.	   The	   grade	   of	   dehydration	   was	   assessed	  
based	   on	   physician’s	   opinion:	   state	   of	   consciousness	   (eg.	   normal,	   irritable,	   lethargic),	   thirst	   (normal,	  
increased),	   diuresis	   (normal,	   decreased),	   degree	  of	  dehydration	   in	   relation	  with	  body	  weight	   (<5%,	  5-­‐9%,	  
>10%),	  capillary	  refill	  time	  (<2	  seconds,	  2-­‐3	  seconds,	  >3	  seconds),	  respiratory	  rate	  according	  to	  age	  (normal,	  
increased)	  and	  skin	  turgor	  (immediate	  retraction,	  1-­‐2	  seconds,	  >2	  seconds).	  
Hospital	  management	  
Pediatricians	   were	   asked	   to	   report	   whether	   children	   underwent	   lab	   (CBC,	   CRP,	   electrolytes,	   acid-­‐basic	  
equilibrium)	  and/or	  microbiological	  investigations	  (stool	  cultures	  and	  fecal	  antigens	  research);	  if	  performed	  
physicians	  should	  report	  the	  value	  for	  some	  of	  them	  (Hb,	  WBC,	  CRP,	  Na+	  and	  HCO3-­‐).	  Type	  of	  rehydration	  
and	   pharmacological	   treatment	  were	   also	   recorded.	   In	   particular,	   the	   rehydration	   regime	   (exclusive	   oral	  
rehydration,	   IV	   rehydration	   <24h	   or	   >24h),	   drug	   prescriptions	   (antibiotics,	   acetorphan/racecadotril,	  
smectite,	   probiotics,	   antiemetics)	  were	   recorded.	  Withdrawal	   of	   food	   and	   any	   changes	   in	   diet	   or	   breast-­‐
feeding	  were	  also	  to	  be	  indicated.	  Finally,	  weight	  at	  discharge	  was	  reported	  in	  order	  to	  calculate	  variations	  
and	  better	  assess	  the	  effect	  of	  rehydration	  therapy	  and	  gain	  of	  weight.	  
	  
Outcomes	  
Primary	  outcomes	  were:	  
1.	   Appropriateness	  of	  hospital	  admission,	  based	  on	  physicians’	  adherence	  to	  guidelines	  criteria	  
for	  hospitalization	  
2.	   Compliance	  to	  guidelines	  for	  clinical	  practice	  in	  hospitalized	  children,	  assessed	  on	  physicians’	  
ability	   of	   assessing	   dehydration,	   requiring	   appropriate	   diagnostic	   tests	   and	   prescribing	  
recommended	  treatments.	  
In	  addition,	  the	  number	  and	  type	  of	  most	  common	  violations	  to	  guidelines	  recommendations	  were	  
considered	  as	  secondary	  outcomes.	  Outcomes	  were	  also	  analyzed	  according	  to	  geographical	  area,	  
hospital	  setting	  and	  baseline	  characteristic	  or	  treatment,	  and	  risk	  for	  prolonged	  hospitalization.	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Assessment	  of	  adherence	  to	  guidelines	  recommendations	  
The	  ESPGHAN/ESPID	  guidelines	  [5]	  were	  taken	  as	  the	  standard	  to	  assess	  physicians’	  compliance	  to	  
evidence-­‐based	  recommendations.	  However,	  we	  previously	   reported	   that	   the	   level	  of	  guidelines	  
for	  AGE	  is	  consistently	  high	  and	  the	  specific	  recommendations	  are	  substantially	  similar	  [12].	  
Adherence	  to	  guidelines	  was	  assessed	  with	  reference	  to	  the	  criteria	  used	  by	  physicians	  to	  admit	  a	  
child	  with	  AGE	  (indications	  to	  hospital	  admission),	  and	  prescription	  and	  procedures	  applied	  during	  
child	  hospital	  stay	  (clinical	  practice	  compliance).	  	  
	  
Indications	  to	  hospital	  admission	  
The	   following	   conditions	   are	   reported	   by	   ESPGHAN/ESPID	   guidelines	   as	   recommendations	   for	  
hospital	  admission	  [5]:	  
-­‐	  Shock	  
-­‐	  Severe	  dehydration	  (>9%	  of	  body	  weight)	  
-­‐	  Neurological	  abnormalities	  
-­‐	  Intractable	  or	  bilious	  vomiting	  
-­‐	  ORS	  treatment	  failure	  
-­‐	  Suspected	  surgical	  condition	  
-­‐	  Caregivers	  cannot	  provide	  adequate	  care	  at	  home	  and/or	  there	  are	  social	  or	  logistical	  concerns	  
The	  presence	  of	  at	   least	  one	  of	   these	  conditions	  was	  considered	  as	  an	  appropriate	   indication	  to	  
admit	  a	  child	  with	  AGE.	  Severe	  clinical	  conditions,	  such	  as	  shock,	  suspected	  surgical	  conditions	  and	  
bilious	   vomiting	   were	   always	   considered	   appropriate.	   The	   other	   conditions	   needed	   to	   be	  
specifically	  reported	  and	  described	  by	  the	  physician	  in	  the	  CRF	  to	  be	  assessed	  for	  appropriateness.	  	  
The	  severity	  of	  dehydration	  was	  evaluated	  according	  to	  objective	  clinical	  signs	  (capillary	  refill	  time,	  
skin	  turgor	  etc)	  and	  change	  in	  child	  weight.	  Therefore,	  estimates	  reported	  by	  physicians	  and	  based	  
on	  child	  appearance	  (mildly,	  moderately,	  severely	  dehydrated)	  were	  considered	  unreliable.	  More	  
specifically,	  if	  objective	  clinical	  parameters	  of	  dehydration	  did	  not	  reflect	  the	  grade	  of	  dehydration	  
reported	  by	   the	  physician	   at	   admission,	   the	  hospitalization	  was	  defined	   as	   “not	   appropriate”	   in	  
absence	  of	  further	  indications.	  Persistent	  vomiting	  that	  leads	  to	  oral	  rehydration	  failure	  defines	  an	  
intractable	   vomiting	   episode.	   Neurological	   abnormalities,	   unconsciousness,	   lethargy	   and/or	  
seizures	   are	   reported	   by	   guidelines	   as	   specific	   indications	   for	   admission,	   but	   isolated	   crying	   or	  
irritability	  not	  related	  to	  clinical	  signs	  of	  dehydration	  were	  not	  considered	  as	  adequate	  criteria	  of	  
admission.	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Logistical	   concern	   and	   inadequacy	   of	   family	   to	   manage	   the	   child	   at	   home	   were	   considered	  
appropriate	  criteria	  only	  if	  described	  in	  details	  by	  physician	  (eg.	  distance	  from	  the	  hospital,	  family	  
not	  appropriate	  to	  manage	  the	  child	  at	  home).	  
In	   addition	   to	   these	   criteria,	   the	   explicit	   request	   of	   hospitalization	   by	   the	   family	   was	   also	  
considered	  as	  a	  good	  reason	   for	  hospitalization,	   if	   supported	  by	  physician	  concern	  and	   if	  details	  
were	  provided.	  
	  
Compliance	  with	  clinical	  practice	  guidelines	  	  
Once	   the	   child	   was	   admitted	   to	   the	   hospital,	   clinical	   practice	   compliance	   to	   evidence-­‐based	  
recommendations	  was	  evaluated	  based	  on	  physicians’	  ability	   to	  assess	  dehydration,	   the	  need	  of	  
laboratory	  investigations	  and	  the	  appropriateness	  of	  rehydration	  regime,	  nutritional	  interventions	  
and	  drug	  prescriptions.	  	  
In	  details,	  the	  following	  domains	  were	  considered	  for	  compliance:	  
1.	   Evaluation	  of	  the	  main	  signs/symptoms	  to	  assess	  dehydration	  (Does	  the	  physician	  report	  the	  
capillary	  refill	  time,	  skin	  turgor,	  respiratory	  pattern…?)	  
2.	   Concordance	   between	   the	   objective	   assessment	   of	   dehydration	   and	   physician	   estimate	   (Is	  
physician	  able	  to	  adequately	  assess	  the	  reported	  signs?)	  
3.	   Nutritional	  interventions	  (eg.	  withdrawal,	  changes	  in	  diet	  or	  feeding)	  
4.	   Prescription	  of	  blood	  tests	  (other	  than	  electrolytes)	  
5.	   Rehydration	  route	  (oral,	  nasogastric	  or	  intravenous)	  
6.	   Prescription	  of	  stool	  culture	  or	  faecal	  microbiology	  
7.	   Prescription	  of	  probiotics	  (indications	  and	  strains)	  
8.	   Prescription	  of	  antiemetics	  (indications	  and	  drugs)	  
9.	   Prescription	  of	  antibiotics	  (indications	  and	  drugs)	  
10.	   Prescription	  of	  anti-­‐diarrheal	  drugs	  
	  
The	  overall	   compliance	  was	   calculated	  based	  on	   the	  presence	  of	  minor	   and	  major	   violations	   to	  
each	  of	  the	  domains	  reported	  above.	  
A	  major	  violation	  was	  defined	  as:	  
-­‐	   a	  medical	  behavior	   inconsistent	  with	  guidelines	   recommendations	   that	  might	  negatively	  affect	  
the	   course	   of	   the	   disease	   and/or	  might	   be	   associated	   with	   unnecessary	   costs	   or	   inappropriate	  
interventions	  or	  any	  violation	  to	  “high	  grade”	  recommendations	  in	  referral	  guidelines	  (strength	  of	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evidence	  I	  and	  II	  according	  to	  Muir-­‐Gray).	  An	  example	  of	  major	  violation	  was	  the	  prescription	  of	  
not	  recommended	  drug	  or	  prescription	  of	  hydrolyzed	  formula.	  
A	  minor	  violations	  was	  defined	  as:	  
-­‐	   a	   violations	   that	   did	   not	   substantially	   change	   the	   outcome	   but	   was	   generally	   considered	  
inappropriate	  or	  any	  violation	  to	  “low	  grade”	  recommendations	  in	  referral	  guidelines	  (strength	  of	  
evidence	  III,	  IV	  and	  V	  according	  to	  Muir-­‐Gray).	  An	  example	  of	  minor	  violation	  was	  the	  prescription	  
of	  a	  probiotic	  strains	  whose	  evidence	  are	  not	  conclusive	  (eg.	  Lactobacillus	  reuteri)	  or	  introduction	  
of	  an	  elimination	  diets	  (eg.	  BRAT)	  
	  
In	  our	  model,	  any	  major	  violation	  reduces	  the	  overall	  compliance	  of	  10%	  and	  any	  minor	  violation	  
of	   the	  5%;	   the	   final	   score	   in	  percentage	  was	  calculated	  by	   the	   sum	  of	   results	   reported	   for	  each	  
domain	  (with	  an	  ideal	  maximum	  of	  100%).	  
We	  considered	  full	  compliance	  for	  scores	  >90%	  and	  partial	  compliance	  for	  scores	  	  >80%.	  
A	  more	  detailed	  definition	  of	  major	  and	  minor	  violations	  is	  reported	  in	  the	  Table	  4.2.	  Some	  cases	  
with	  peculiar	  clinical	  conditions	  were	  jointly	  assessed	  by	  all	  authors.	  	  
	  
Table	  4.	  2.	  Definition	  of	  major	  and	  minor	  violations	  according	  to	  each	  domain	  
DOMAIN	   MAJOR	  VIOLATION	   MINOR	  VIOLATION	  
Assessment	  of	  dehydration	   Physician	  does	  not	  report	  any	  of	  
the	  signs/symptoms	  of	  
dehydration:	  capillary	  refill	  time,	  
skin	  turgor,	  thirst,	  respiratory	  
pattern,	  urinary	  output,	  child	  
general	  appearance	  
Physician	  reports	  less	  than	  50%	  
of	  reliable	  signs/symptoms	  of	  
dehydration	  
(capillary	  refill	  should	  be	  
reported)	  
	  





Physician’s	  estimate	  of	  
dehydration	  at	  child	  admission	  
does	  not	  reflect	  the	  grade	  of	  
dehydration	  based	  on	  more	  
reliable	  signs/symptoms	  
Nutritional	  interventions	   -­‐ Withdrawal	  >	  6	  hours	  -­‐ Stop	  breast	  feeding	  -­‐ Lactose-­‐free	  formula	  -­‐ Cow-­‐milk	  protein	  free	  formula	  -­‐ Sport	  drinks	  
Any	  elimination	  diet	  (eg.	  BRAT	  
diet)	  
	  
Blood	  tests	   Do	  not	  require	  electrolytes	  
evaluation	  in	  children	  undergoing	  
blood	  tests	  
Prescription	  of	  blood	  tests	  other	  
than	  electrolytes	  and	  CBC,	  CRP	  
in	  otherwise	  healthy	  children	  
Adequacy	   of	   rehydration	  
regime	  








Stool	  culture	  in	  otherwise	  
healthy	  children	  without	  risk	  
factors	  or	  overt	  bloody	  diarrhea	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Probiotics	   Probiotics	  prescribed	  but	  strain	  
or	  product	  not	  reported	  
	  
-­‐Any	  probiotic	  strains	  different	  
from	  those	  recommended	  by	  
guidelines	  (LGG	  and	  S.boulardii)	  
or	  
-­‐Probiotics	  for	  which	  evidence	  
of	  efficacy	  are	  not	  conclusive	  
Antiemetics	   Antiemetic	  drugs	  specifically	  
contraindicated	  or	  not	  
considered	  as	  appropriate	  
treatment	  in	  guidelines	  (eg.	  
Metoclopramide,	  Domperidone)	  
Antiemetic	  drugs	  prescribed	  in	  
absence	  of	  intractable	  or	  
persistent	  vomiting	  or	  when	  
oral	  rehydration	  failure	  was	  not	  
reported	  
Antibiotics	   Any	  antibiotic	  prescribed	  without	  
a	  positive	  culture	  or	  a	  declared	  
risk	  factor	  
Treatment	  of	  non-­‐typhi	  
Salmonella	  in	  healthy	  children	  
Treatment	  of	  Campylobacter	  >	  
48-­‐72	  hours	  after	  the	  onset	  of	  
disease	  
Anti-­‐diarrheal	  drugs	   All	  drugs	  other	  than	  those	  
considered	  as	  appropriate	  







The	   SPSS	   software	   (version	   20.0;	   SPSS	   Inc.,	   Chicago,	   IL,	   USA)	   and	   R	   (version	   2.5.0;	   The	   R	  
Foundation	   for	   Statistical	   Computing)	   were	   used	   for	   statistical	   analysis.	   Analyses	   included	   only	  
available	  data	  and	  missing	  values	  were	  not	  imputed.	  Data	  were	  summarized	  as	  means	  ±	  standard	  
deviation	   (95%	  CI	   on	   the	  mean)	   for	   continuous	   variables	   and	   as	   frequencies	   (%)	   for	   categorical	  
variables.	  Concordance	  between	  subjective	  (as	  reported	  by	  physicians	  based	  on	  child	  appearance)	  
and	  objective	  (as	  evaluated	  by	  clinical	  signs,	  i.e.	  capillary	  refill	  time,	  skin	  turgor	  etc)	  assessment	  of	  
the	  severity	  of	  dehydration	  was	  based	  on	  the	  unweighted	  and	  quadratic	  weighted	  Cohen’s	  kappa	  
statistics.	  
Univariate	   and	  multivariate	   logistic	   regression	   analysis	  was	   applied	   to	   identify	   the	  main	   factors	  
associated	  with	  the	  following	  outcomes	  of	  interest:	  	  inappropriateness	  of	  hospital	  admission,	  non-­‐
compliance	   with	   management	   guidelines,	   inappropriate	   medical	   interventions	   (prescription	   of	  
antibiotics,	  chance	  in	  diet,	  microbiological	  investigation	  request)	  and	  prolonged	  hospital	  stay.	  	  
For	  each	  outcome	  a	  different	  set	  of	  potential	  predictors	  was	  chosen	  based	  on	  previous	  literature	  
and	   on	   their	   known	   relationship	   with	   the	   outcome.	   Then,	   those	   factors	   showing	   a	   bivariate	  
association	  with	   the	  dependent	  variable	  at	  a	  p<0.2	  were	   fitted	   in	  block	   in	  a	  multivariate	   logistic	  
regression	   model.	   All	   models	   were	   age	   adjusted	   regardless	   of	   the	   p	   value.	   Associations	   were	  
expressed	  as	  unadjusted	  and	  adjusted	  Odds	  Ratio	  with	  95%	  Confidence	  Intervals	  (CI).	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All	  significance	  tests	  were	  two-­‐sided	  with	  the	  significance	  level	  set	  at	  0.05.	  
	  
4.3.	  Results	  of	  the	  national	  multicenter	  observational	  study	  
	  
Six	  hundred	  and	   twelve	  children	   (328	  male,	  mean	  age	  22.8±15.4	  months)	  hospitalized	   for	  acute	  
gastroenteritis	   were	   enrolled	   in	   31	   hospitals.	   The	   general	   characteristics	   of	   children	   and	   their	  
home	  management	  prior	  to	  reach	  the	  ED	  are	  reported	  in	  Table	  4.3.	  
Enrolling	   hospitals	   were	   divided	   in	   small	   (15	   hospitals)	   and	   large	   (16	   hospitals)	   health-­‐care	  
structures	   according	   to	   the	   number	   of	   available	   beds	   for	   children	   (less	   or	   more	   than	   15)	   and	  
number	  of	  hospitalizations	  per	  year	  (less	  or	  more	  than	  1000/year).	  Most	  patients	  were	  enrolled	  in	  
non-­‐teaching	  (433/612)	  and	  large	  hospitals	  (377/612)	  (Table	  4.3).	  	  
Five	   hundred	   eighteen	   children	   (85%)	   were	   hospitalized	   after	   a	   spontaneous	   access	   to	   the	  
emergency	  department,	  and	  only	  a	  minority	  of	  them	  was	  referred	  to	  emergency	  by	  primary	  care	  
pediatricians	   (7%),	   other	   hospitals	   (6%)	   or	   domiciliary	   emergency	   medical	   service	   (2%)	   before	  
arriving	  at	  hospital.	  	  
	  
	  
Table	  4.3.	  General	  characteristics	  of	  612	  children	  hospitalized	  for	  acute	  gastroenteritis	  
	  
General	  characteristics	  and	  home	  management	  
M/F	   328/284	  
Mean	  age(months)	  ±SD	  (95%CI)	   22.8±15.4	  (21.5-­‐24.0)	  
Oral	  rehydration	  (n/612	  and	  %)	  
-­‐ Yes	  
-­‐ No	  





Diet	  (n/612and	  %)	  
-­‐ Breast	  fed	  children	  
-­‐ Formula	  fed	  children	  
-­‐ Mixed	  breast	  feeding	  children	  






Antidiarrheal	  drugs	  prescription	  (n/612	  and	  %)	  
-­‐ Yes	  
-­‐ No	  





First	  medical	  assessment	  (n/612	  and	  %)	  
-­‐ Emergency	  department	  
-­‐ Primary	  care	  paediatrician	  
-­‐ Other	  hospital	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Hospital	  characteristics	  
Mean	  length	  of	  stay	  (days)	  ±	  SD	  (95%	  CI)	   4.3±2.0	  (4.2-­‐4.5)	  
Regime	  of	  hospitalization	  (n/612	  and	  %	  of	  children)	  
-­‐ Hospitalization	  	  




Type	  of	  hospital(n/612	  and	  %	  of	  children)	  
-­‐ Non-­‐Teaching	  hospital	  	  




Dimension	  of	  hospital	  (n/612	  and	  %	  of	  children)	  
-­‐ Large	  (n=16)	  






Clinical	  conditions	  and	  assessment	  of	  dehydration	  
Eighty-­‐eight	  per	  cent	  of	  children	  presented	  with	  watery	  (311,	  52%)	  or	  semi-­‐liquid	  (212,	  36%)	  stool	  
pattern	   and	   7%	   reported	   bloody	   diarrhea.	   Vomiting	   was	   reported	   in	   79%	   of	   patients.	   About	   a	  
quarter	  of	  children	  (23%)	  had	  another	  illness	  together	  with	  AGE:	  93/612	  (15%)	  were	  admitted	  with	  
a	  concomitant	  acute	  illness	  (in	  most	  cases	  an	  upper	  respiratory	  infection)	  and	  other	  49/612	  (8%)	  
children	  had	  an	  underlying	  chronic	  condition	  (Table	  4.4).	  	  
	  
Table	  4.4.	  Clinical	  conditions	  at	  admission	  to	  the	  hospital	  	  
Clinical	  features	  










Stool	  pattern	  (n/593	  and	  %)	  
-­‐ Watery	  








Bloody	  diarrhoea	  (n/593	  and	  %)	   41	  (7%)	  
Episodes	  of	  vomiting	  (n/612	  and	  %)	  
-­‐ No	  vomiting	  








Abdominal	  pain	  (n/612	  and	  %)	   247	  (40%)	  
Underlying	  chronic	  conditions	  (n/612	  and	  %)	   49	  (8%)	  
Concomitant	  acute	  illnesses	  (n/612	  and	  %)	   93	  	  (15%)	  
Dehydration	  parameters	  
Capillary	  refill	  time.	  n/612	  (%)	  
-­‐ <2sec	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-­‐ Not	  reported	   65	  (11%)	  
Consciousness.	  n/612	  (%)	  
-­‐ Normal	  
-­‐ Restless,	  irritable	  
-­‐ Lethargic-­‐unconscious	  






Skin	  turgor	  n/612	  (%)	  
-­‐ Immediate	  skin	  retraction	  
-­‐ Slow	  retraction	  (1-­‐2sec)	  
-­‐ Very	  slow	  retraction	  (>2sec)	  






Thirst	  n/612	  (%)	  
-­‐ Normal	  
-­‐ Increased	  















Respiratory	  rate	  according	  to	  age	  (n/N	  and	  %)	  
-­‐ Normal	  
-­‐ Increased	  






Four	  hundred	  sixteen	  patients	  at	  admission	  (68%)	  were	  labeled	  by	  physician	  as	  mildly	  dehydrated,	  
165	  (27%)	  showed	  a	  moderate	  dehydration	  and	  only	  10	  (1.6%)	  as	  having	  a	  severe	  dehydration	  or	  
shock	  (Table	  3).	  However,	  the	  objective	  grade	  of	  dehydration	  evaluated	  according	  to	  the	  six	  most	  
reliable	   clinical	   signs	   (Table	   4.4),	   was	   significantly	   different	   from	   the	   degree	   of	   dehydration	  
estimated	   by	   physicians,	   being	   75%,	   15%	   and	   1%	   of	   children	   mild,	   moderate	   or	   severely	  
dehydrated,	   respectively	   (Table	   4.5).	   The	   overall	   concordance	   between	   dehydration	   grade	  
estimated	   by	   physicians	   and	   the	   objective	   assessment	   was	   fair	   and	   the	   chance	   corrected	  
agreement,	  measured	  by	  both	  un-­‐weighted	  and	  weighted	  kappa,	  was:	  0.30	  95%CI	  (0.39-­‐0.48)	  and	  
0.37	  95%	  CI	  (0.46-­‐0.56),	  respectively	  (Table	  4.5).	  	  
The	  majority	  of	  children	  (453/612,	  74%)	  underwent	  IV	  rehydration.	  Of	  those	  180	  (40%)	  received	  IV	  
fluids	  for	  less	  than	  24	  hours	  and	  273	  (60%)	  for	  a	  longer	  period.	  Surprisingly	  a	  quarter	  of	  admitted	  
children	   (159/612,	   25%)	   received	   only	   oral	   rehydrated	   during	   their	   stay.	   No	   child	   received	  
rehydration	  through	  nasogastric	  tube.	  	  
The	  mean	  weight	  gain	  during	  hospitalization	  was	  only	  of	  60.4	  grams	   (95%CI	  22.4-­‐98.5).	  Only	  31	  
(7%)	  children	  gained	  more	  than	  5%	  of	  their	  body	  weight	  compared	  to	  that	  recorded	  at	  admission.	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Table	  4.5.	  Assessment	  of	  dehydration	  of	  612	  children	  admitted	  for	  AGE	  
Grade	  of	  dehydration	  
As	  estimated	  by	  
physician	  
According	  to	  clinical	  
dehydration	  signs	   Concordance	  
n	  (%)	   n	  (%)	  






Moderate	  (5-­‐9%)	   165	  (27%)	   93	  (15%)	   	  78	  
	  
0.37	  
Severe	  (≥	  10%)	   10(1.6%)	   5	  (1%)	   (0.46-­‐0.56)	  
Not	  reported/assessable	   21	  (3.4%)	   57	  (9%)	   	  
Change	  in	  weight	  during	  hospitalization	   Mean+SD	  (95%	  CI)	   p*	  
Weight	  at	  admission	  (g)	   11.077+3.815	  	  	  	  	  	  	  	  	  	  (10.723	  -­‐	  11.431)	  
0.002	  
Weight	  at	  discharge	  (g)	   11.138+3.800	  	  	  	  	  	  	  	  	  	  (10.785	  –	  11490)	  
Mean	  weight	  gain(g)	   60.4+411	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (22.4	  –	  98.5)	   -­‐	  
Children	  who	  acquired	  >	  5%	  of	  weight	  	  (n/%)	   31/449	  (7%)	   -­‐	  
Concordance	  was	  calculated	  with	  weighted	  and	  unweighted	  Cohen’s	  K	  statistic.	  	  
*Significance	  test	  is	  referred	  to	  comparison	  between	  the	  weight	  at	  admission	  and	  discharge	  
	  
Appropriateness	  of	  hospital	  admission	  
The	  main	   reasons	   for	   hospital	   admission	  were:	   severe	   clinical	   conditions	   in	   438	   (73%)	   children,	  
explicit	   family	   request	   of	   hospitalization	   in	   98	   (16%),	   and	   logistical	   concerns	   or	   poor	   caregivers	  
reliability	   in	   66	   (11%)	   children.	   Reason	   for	   hospital	   admission	   was	   not	   reported	   for	   10/612	  
patients.	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Figure	  4.1.	  Appropriate	  and	  inappropriate	  hospital	  admissions	  among	  612	  children	  with	  AGE.	  
	  
Only	  188	  out	  of	  the	  438	  children	  who	  were	  admitted	  for	  severe	  clinical	  conditions,	  as	  reported	  by	  
physicians,	  actually	  had	  an	  indication	  to	  hospital	  admission	  based	  on	  the	  criteria	  in	  guidelines.	  We	  
considered	  as	  appropriate,	  those	  cases	  (66/602)	  in	  which	  physicians	  declared	  to	  admit	  a	  child	  even	  
if	  his/her	  clinical	  conditions	  did	  not	   require	  hospitalization,	  but	   the	  caregivers	  could	  not	  provide	  
adequate	  care	  at	  home	  or	  there	  were	  social	  or	  logistical	  concerns	  that	  might	  pose	  a	  risk	  for	  child	  
health	  conditions	  (eg.	  long	  distance	  from	  the	  hospital	  together	  with	  mild	  clinical	  feature).	  	  	  
Appropriateness	   of	   hospital	   admission	   was	   fond	   to	   be	   limited	   to	   setting	   and	   healthcare	  
organization	  factors	  (Table	  4.6).	  Appropriateness	  was	  greater	  in	  small	  (OR=1.40;	  95%CI	  1.01-­‐1.95)	  
and	  teaching	  hospital	  (OR=0.68;	  95%CI	  0.47-­‐1.00).	  Children	  arriving	  at	  the	  hospital	  between	  8.00	  
and	   20.00	   and/or	   during	   the	   working	   days	   run	   a	   higher	   risk	   of	   inappropriate	   admission	   when	  
compared	  to	  those	  accessing	  in	  the	  weekend	  (OR=0.6;	  95%CI	  0.4-­‐0.8)	  or	  at	  night	  (OR=0.4;	  95%CI	  
0.3-­‐0.7).	   Those	   specific	   risk	   factors	  were	   confirmed	   both	   in	   univariate	   and	  multivariate	   analysis	  
(Table	  4.	  6).	  
	  
Compliance	  with	  management	  recommendations	  during	  hospital	  stay.	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Once	   admitted	   to	   the	  hospital,	   2/3	  of	   patients	  were	  managed	   in	   accordance	   to	   evidence-­‐based	  
recommendations,	  with	  a	  mean	  compliance	  of	  	  87,63%	  of	  medical	  interventions.	  More	  specifically,	  
21%	  (126/612)	  and	  45%	  (274/612)	  of	  children	  were	  managed	   in	  full	  and	  partial	  compliance	  with	  
guidelines	  recommendations,	  respectively	  (Figure	  2).	  	  
	  
Table	  6.	  Determinants	  of	  inappropriate	  hospital	  admissions	  and	  compliance	  to	  guidelines	  	  
	  
Univariate	  Analysis	   Multivariate	  Analysis	  
	  
OR	  (95%CI)	   p	   OR	  (95%CI)	   p	  
INAPPROPRIATENESS	  	  OF	  HOSPITAL	  ADMISSION	  
DETERMINANTS	  
Hospital	  dimension	  (Large	  vs	  Small)	  	   1.40	  (1.01-­‐1.95)	   0.042	   1.59	  (1.04-­‐2.44)	   0.033	  
Type	  of	  hospital	  (Teaching	  vs	  Non	  teaching)	  	   0.68	  (0.47-­‐1.00)	   0.052	   0.60	  (0.36-­‐1.01)	   0.057	  
Time	  of	  admission	  (20-­‐8	  vs	  8-­‐20)	  	   0.46	  (0.29-­‐0.73)	   0.001	   0.57	  (0.34-­‐0.93)	   0.027	  
Admission	  day	  (Saturday/Sunday	  vs	  Monday/Friday)	   0.6	  (0.41-­‐0.87)	   0.007	   0.55	  (0.36-­‐0.85)	   0.008	  
Child	  age	   1.00	  (0.99-­‐1.01)	   0.288	   1	  (0.99-­‐1.01)	   0.985	  
First	  medical	  assessment	  
	  
0.555	  
	   	  
-­‐ Primary	  care	  paediatrician	   1	  
	  
§	   §	  
-­‐ Other	  hospital	  	   1.85	  (0.74-­‐4.58)	   0.182	   §	   §	  
-­‐ Emergency	  department	   1.47	  (0.79-­‐2.75)	   0.22	   §	   §	  
-­‐ Emergency	  medical	  service	  	   1.67	  (0.47-­‐5.95)	   0.424	   §	   §	  
NON-­‐COMPLIANCE	  WITH	  MANAGEMENT	  GUIDELINES	  DURING	  HOSPITAL	  STAY	  
CHILD	  RELATED	  FACTORS	  
Age	  	   1.00	  (0.99-­‐1.01)	   0.898	   0.99	  (0.98-­‐1.01)	   0.641	  
Underlying	  chronic	  conditions	  (Yes	  vs.	  No)	   0.83	  (0.44-­‐1.56)	   0.570	   §	   §	  
Concomitant	  acute	  illnesses	  (Yes	  vs.	  No)	   1.32	  (0.84-­‐2.08)	   0.228	   §	   §	  
HEALTH	  CARE	  RELATED	  FACTORS	  
Hospital	  dimension	  (Large	  vs	  Small)	  	   0.95	  (0.68-­‐1.35)	   0.811	   §	   §	  
Type	  of	  Hospital	  (Teaching	  vs	  Non	  teaching)	  	   0.69	  (0.47-­‐1.00)	   0.052	   0.59	  (0.39-­‐0.88)	   0.009	  









-­‐ Explicit	  family	  request	   0.47	  (0.28-­‐0.79)	   0.004	   0.20	  (0.11-­‐0.38)	   <0.001	  
-­‐ Logistical	  concerns	  or	  poor	  caregivers	  reliability	  	   0.31	  (0.15-­‐0.60)	   0.001	   0.25	  (0.11-­‐0.54)	   <0.001	  
Appropriateness	  of	  hospital	  admission	  (No	  vs.	  Yes)	   1.29	  (0.92-­‐1.81)	   0.142	   1.55	  (1.00-­‐2.39)	   0.047	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Figure	  4.2.	  Compliance	  to	  guidelines	  recommendations	  among	  children	  hospitalized	  for	  AGE	  
Note:	   Compliance	   was	   calculated	   according	   to	   the	   presence	   of	   major	   and/or	   minor	   violations	  
committed	  by	  physicians	  during	  the	  hospital	  stay	  
	  
Note:	   Compliance	   was	   calculated	   according	   to	   the	   presence	   of	   major	   and/or	   minor	   violations	  
committed	  by	  physicians	  during	  the	  hospital	  stay	  
	  
Most	  common	  violations	  to	  guidelines	  are	  reported	  on	  a	  Pareto	  Chart	  in	  Figure	  3.	  	  Inappropriate	  
microbiological	   investigations	   (404;	   35,8%)	   and	   nutritional	   interventions	   (310,	   27,6%)	   were	   the	  
two	   major	   violations.	   Anti-­‐diarrheal	   drugs	   not	   included	   in	   the	   guidelines	   was	   the	   third	   most	  
common	  violation	   (271,	  24%),	  with	  161	  prescriptions	  of	  not-­‐indicated	  probiotics	   (14,2%),	  103	  of	  
antibiotics	  (9,2%)	  and	  7	  of	  other	  anti-­‐diarrheal	  drugs	  (0,6%)	  (Figure	  4.3).	  
	  
Figure	  4.3.	  Major	  violations	  to	  guidelines	  in	  children	  hospitalized	  for	  AGE.	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Note:	  Pareto	  Chart	  reporting	  the	  number	  of	  violation	  on	  columns	  and	  the	  cumulative	  percentage	  
on	  the	  line	  
	  
Children	   hospitalized	   in	   teaching	   hospitals	   were	   more	   appropriately	   managed	   than	   those	   in	  
general	  hospitals	  (OR=0.59;	  95%CI	  0.39-­‐0.88).	  Children	  who	  were	  admitted	  because	  of	  poor	  family	  
reliability	  (OR=0.31;	  95%CI	  0.15-­‐0.60)	  or	  based	  on	  an	  explicit	  family	  request	  (OR=0.47;95%CI	  0.28	  –	  
0.79),	   had	   a	   significantly	   lower	   risk	   of	   being	   managed	   inappropriately	   (p=0.001	   and	   p=0.004,	  
respectively)	  (Table	  4).	  
Major	  determinants	  for	  the	  most	  common	  violations	  are	  reported	  in	  Table	  4.7.	  
The	   presence	   of	   more	   than	   5	   diarrheal	   stools	   was	   the	   only	   feature	   linked	   with	   the	   request	   of	  
microbiological	  investigations	  (OR=1.66,	  95%CI	  1.06-­‐2.61).	  Antibiotics	  were	  prescribed	  more	  likely	  
in	  children	  with	  bloody	  diarrhea	  (OR=3.34,	  95%CI	  1.51–7.39),	  in	  those	  who	  showed	  high	  value	  of	  
inflammatory	  markers	   (OR=5.9;	   95%CI	   3.19–10.9),	   or	   in	   those	   children	   with	   concomitant	   acute	  
illness	  (OR=3.05;95%CI	  1.59-­‐5.83).	  	  
The	  use	  of	  antiemetics	  was	  higher	  in	  children	  managed	  in	  a	  short	  observation	  regimen	  (7/57)	  than	  
in	  those	  admitted	  to	  routine	  hospitalization	  (11/555)	  (11%	  vs	  2%	  p=0.0006).	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Table	  4.7.	  	  Determinants	  of	  violations	  and	  inappropriate	  medical	  interventions	  
	  	   ANTIBIOTICS	   CHANGE	  IN	  DIET	   STOOL	  COLTURE	  
PROLONGED	  
HOSPITALIZATON	  
	  	   A.O.R.	  [95%	  C.I.]	   p	   A.O.R.	  [95%	  C.I.]	   p	   A.O.R.	  [95%	  C.I.]	   p	   A.O.R.	  [95%	  C.I.]	   p	  
Age	  (months)	   1.01	  [0.99	  -­‐	  1.03]	   0.274	   1.02	  [1.01	  -­‐	  1.04]	   0.002	   0.99	  [0.98	  -­‐	  1.01]	   0.286	   0.99	  [0.98-­‐1]	   0.186	  
N	  episodes	  of	  
diarrhoea/day	   §	  
	   	   	   	   	  
-­‐	   	  




-­‐	   	  
3-­‐5	  episodes	   §	   	   1.34	  [0.86	  -­‐	  2.08]	   0.191	   1.47	  [0.94	  -­‐	  2.28]	   0.088	   -­‐	   	  
>	  5	  episodes	   §	   	   1.48	  [0.96	  -­‐	  2.30]	   0.076	   1.66	  [1.06	  -­‐	  2.61]	   0.028	   -­‐	   	  
N	  episodes	  of	  
vomiting	  
§	  
	   	   	   	   	  
-­‐	   	  
No	  episodes	   §	   	   1	  
	  
-­‐	   	   -­‐	   	  
1-­‐3	  episodes	   §	   	   0.44	  [0.27	  -­‐	  0.74]	   0.002	   -­‐	   	   -­‐	   	  
3-­‐5	  episodes	   §	   	   0.83	  [0.47	  -­‐	  1.45]	   0.511	   -­‐	   	   -­‐	   	  
>	  5	  episodes	   §	   	   0.78	  [0.44	  -­‐	  1.40]	   0.413	   -­‐	   	   -­‐	   	  
Underlying	  chronic	  
conditions	   §	   	   §	   	   -­‐	   	   1.73	  [0.84	  –	  3.56]	   0.134	  
Concomitant	  acute	  
illness	  
3.05	  [1.59	  -­‐	  5.83]	   0.001	   -­‐	   	   0.77	  [0.47	  -­‐	  1.26]	   0.300	   1.80	  [1.03	  –	  3.15]	   0.038	  
Bloody	  diarrhoea	   3.34	  [1.51–7.39]	   0.003	   -­‐	   	   -­‐	  
	  
2.83	  [1.10	  –	  7.26]	   0.030	  
Inflammatory	  
markers	  (high	  vs.	  
normal)	  
5.90	  [3.19	  -­‐	  10.9]	   <0.001	   -­‐	   	   §	   	   -­‐	   	  
White	  Blood	  Count	  
(altered	  vs.	  
normal)	  
1.83	  [1.07–3.15]	   0.064	   -­‐	   	   0.81	  [0.53	  -­‐	  1.24]	   0.335	   -­‐	   	  
Antibiotics	   -­‐	   	   -­‐	   	   -­‐	   	   2.75	  [1.48	  –	  5.12]	   0.001	  
Probiotics	   -­‐	   	   -­‐	   	   -­‐	   	   1.66	  [1.1	  0–	  2.49]	   0.015	  
Antiemetics	   -­‐	   	   -­‐	   	   -­‐	   	   §	   	  
Acetorphan	   -­‐	   	   -­‐	   	   -­‐	   	   §	   	  
§	  Not	  entered	  in	  the	  multivariate	  model	  (univariate	  p>	  0.2)	  due	  to	  an	  univariate	  association	  	  
-­‐	  Not	  in	  the	  set	  of	  predictors	  
	  
Duration	  of	  hospitalization	  
The	  mean	   length	  of	   stay	  was	  4.3±2.0	  days,	  being	  most	  children	   (91%)	   regularly	  hospitalized	  and	  
only	  a	  minority	  (9%)	  managed	  in	  a	  brief	  observation	  regime	  (Table	  4.3).	  
A	   hospital	   stay	   >	   4	   days	  was	   considered	   as	   a	   prolonged	   hospitalization,	   and	   relative	  major	   risk	  
factors	  were	   identified	  (Table	  4.7).	  The	  presence	  of	  other	  acute	  clinical	  conditions	  together	  with	  
AGE	  (OR=1.8	  ;	  95%CI	  1.03–3.15,	  p=0.04)	  or	  episodes	  of	  bloody	  diarrhea	  (OR=2.83;	  95%CI	  1.1–7.26;	  
p=0,03)	  were	  identified	  as	  independent	  risk	  factor	  for	  prolonged	  hospital	  stay.	  Among	  treatments,	  
the	  use	  of	  antibiotics	   (OR=2.75;	  95%CI	  1.48	  –	  5.12)	  and	  probiotics	   (OR=1.66	   ;	  95%CI	  1.1	  –	  2.49)	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was	   significantly	   associated	   with	   prolonged	   hospitalization	   (p=0.001;	   p=0.015,	   respectively).	   In	  
contrast,	  the	  grade	  of	  dehydration	  and	  relative	  characteristics	  of	  rehydration	  were	  not	  related	  to	  a	  
prolonged	  stay.	  	  
	  
4.4	  Discussion	  	  
	  
This	  is	  the	  first	  European	  prospective	  study	  that	  specifically	  assesses	  physicians’	  compliance	  with	  
guidelines	   recommendations	   for	   hospital	   admissions	   and	  management	   of	   AGE	   in	   children.	   Our	  
results	   showed	   that	   more	   than	   50%	   of	   children	   with	   AGE	   were	   inappropriately	   admitted,	   and,	  
about	  one	  third,	  of	  those	  inappropriately	  admitted,	  received	  medical	  inappropriate	  interventions	  
during	   hospital	   stay	   in	   Italy.	   A	   similar	   rate	   of	   compliance	   in	   hospitalized	   children	  with	   AGE	   has	  
been	  recently	  shown	  in	  United	  States	  [8].	  
Physicians’	  adherence	  to	  standard	  of	  care	  and	  appropriateness	  of	  interventions	  is	  a	  major	  issue	  in	  
health	  [8–10].	  Overall,	  medical	  behaviors	  applied	  in	  discord	  with	  those	  recommended	  in	  evidence-­‐
based	  criteria	  are	  strongly	  related	  to	  higher	  costs	  and	  worst	  clinical	  outcomes	  [7,8],	  but	  the	  clinical	  
and	  economic	  burden,	  steadily	  rises	  when	  inappropriateness	  is	  related	  to	  common	  diseases	  such	  
as	  AGE.	  	  
In	   developed	   countries,	   the	   burden	   of	   AGE	   is	   still	   huge	   because	   of	   the	   high	   number	   of	  
hospitalizations,	   outpatients	   consultations	   and	  medical	   interventions.	   A	   widespread	   vaccination	  
campaign,	   as	   performed	   in	   the	   United	   States,	   led	   to	   a	   significant	   reduction	   of	   gastroenteritis-­‐
related	  costs	  and	  hospitalizations,	  by	  reducing	  Rotavirus	  infection	  episodes	  in	  young	  children	  [13].	  
However,	   the	   vaccination	   it	   is	   not	   routinely	   applied	   in	   all	   countries	   [14],	   and	   even	   if	   applied	  
routinely,	  it	  is	  expected	  to	  decrease	  the	  overall	  rate	  of	  AGE	  by	  25-­‐28%	  	  [15].	  
The	  assessment	  of	  dehydration	  in	  children	  with	  AGE	  is	  the	  key	  step	  for	  diagnosis	  and	  treatment,	  
and	   drives	  medical	   behaviors.	   According	   to	   guidelines	   the	   best	   estimate	   of	   AGE	   severity	   is	   the	  
degree	  of	  dehydration	   [5].	  The	  concordance	  between	  physicians’	  estimate	  of	  dehydration	  grade	  
and	  the	  objective	  assessment	  was	  fair,	  meaning	  that	  several	  physicians	  overestimated	  the	  grade	  of	  
dehydration.	  Severe	  dehydration	   is	   the	  major	   indication	   to	  hospital	  admission	   in	   those	  children,	  
and	   variation	   in	   weight	   (at	   least	   5%),	   if	   available,	   is	   usually	   reported	   as	   the	   most	   reliable	  
parameter	  to	  assess	  fluid	  losses	  [5].	  However,	  in	  our	  population,	  only	  a	  small	  minority	  of	  children	  
underwent	   a	   significant	   weight	   gain	   after	   discharge	   and	   the	   mean	   weight	   gain	   was	   about	   60	  
grams.	  Even	   if	  during	  hospitalization	  some	  children	  may	  experience	  a	  weight	   loss	  due	   to	   lack	  of	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appetite,	  blood	  samples	  and	  other	  physical	  and	  psychological	  factors,	  it’s	  highly	  probable	  that	  the	  
vast	  majority	  of	  those	  children	  was	  not	  significantly	  dehydrated	  at	  admission.	  These	  findings	  are	  
confirmed	   by	   the	   objective	   evaluation	   of	   dehydration	   based	   on	   established	   clinical	   markers:	  
considering	  that	  only	  16%	  of	  children	  was	  moderate-­‐to-­‐severe	  dehydrated,	  but	  74%	  underwent	  IV	  
rehydration	  (and	  273	  children	  for	  more	  than	  24	  hours).	  A	  similar	  discrepancy	  between	  guidelines	  
and	   practice	   was	   evident	   in	   a	   previous	   Canadian	   study	   that	   reported	   a	   moderate-­‐to-­‐severe	  
dehydration	  in	  only	  2%	  of	  children	  with	  gastroenteritis	  although	  30%	  of	  them	  received	  intravenous	  
rehydration	  	  [16].	  	  
Characteristics	   of	   health	   care	   institutions	   (teaching	   vs	   non-­‐teaching,	   dimension	   of	   institution,	  
location/setting),	  rather	  than	  specific	  factors	  related	  to	  the	  child,	  were	  the	  major	  risk	  factors	  for	  
inappropriate	  hospital	   admission.	  A	   similar	  high	  variability	   in	   the	  management	  of	  AGE	  has	  been	  
reported	  among	  different	  institutions,	  either	  in	  United	  States	  or	  Canada	  [17,18].	  These	  variations	  
in	  treatment	  are	  not	  accounted	  by	  significant	  differences	  in	  disease	  prevalence	  or	  etiology	  [8,19].	  
In	   addition,	   it	   has	   been	   demonstrated	   that	   an	   educational	   intervention	   focused	   on	   guidelines	  
criteria	   for	   hospital	   admission	   may	   significantly	   reduce	   the	   number	   of	   inappropriate	   hospital	  
admission	   for	   other	   common	   pediatric	   illnesses	   [11].	   This	   result	   highlights	   the	   importance	   of	  
medical	  education	  and	  up-­‐dating	  in	  determining	  medical	  clinical	  practice.	  
In	  our	  population,	  an	  additional	  determinant	  of	  inappropriateness	  was	  the	  hospital	  access	  during	  
the	  daytime	  in	  working	  days.	  This	  finding,	   is	  similar	  to	  that	  reported	  in	  some	  previous	  results	  on	  
admission	  of	  children	  with	  influenza-­‐like	  -­‐illness	  [20],	  and	  may	  be	  related	  either	  to	  the	  overload	  in	  
emergency	  department	  (ED)	  during	  the	  working	  days	  in	  winter	  season	  or	  also	  to	  the	  availability	  of	  
beds	  in	  the	  ward.	  The	  latter	  is	  probably	  the	  major	  determinant	  for	  hospital	  admission,	  as	  already	  
proposed	   in	  previous	  study	   in	  children	  with	  AGE	   [21].	  This	  pattern	  may	  be	  related	  to	  conditions	  
that	  are	  typical	  of	  winter	  season,	  when	  EDs	  are	  characterized	  by	  a	  overwhelming	  access	  rate	  and	  a	  
little	  time	  available	  for	  medical	  decisions,	  but	  also	  to	  a	  defensive	  medicine	  approach	  that	  has	  been	  
already	  reported	  for	  other	  common	  infections	  in	  childhood	  [22].	  	  
In	   Italy,	   any	   child	   up	   to	   16	   years	   is	   seen	   for	  well	   being	   visits,	   vaccinations	   and	  management	   of	  
acute	  and	  chronic	  mild	   illnesses	  by	  primary-­‐care	  pediatricians	  who	  are	  part	  of	   the	  public	  Health	  
Care	  System.	  Despite	  this	  healthcare	  organization,	  in	  our	  study,	  the	  vast	  majority	  of	  children	  with	  
AGE	  were	  admitted	  after	  a	  spontaneous	  access	  to	  the	  ED,	  thus	  skipping	  the	  filter	  of	  primary	  care	  
assistance.	  In	  addition,	  considering	  that	  the	  rate	  of	  inappropriate	  admission	  was	  similar	  in	  children	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seen	  or	  not	  seen	  by	  primary	  care	  pediatricians	  before	  reaching	  the	  hospital,	   it	   seems	  that	   there	  
was	  no	  “selection”	  of	  most	  severe	  cases	  before	  ED	  access.	  
Although	  the	  rate	  of	  inappropriate	  hospitalizations	  was	  high,	  once	  admitted,	  the	  mean	  compliance	  
with	   guidelines	   recommendations	   during	   their	   stay	   was	   fairly	   good	   (66%)	   and	   similar	   to	   that	  
reported	  in	  United	  States	  (69%)	  [8].	  Physicians’	  compliance	  was	  strongly	  related	  to	  the	  reason	  of	  
admission:	   it	   was	   better	   in	   those	   patients	  with	   no	   real	   indications	   to	   admission	   (explicit	   family	  
request	   or	   logistical	   concerns/poor	   caregivers	   reliability).	   This	   was	   probably	   due	   to	   a	   high	  
consciousness	   level	   of	   not	   appropriate	   hospital	   admission.	   It	   could	   be	   argued	   that	   severity	   of	  
clinical	   conditions	   in	   inpatients	   usually	   induces	   physicians	   to	   exceed	   in	  medical	   interventions	   in	  
order	  to	  avoid	  any	  legal	  issues,	  feeding	  the	  ghost	  of	  “defensive	  medicine”.	  
Most	   common	   violations	   to	   guidelines	   were:	   inappropriate	   request	   of	   microbiological	  
investigation,	   nutritional	   interventions	   and	   antibiotic	   prescriptions.	   Microbiology	   is	   not	  
recommended	  by	  guidelines	  as	  it	  has	  no	  impact	  on	  medical	  interventions.	  	  
Antibiotics	  were	  more	   likely	  prescribed	   in	  children	  with	   increased	   inflammatory	  markers	  such	  as	  
CRP	  and/or	  high	  WBC.	  However,	  blood	  investigations,	  not	  routinely	  recommended	  by	  guidelines,	  
are	  not	  predictive	  for	  a	  bacterial	   infection.	  Some	  authors	  proposed	  a	  role	  of	  CRP	  as	  predictor	  of	  
bacterial	   etiology,	  but	  only	   very	  high	  values	   (95mg/dl)	   show	  a	  good	   sensitivity	  and	   specificity	   in	  
children	   with	   acute	   diarrhea	   [23–25].	   In	   addition,	   the	   assumption	   of	   antibiotics	   during	  
hospitalization	   was	   strongly	   related	   with	   a	   prolonged	   hospital	   stay	   and	   this	   relation	   was	  
independent	  from	  the	  presence	  of	  concomitant	  acute	  illnesses.	  	  
Probiotics	   strains	   with	   proved	   efficacy	   (Lactobacillus	   GG	   and	   S.	   boulardii)	   are	   currently	  
recommended	  by	  guidelines	  as	  the	  first	  line	  treatment	  in	  addition	  to	  ORS	  [4][5].	  In	  our	  population,	  
the	   prescription	   of	   probiotic	   was	   associated	   with	   prolonged	   hospital	   stay.	   However,	   70%	   of	  
prescribed	  probiotic	  strains	  were	  not	  those	  indicated	  by	  guidelines	  as	  effective.	  
Although	  70%	  of	  children	  experienced	  vomiting	  at	   the	  onset	  of	  AGE,	  only	  a	  minority	  of	  patients	  
received	   antiemetics.	   The	   use	   of	   antiemetics	   is	   a	   very	   hot	   issue	   in	   AGE.	   Recent	   evidence	  
demonstrates	  a	  significant	  impact	  of	  ondansetron	  in	  reducing	  hospitalization	  as	  well	  as	  the	  need	  
of	   IV	   rehydration	   in	  children	  admitted	   to	  ED	   [26][27].	   In	  our	  population,	  antiemetics	  were	  more	  
commonly	  prescribed	   in	   emergency	  department	  or	   short	   observation	   setting.	  Discussion	  among	  
experts	   is	   still	   active	   on	   this	   issue	   and,	   even	   if	   currently	   no	   guidelines	   recommend	   the	   use	   of	  
ondansetron	   in	   routine	   clinical	   practice,	   a	   larger	   use	   in	   United	   States	   and	   Canada	   has	   been	  
reported	  [26][27].	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As	   previously	   shown,	   the	   significant	   variability	   in	   clinical	   practice	   and	   the	   lack	   of	   adherence	   to	  
standard	   of	   care	   might	   be	   linked	   to	   differences	   in	   outcomes	   and	   health	   care	   expenses	   in	  
industrialized	  countries	   [28].	  Considering	  that	   the	  cost	   for	  a	  single	  hospital	  admission	  for	  AGE	   in	  
Italy	   is	  €1300,	  and	   that	  about	  50%	  of	  hospitalizations	  are	  currently	   inappropriate,	  we	  estimated	  
that	  a	  full	  adherence	  to	  guidelines	  recommendations	  for	  hospital	  admission	  might	  cut	  the	  healthy	  
costs	  by	  about	  €450.000	  in	  our	  population	  and	  that	  a	  routine	  application	  of	  standardize	  care	  may	  
save	  about	  1	  billion	  of	  health	  care	  expenses	  related	  to	  AGE	  in	  Italy.	  	  
	  
In	  conclusion,	  inappropriate	  hospital	  admissions	  and	  medical	  interventions	  are	  still	  common	  in	  the	  
management	   of	   children	   with	   AGE.	   Major	   risk	   factors	   for	   inappropriateness	   are	   related	   to	  
physician	  education	  and	  setting	  rather	  than	  to	  child	  and	  disease	  characteristics.	  Large	  quality	  care	  
improvement	  process	  based	  on	  local	  implementation	  of	  evidence-­‐based	  practice	  may	  have	  a	  huge	  
impact	  on	  clinical	  outcomes	  and	  health	  care	  costs.	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CHAPTER	  5	  
IMPLEMENTATION	  OF	  EFFECTIVE	  PROBIOTIC	  STRAINS	  
FOR	  THE	  MANAGEMENT	  OF	  CHILDREN	  HOSPITALIZED	  
FOR	  ACUTE	  GASTROENTERITIS	  
	  
5.1	  Rationale	  and	  identification	  of	  the	  clinical	  problem	  
	  
Since	  the	  introduction	  of	  rotavirus	  vaccine,	  disease	  burden	  due	  to	  acute	  gastroenteritis	  (AGE),	  
as	  measured	  by	  healthcare	  utilization	  and	  costs,	  has	  decreased	  substantially	  [1,	  2].	  	  However,	  
AGE	  remains	  a	  burden	  because	  1/3	  of	  children	  under	  age	  3	  are	  still	  unvaccinated	  [2].	  	  
The	  mainstay	  of	  treatment	  for	  AGE	  has	  historically	  been	  rehydration,	  which	  does	  not	  reduce	  
the	   severity	   or	   the	   duration	   of	   intestinal	   symptoms	   [3].	   	   Probiotics	   are	   able	   to	  modify	   the	  
composition	   of	   the	   intestinal	   microflora,	   act	   against	   enteric	   pathogens	   and	   play	   an	  
immunomodulatory	  action,	  also	   if	  a	  definitive	  mechanism	  of	  action	  has	  yet	  to	  be	  defined.	  A	  
meta-­‐analysis	   of	   probiotics	   for	   pediatric	   AGE	   demonstrated	   that	   the	   probiotic	   strain	  
Lactobacillus	  rhamnosus	  GG	  (LGG)	  showed	  a	  significant	  reduction	  in	  the	  duration	  of	  diarrhea	  
and	   risk	   of	   diarrhea	   lasting	   more	   than	   7	   days	   [4].	   	   Evidence-­‐based	   guidelines	   produced	   in	  
developed	  countries	  identify	  LGG	  as	  a	  valid	  and	  effective	  adjunct	  to	  oral	  rehydration	  solution	  
for	  the	  treatment	  of	  AGE	  [5-­‐7].	  	  
Adherence	  to	  standard	  of	  care	  for	  AGE	  in	  United	  States	  is	  far	  from	  optimal	  [8].	  A	  recent	  survey	  
on	   North	   American	   physicians	   practicing	   pediatric	   emergency	   medicine	   reported	   a	  
prescription	  of	  Probiotics	  in	  only	  15%	  of	  children	  with	  AGE	  in	  Canada	  and	  United	  states	  [9].	  	  
About	  70%	  of	  those	  physicians	  working	  in	  United	  States	  referred	  that	  a	  better	  knowledge	  of	  
high	   quality	   probiotic	   strains	   available	   in	   USA	   would	   increase	   the	   likelihood	   of	   their	  
recommendation,	   and	   that	   the	   absence	   of	   a	   clinical	   trial	   conducted	   in	   North	   America	  
represented	  the	  main	  barrier	  for	  prescription.	  	  	  
	  
5.2	   Evidence	   in	   support	   to	   the	   use	   of	   Lactobacillus	   rhamnosus	   GG	   for	   the	   treatment	   of	  
children	  hospitalized	  for	  acute	  diarrhea	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Acute	   gastroenteritis	   is	   probably	   the	   main,	   certainly	   the	   original	   field	   of	   application	   for	  
probiotics.	  A	   large	  number	  of	  data	  have	  been	  obtained	  since	  the	  paper	   that	   firstly	  provided	  
relevant	  evidence	   for	   the	  efficacy	  of	  Lactobacillus	   rhamnosus	  GG	   (LGG)	   in	   the	   treatment	  of	  
AGE	  [10].	  
In	  the	   last	  years,	  an	   increasing	  number	  of	  RCTs	  have	  been	  published	  on	  this	   issue	   in	  various	  
settings	  and	  with	  different	  outcomes.	  However,	  the	  data	  available	  are	  progressively	  merging	  
in	  providing	  compelling	  indications	  that	  probiotic	  administration	  is	  effective	  against	  AGE.	  	  
From	   a	   review	   of	   guidelines	   available	   worldwide,	   six	   produced	   either	   in	   developed	   or	  
developing	   countries	   consider	   the	   use	   of	   probiotic	   as	   a	   therapeutic	   option	   in	   addition	   to	  
rehydration	  [6,	  11,	  12,	  13,	  14,	  15]	  
LGG	   is	   the	  most	   studied	   strain	   and,	   as	   a	   consequence,	   has	  obtained	   consistent	   evidence	  of	  
efficacy.	   All	   the	   documents	   including	   probiotics	   in	   their	   recommendations,	   consider	   LGG	   as	  
the	   main	   intervention	   based	   on	   clinical	   evidence.	   There	   is	   “conclusive”	   evidence	   that	   GG	  
reduces	  the	  severity	  and	  duration	  of	  diarrhea	  in	  multiple	  conditions.	  
The	  recommendation	  slightly	  varies	  among	  different	  guidelines	  according	  to	   the	  setting	  and	  
the	   availability	   of	   products	   on	   the	  market.	   As	   an	   example,	   	   in	   Australia,	   although	   evidence	  
support	  the	  use	  of	  LGG	  no	  probiotics	  are	  available.	  	  
Two	  authoritative	  documents	  have	  been	  developed	  in	  2014	  by	  the	  ESPGHAN,	  one	  is	  a	  position	  
paper	  that	  specifically	  addresses	  the	  use	  of	  probiotics	  in	  children	  with	  AGE	  [16]	  and	  the	  other	  
is	   a	   more	   complete	   document	   on	   the	   overall	   management	   of	   AGE	   in	   children	   [11].	   Those	  
documents	  provide	   clear-­‐cut	   recommendations.	  Recommendations	  were	  provided	  only	   if	   at	  
least	  two	  distinct	  RCTs	  were	  available.	  Briefly,	  according	  to	  published	  data,	  selected	  probiotic	  
reduce	  the	  severity	  and	  duration	  of	  symptoms	  by	  approximately	  24	  hours	  (without	  substantial	  
differences	  in	  efficacy	  among	  effective	  strains),	  and	  the	  risk	  of	  complications.	  	  
A	  total	  of	  4	  strains	  were	  recommended	  for	  active	  treatment	  of	  gastroenteritis,	   in	  adjunct	  to	  
oral	  rehydration	  therapy.	  However,	  LGG	  that	  was	  “strongly	  recommended”,	  was	  the	  only	  one	  
that	  received	  a	  similar	  recommendation	  in	  2008	  version	  of	  guidelines	  [5].	  
	  
Though	  LGG	  has	  primarily	  been	  studied	   in	  preschool	  children,	   it	  has	  been	  tested	   in	  children	  
older	   than	  5	   years	   and	   in	   adults	   [17],	  with	   similar	   results	   as	   that	   for	   younger	   children	   [18].	  
Considering	  the	  available	  evidence	  and	  the	  safety	  profile	  of	  probiotics,	  the	  recommendation	  
for	  use	  of	  LGG	  as	  treatment	  for	  acute	  diarrhea	  can	  be	  generalized	  to	  include	  older	  children.	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A	  recent	  meta-­‐analysis	  [19]	  of	  11	  RCTs	  involving	  2444	  children	  with	  acute	  infectious	  diarrhea	  
found	   that	   LGG	   is	   associated	   with	   a	   significant	   reduction	   in	   diarrhea	   duration	   (mean	  
difference,	  MD	  -­‐1.05	  days,	  95%	  CI	  -­‐1.7	  to	  -­‐0.4),	  LGG	  was	  effective	  in	  children	  treated	  in	  Europe	  
(five	  RCTs,	  n	  =	  744,	  MD	  -­‐1.27	  days,	  95%	  CI	   -­‐2.04	  to	   -­‐0.49);	   in	   the	  non-­‐European	  setting,	   the	  
difference	   between	   the	   LGG	   group	   and	   the	   control	   group	   was	   of	   a	   borderline	   statistical	  
significance	  (six	  RCTs,	  n	  =	  1700,	  MD	  -­‐0.87,	  95%	  CI	  -­‐1.81	  to	  0.08).	  
A	  previous	  meta-­‐analysis	   reported	  a	   reduction	   in	   the	   risk	  of	   diarrhea	   longer	   than	  7	  days	   (1	  
RCT,	  Relative	  Risk	   (RR):	  0.25,	  95%	  CI:	  0.09	   to	  0.75),	   and	  duration	  of	  hospitalization	   (3	  RCTs,	  
number	  of	  participants	  =535;	  WMD	  -­‐0.58,	  95%	  CI:	  -­‐0.8	  to	  -­‐0.4)	  [4].	  
	  
Dose-­‐dependent	  effect	  	  
The	   specific	  dose	  of	  probiotics	   is	   still	   an	   issue.	   Specifically	   for	   the	   treatment	  of	  AGE,	   strong	  
evidence	  supported	  a	  dose-­‐related	  effect,	  being	  high	  doses	  of	  LGG	  (>	  1010	  CFUs/day)	  (eight	  
RCTs,	   n	   =	   1488,	   MD	   -­‐1.11	   days,	   95%	   CI	   -­‐1.91	   to	   -­‐0.31)	   more	   effective	   than	   low	   doses	   in	  
reducing	  the	  duration	  of	  diarrhea(three	  RCTs,	  n	  =	  956,	  MD	  -­‐0.9	  day,	  95%	  CI	  -­‐2.5	  to	  0.69)	  [19].	  
Since	  the	  demonstration	  of	  a	  significant	  reduction	  of	  Rotavirus	  shedding	  in	  stools	  in	  children	  
receiving	   Lactobacillus	   rhamnosus	   [10],	   and	   the	   following	   evidence	   of	   a	   dose-­‐dependent	  
effect	  [20],	  other	  documents	  reported	  that	  probiotics	  overall	  seems	  to	  have	  a	  stronger	  effect	  
in	  Rotavirus-­‐positive	  diarrhea	  rather	  than	   in	  other	  etiology.	   It	  should	  be	  considered	  that	  the	  
spreading	  of	  Rotavirus	  immunization	  might	  change	  in	  part	  the	  current	  scenario.	  
	  
Health	  benefits	  	  
The	  health	  benefits	  for	  LGG	  administration	  in	  adjunct	  to	  ORS	  consist	  of	  reduction	  of	  diarrhea	  
duration,	   reduction	   in	   risk	   of	   having	   a	   protracted	   diarrhea	   and	   reduction	   of	   duration	   of	  
hospitalization.	  	  
Indirectly,	  the	  use	  of	  LGG	  could	  lead	  to	  a	  reduction	  of	  AGE-­‐related	  costs	  in	  term	  of	  work	  days	  
lost	  by	   the	   family	  and	  days	  of	  hospitalization;	  and	   the	   routine	  use	  of	   LGG	   in	   inpatients	  and	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5.3	   Intervention	   to	   implement	   the	   use	   of	   Lactobacillus	   rhamnosus	   GG	   in	   a	   tertiary	   care	  
children	  hospital	  
	  
In	  2005,	  and	  again	   in	  2011,	   the	  Cincinnati	  Children	  Hospital	  Medical	  Center	   in	  Ohio,	  United	  
States	   developed	   an	   evidence-­‐based	   Clinical	   Practice	   Guideline,	   which	   recommended	  
consideration	   of	   probiotic	   use	   in	   patients	   with	   AGE	   [21].Despite	   the	   evidence	   and	   local	  
recommendations,	   only	   1%	   of	   AGE	   patients	   admitted	   to	   our	   general	   pediatric	   service	  were	  
prescribed	  probiotics.	  	  	  
	  
Aims	  of	  the	  study	  
The	  aim	  of	  this	  study	  was	  to	  increase	  the	  prescription	  of	  Lactobacillus	  GG	  at	  admission	  from	  
1%	   to	   90%	   within	   120	   days	   for	   children	   hospitalized	   on	   a	   general	   pediatric	   service	   with	   a	  




Cincinnati	   Children’s	   Hospital	  Medical	   Center	   (CCHMC)	   is	   a	   large,	   urban	   pediatric	   academic	  
medical	  center	  located	  in	  the	  Midwest	  United	  States,	  which	  uses	  an	  electronic	  medical	  record	  
(EMR)	   for	   all	   inpatients.	   	   In	   fiscal	   year	   2011,	   CCHMC	   had	   528	   registered	   inpatient	   beds	   of	  
which	   200	   were	   patients	   admitted	   with	   the	   diagnosis	   of	   AGE.	   	   Patients	   admitted	   to	   the	  
general	  pediatric	  service	  are	  admitted	  at	  the	  main	  campus	  and	  a	  satellite	  community	  campus.	  	  
At	   the	  main	  hospital,	   care	   is	   provided	  by	   teams	  of	   residents	   and	  medical	   students	   that	   are	  
supervised	   by	   CCHMC	   pediatric	   hospitalists	   for	   85%	   of	   the	   patients	   and	   community-­‐based	  
pediatricians	   for	   15%	   of	   the	   patients.	   	   Approximately	   160	   medical	   students	   and	   residents	  
receive	  clinical	   training	  annually	  on	   the	  general	  pediatric	   service.	   	  This	  quality	   improvement	  
initiative	  took	  place	  on	  three	  general	  pediatric	   inpatient	  units,	   two	  at	   the	  main	  campus	  and	  
one	  at	  the	  satellite	  location.	  
	  
Planning	  the	  Intervention	  
A	  CCHMC	  general	  pediatric	  hospitalist	  attending	  physician	  led	  a	  multidisciplinary	  team	  which	  
included	   other	   hospital	   medicine	   attending	   physicians,	   a	   visiting	   pediatrician,	   a	   research	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assistant,	  physician	  and	  nurse	  representatives	  of	   the	  evidence	  based	  guideline	  development	  
group,	   and	   a	   quality	   improvement	   coach.	   The	   team	   used	   a	   Rapid	   Cycle	   Improvement	  
Collaborative	  (RCIC)[11]	  at	  CCHMC	  to	  achieve	  the	  goal	  of	  increasing	  probiotic	  prescription	  on	  
admission	  within	  a	  120-­‐day	  period.	  This	  involved	  group	  learning	  sessions	  over	  4	  months	  with	  
didactic	   presentations	   and	   structured	   group	   activities	   to	   learn	   the	  Model	   for	   Improvement	  
[23]	  and	  apply	  Quality	  Improvement	  (QI)	  methods	  to	  achieve	  an	  improvement	  goal.	  	  The	  team	  
mapped	   the	  existing	  AGE	  admission	  process,	   conducted	  a	   failure	  mode	  effects	   analysis[24],	  
and	   identified	   key	   drivers	   of	   LGG	   use,	   and	   developed	   interventions	   to	   promote	   LGG	   use.	  	  
Figure	  5.1	  depicts	  the	  final	  key	  driver	  diagram.	  
	  
Figure	  5.1.	  Key	  drivers	  diagram	  
	  
The	  team	  developed	  a	  SMART	  aim	  that	  was	  specific,	  measureable,	  actionable,	   relevant,	  and	  
time-­‐bound,	   to	   increase	  the	  prescription	  rate	  of	  LGG	  at	  admission	   from	  1	  %	  to	  >90%	  within	  
120	  days	   for	   children	  hospitalized	  on	   the	   general	   pediatric	   service	  with	   a	  diagnosis	   of	  AGE.	  
Patients	  considered	   for	   inclusion	  were	  between	  2	  months	  and	  18	  years	  old	  admitted	  to	   the	  
general	   pediatric	   service	  with	   the	   diagnosis	   of	   AGE.	   Acute	  Gastroenteritis	  was	   defined	   as	   a	  
decrease	  in	  stool	  consistency	  and/or	  an	  increase	  in	  frequency	  of	  evacuations	  with	  3	  or	  more	  
stools	   in	   the	   preceding	   24	   hour	   period,	   with	   our	   without	   vomiting	   or	   fever.	   Patients	   with	  
complex	  medical	  conditions	  or	  with	  presumed	  bacterial	  gastroenteritis	  were	  excluded.	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Improvement	  Activities	  
Interventions	  focused	  on	  4	  main	  areas	  to	  address	  the	  key	  drivers	  identified.	  The	  interventions	  
were	  tested	  through	  Plan-­‐Do-­‐Study-­‐Act	  (PDSA)	  cycles	  [23]	  on	  three	  general	  medical	  units	  and	  
adapted	  as	  needed.	  
	  
Education	  
• In	   April	   2011,	   the	   improvement	   team	   presented	   the	   evidence	   for	   LGG	   to	   residents	   and	  
medical	  students	  at	  a	  morning	  conference	  and	  to	  the	  general	  pediatric	  attending	  physicians	  at	  
a	   regularly	   scheduled	   section	   meeting.	   Participants	   completed	   pre-­‐	   and	   post-­‐	   assessment	  
surveys	   on	   their	   knowledge	   and	   practice	   of	   the	   evidence	   that	   LGG,	   when	   administered	   to	  
children	  with	  AGE,	  shortens	  the	  course	  of	  acute	  and	  protracted	  diarrhea.	  Nursing	  staff	  on	  the	  
general	  pediatric	  units	  were	   informed	  of	  this	  same	   information	  by	  the	  nursing	   leadership.	  A	  
second	   educational	   session	  was	   given	   in	   July	   2011	   to	   teach	   the	   incoming	   residents	   and	   to	  
remind	  the	  existing	  residents	  about	  probiotics	  and	  AGE.	  	  	  
• To	  spread	  knowledge	  of	  the	  evidence	  and	  the	  team’s	  improvement	  efforts,	  several	  means	  
of	  communication	  were	  used	  to	  reach	  out	  to	  community	  physicians	  and	  other	  members	  of	  the	  
CCHMC	  community.	  A	  one-­‐page	  flyer	  summarizing	  the	  evidence	  and	  implementation	  project	  
was	   disseminated	   to	   physician	   practices	   by	   CCHMC	   representatives	   who	   serve	   as	   liaisons	  
between	  the	  hospital	  and	  community-­‐based	  practices.	  A	  paragraph	  on	  the	  evidence	  and	  the	  
LGG	  project	  was	  also	  posted	  on	   the	  CCHMC	   internal	  website	  and	   included	   in	  an	   institution-­‐
wide	  staff	  bulletin	  distributed	  to	  medical	  staff.	  Contact	  information	  for	  the	  team	  leader	  and	  a	  
web	  link	  to	  our	  institutional	  Best	  Evidence	  Statement	  [25],	  which	  summarizes	  the	  evidence	  for	  
use	  of	  LGG	  in	  children	  with	  diarrhea,	  were	  included	  on	  all	  materials.	  
• To	  further	  remind	  residents	  and	  also	  capture	  visiting	  residents	  and	  medical	  students	  who	  
were	  unfamiliar	  with	  the	  project,	  a	  member	  of	  the	  improvement	  team	  attended	  the	  monthly	  
general	   pediatric	   team	   orientation	   meeting	   to	   provide	   a	   very	   brief	   reminder.	   Relevant	  
information	   regarding	   eligibility	   criteria	   and	   dosage	   information	   was	   posted	   in	   the	   team	  
rooms	  and	  on	  the	  resident	  website.	  Several	  months	   into	  the	  project,	   the	  residency	  program	  
migrated	  to	  shift	  based	  scheduling	  to	  address	  new	  Accreditation	  Council	  for	  Graduate	  Medical	  
Education	   (ACGME)	   work	   hour	   restrictions,	   which	   meant	   residents	   working	   the	   night	   shift	  
were	  not	  able	  to	  attend	  the	  team	  orientation	  meeting.	  	  To	  educate	  the	  night	  shift	  residents,	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two	  slides	  summarizing	  the	  LGG	  project	  were	  delivered	  during	  their	  existing	  weekly	  evening	  
educational	  sessions.	  
	  
Feedback	  on	  Performance	  
Updated	   run	  charts	  were	  posted	   in	  both	   resident	   team	  rooms	  and	  attending	  workrooms	   to	  
provide	  feedback	  for	  the	  medical	  team.	  
	  
Pharmacy	  
In	  April	  2011,	  to	  address	  the	  problem	  that	  LGG	  not	  available	  at	  the	  satellite	  campus’	  inpatient	  
pharmacy,	  the	  satellite	  pharmacy	  partnered	  with	  our	  group	  and	  began	  to	  stock	  LGG.	  
	  
Order	  set	  
To	  incorporate	  a	  higher	  reliability	  intervention,[26,	  27]	  the	  team	  worked	  with	  an	  EMR	  system	  
specialist	   to	   update	   the	   existing	   gastroenteritis	   order	   set	   to	   include	   a	   hyperlink	   to	   the	  Best	  
Evidence	   Statement	   and	   an	   order	   that	   defaulted	   to	   the	   prescription	   of	   	   LGG	   specifying	   the	  
appropriate	  dose	  and	  schedule	  of	  administration.	  	  
	  
Identify	  and	  mitigate	  
A	  research	  assistant	  reviewed	  the	  EMR	  each	  weekday	  to	  identify	  eligible	  patients	  with	  AGE.	  To	  
prevent	   failures,	   the	   research	   assistant	   notified	   the	   attending	   physician	   and	   residents	  
responsible	  for	  the	  patient’s	  care	  by	  email	  when	  an	  eligible	  patient	  was	  identified	  who	  did	  not	  
have	   LGG	   ordered.	   The	   email	   notification	   included	   a	   reminder	   of	   the	   LGG	   project	   aim,	  
evidence	  for	  LGG	  use	  in	  AGE	  patients	  and	  information	  on	  the	  appropriate	  dosage	  and	  timing	  
of	   administration.	   	   This	   weekday	   mitigation	   strategy	   was	   designed	   to	   remind	   the	   team	   in	  
semi-­‐real	  time	  so	  they	  could	  prescribe	  LGG	  if	  they	  deemed	  medically	  appropriate.	  
	  
Methods	  of	  Evaluation	  
Pre	   intervention	  data	  was	   collected	   through	  manual	   chart	   review	  of	   all	   patients	   discharged	  
from	   the	   general	   pediatrics	   service	   between	   January	   1,	   2011	   and	   April	   3,	   2011.	   Post	  
intervention	   data	   were	   obtained	   through	   a	   daily	   scan	   of	   general	   pediatrics	   patients	   and	  
manual	  chart	  review	  of	  eligible	  patients	  admitted	  between	  April	  4,	  2011	  and	  January	  22,	  2012.	  
A	  research	  assistant	  trained	  in	  data	  collection	  and	  interpretation	  reviewed	  the	  list	  of	  hospital	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medicine	   patients	   each	   weekday,	   searching	   the	   problem	   list	   and	   chief	   complaint	   for	   the	  
following	   keywords:	   acute	   gastroenteritis,	   diarrhea,	   dehydration,	   or	   vomiting,	   to	   identify	  
eligible	   patients.	   	   On	   Monday	   morning,	   the	   research	   assistant	   would	   also	   review	   patients	  
admitted	   during	   the	   weekend.	   Once	   a	   patient	   had	   been	   identified,	   the	   research	   assistant	  
noted	   whether	   the	   patient	   met	   the	   inclusion	   criteria	   for	   the	   QI	   project.	   The	   eligibility	   of	  
patients	   of	   questionable	   inclusion/exclusion	   status	   was	   determined	   by	   consensus	   after	   the	  
case	  was	  reviewed	  with	  at	  least	  two	  physicians	  on	  the	  improvement	  team.	  Prescription	  of	  LGG	  
at	   admission	   was	   defined	   as	   LGG	   being	   ordered	   for	   an	   eligible	   patient	   within	   18	   hours	   of	  
admission,	  regardless	  of	  whether	  the	  team	  received	  a	  reminder.	  
	  
Analysis	  
The	   research	   assistant	   recorded	   data	   and	   created	   run	   charts	   using	   Microsoft	   Excel®.	   Run	  
charts	  [28]	  display	  data	  in	  a	  timed	  sequence	  and	  help	  detect	  special	  causes	  of	  variation.	  Run	  
charts	  were	  updated	  weekly	  to	  reflect	  the	  percentage	  of	  eligible	  patients	  receiving	  LGG	  at	  the	  
main	  campus,	  satellite	  campus,	  and	  both	  locations	  combined.	  	  
	  
5.4	  Results	  of	  the	  rapid	  implementation	  program	  
	  
Prescription	  of	  LGG	  at	  admission	  for	  children	  with	  AGE	   increased	  from	  1%	  to	  100%	  within	  6	  
weeks	  of	  beginning	  the	  project	  (Figure	  5.2).	  	  
The	   educational	   sessions	   for	   attending	   physicians,	   residents,	   and	  medical	   students	  were	   an	  
effective	   method	   of	   knowledge	   transfer.	   	   After	   the	   sessions,	   participants	   were	   more	  
knowledgeable	   that	  probiotics	   reduce	  the	  duration	  of	  diarrhea	   in	  a	  dose	  dependent	   fashion	  
and	  were	  more	  likely	  to	  prescribe	  probiotics	  (Table	  A).	  	  
Three	   failures	   accrued	   soon	   after	   the	   new	   interns	   started	   in	   July	   2011.	   Subsequently,	  
prescription	  of	  LGG	  at	  admission	  has	  been	  sustained	  for	  the	  past	  6	  months.	  	  
As	  expected,	  our	  average	  length	  of	  stay	  did	  not	  change	  as	  a	  result	  of	  our	  interventions	  (Table	  
B).	  
	  
Table	   5.1.	   Survey	   of	   Practitioners’	   Knowledge	   about	   probiotics	   and	   current	   or	   planned	  
prescribing	  habits	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Figure	  5.2.	  Run	  chart	  of	  the	  prescription	  of	  LGG	  in	  children	  admitted	  to	  CCHMC	  for	  AGE	  
	  
Conclusions	  
	   The	   rapid	   implementation	   of	   evidence-­‐based	   practice	   is	   possible	   when	   utilizing	  
improvement	   science	   methods.	   	   Keys	   to	   the	   success	   of	   our	   specific	   project	   were	  
interdisciplinary	   collaboration,	   use	   of	   an	   electronic	   medical	   record,	   and	   identification	   and	  
mitigation	  of	  failures.	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CHAPTER	  6	  
E-­‐LEARNING	  AS	  A	  TOOL	  FOR	  IMPLEMENTATION	  
OF	  CLINICAL	  PRACTICE	  GUIDELINES	  ON	  ACUTE	  GASTROENTERITIS	  
	  
	  
6.1	  Rationale	  of	  the	  initiative	  
	  
E-­‐learning	   is	  being	  explored	  as	  a	   tool	   for	  education	   in	  medical	  science	  with	  promising	  results.	  E-­‐
learning	   was	   effective	   in	   improving	   pediatric	   prescribing	   skills	   of	   junior	   doctors,	   and	   outcomes	  
were	  maintained	  over	  a	  3-­‐month	  period	  [1].	  Residents,	  registrars	  and	  nurses	  taking	  an	  e-­‐learning	  
program	  on	  pediatric	  cardiopulmonary	  resuscitation	  achieved	  a	  significant	   improvement	   in	  basic	  
and	   advanced	   life	   support	   techniques	   [2].	   However,	   the	   potential	   use	   of	   technology	   in	  medical	  
education	  and	  transfer	  of	  knowledge	  to	  practice	   is	  not	  fully	  exploited	  and	  the	   impact	  on	  patient	  
outcomes	  following	  e-­‐learning	  courses	  has	  yet	  to	  be	  determined	  [3].	  
AGE	   is	  an	   ideal	  candidate	  condition	   for	  CPG	   implementation	   through	  e-­‐learning,	  due	  to	   its	  huge	  
burden	   and	   broad	   interest	   as	   well	   as	   a	   recognized	   target	   for	   implementation.	   Recently,	   the	  
Federation	   of	   the	   Societies	   of	   Pediatric	   Gastroenterology	   Hepatology	   and	  Nutrition	   (FISPGHAN)	  
indicated	  that	  e-­‐learning	  programs	  are	  an	  educational	  priority	  and	  should	  be	  exploited	  to	  decrease	  
AGE-­‐related	  mortality	  worldwide[4].	  
We	  aimed	  at	  assessing	  the	  impact	  of	  an	  e-­‐learning	  course	  on	  the	  management	  of	  AGE	  in	  children	  
of	   Europe	   based	   on	   the	   CPG	   jointly	   produced	   by	   the	   European	   Society	   for	   Pediatric	  
Gastroenterology	  Hepatology	  and	  Nutrition	  (ESPGHAN)/European	  Society	   for	  Pediatric	   Infectious	  
Diseases	   (ESPID)	   [5]	   on	   knowledge	   and	   clinical	   practice	   in	   European	   pediatricians	   and	   general	  
practitioners.	  
An	  e-­‐learning	  approach,	  for	  the	  dissemination	  and	  implementation	  of	  CPGs	  has	  been	  designed,	  to	  
be	  tailored	  to	  learner-­‐specific	  needs	  and	  a	  specific	  project	  was	  awarded	  a	  grant	  by	  UEG	  within	  the	  
monothematic	  initiatives.	  The	  e-­‐learning	  event,	  which	  is	  the	  first	  of	  a	  series	  of	  ESPGHAN	  e-­‐learning	  
initiatives,	  includes	  a	  2	  hour	  interactive	  course	  on	  the	  management	  of	  gastroenteritis	  in	  children	  of	  
Europe	  based	  on	  guidelines.	  
	  
The	  TEEN-­‐AGE	  project	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The	   e-­‐learning	   course	   is	   part	   of	   a	   more	   structured	   project,	   the	   TEEN-­‐AGE	   (Tutorial	   European	  
Electronic	   Network	   on	   Acute	   Gastroenteritis)	   project	   coordinated	   by	   Prof	   Alfredo	   Guarino,	   on	  
behalf	  of	  ESPHGHAN.	  
The	  aims	  of	  TEEN-­‐AGE	  are	  to:	  
• Provide	   an	   e-­‐learning	   course	   for	   dissemination	   and	   implementation	   of	   ESPGHAN/ESPID	  
CPGs	  for	  AGE	  addressed	  to	  physicians	  from	  15	  European	  Countries	  
• Provide	   a	   tutorship	   of	   the	   learners	   by	   experts	   from	   each	   participating	   Country	  with	   the	  
specific	   tasks	   of	   optimizing	   the	   course	   content,	   enrolling	   participants	   among	   physicians	  
working	   in	   primary	   care	   and	   hospitals	   and	   following	   them	   for	   possible	   problems	   or	  
questions.	  
• Identify	  local	  and	  individual	  factors	  that	  affect	  the	  dissemination	  and	  the	  applicability	  of	  the	  
guidelines.	  
• Assess	  the	  impact	  of	  the	  e-­‐learning	  course	  and	  relating	  it	  to	  local	  and	  individual	  variables	  by	  
measuring	  two	  main	  outcomes:	  
o Variation	  in	  knowledge	  (pre-­‐post	  intervention)	  
o Variation	  in	  adherence	  to	  guidelines	  (pre-­‐post	  intervention)	  
	  
Start-­‐up	  with	  the	  teen-­‐age	  workshop	  
The	  Workshop	  entitled	  	  “Online	  Strategies	  for	  the	  Implementation	  of	  European	  CPGs	  in	  Pediatric	  
Gastroenterology”,	  held	  in	  Naples	  on	  17-­‐18	  September	  2012,	  was	  the	  first	  step	  of	  the	  TEEN-­‐AGE	  
project.	  	  
The	  workshop,	  held	  in	  Naples,	  Italy,	  was	  aimed	  at	  presenting	  the	  features	  of	  the	  TEENAGE	  project	  
to	  representatives	  (Pediatric	  Gastroenterologists)	  from	  11	  European	  countries	  that	  will	  act	  as	  local	  
tutors.	  The	  topics	  were:	  
ü training	  in	  guidelines	  implementation	  and	  e-­‐learning	  methodology	  
ü contents	  of	  the	  e-­‐learning	  intervention	  that	  will	  be	  offered	  in	  each	  country	  	  
ü target	  of	  the	  intervention	  and	  modes	  of	  enrollment	  	  
ü measuring	  the	  outcomes	  of	  the	  intervention	  
	  
Target	  of	  the	  intervention	  and	  modes	  of	  enrollment	  
Participants	   to	   the	   workshop	   were	   introduced	   to	   the	   procedures	   of	   enrollment	   of	   the	   study	  
population	  (i.e.,	  the	  participants	  to	  the	  e-­‐learning	  course).The	  participants	  (final	  users)	  enrolled	  in	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the	   project	   are	   called	   “teenagers”,	   from	   the	   acronym	   of	   the	   project.	   The	   “teenagers”	   are	  
physicians	   (both	  pediatricians	  and	  general	  practitioners)	  working	  with	   in-­‐	  and	  out-­‐	  patients	  who	  
are	  expected	  to	  take	  the	  e-­‐learning	  course	  and	  to	  undergo	  a	  pre-­‐	  and	  post-­‐	  course	  evaluation.	  
About	  30	  “teenagers”	  will	  be	  enrolled	  by	  each	  tutor.	  Taking	  part	  to	  the	  project,	  “teenagers”	  will	  
receive	   2	   EAACME	   credits,	   the	   certification	   of	   e-­‐learning	   course	   attendance	   and	   a	   limited	   free	  
access	  to	  the	  online	  version	  of	  Journal	  of	  Pediatric	  Gastroenterology	  and	  Nutrition.	  
	  
Measuring	  the	  outcomes	  of	  the	  intervention	  
a. Knowledge	  outcomes	  
Pre-­‐	   and	  post-­‐	   e-­‐learning	   course	  multiple-­‐choice	  questionnaires	  have	  been	   tested	  by	   the	  
tutors.	   The	   modifications	   were	   introduced	   in	   both	   the	   questionnaires	   and	   the	   course	  
structure.	  	  
b. Clinical	  practice	  outcomes	  
A	  database	  for	  data	  entering	  clinical	  cases	  before	  (baseline)	  and	  after	  the	  e-­‐learning	  course	  
cases	  was	  provided	  to	  each	  tutor.	  Two	  slightly	  different	  databases	  have	  been	  realized,	  for	  
inpatients	   and	   outpatients.	   Inpatients	   are	   defined	   as	   patients	  managed	   in	   a	   hospital,	   no	  
matter	  if	  emergency	  room,	  emergency	  department	  or	  regularly	  admitted	  patients.	  
	  
6.2	  E-­‐learning	  instrument	  and	  methodology	  
	  
Study	  design	  
This	  study	  was	  a	  pre/post	  single-­‐arm	  intervention	  study.	  The	  experimental	  phase	  was	  carried	  out	  
from	  May	   20th	   to	   September	   30th,	   2013.	   However,	   the	   entire	   project,	   including	   the	   e-­‐learning	  
course	   design	   and	   production,	   and	   the	   dataset	   analysis,	   required	   about	   14	  months	   (September	  
2012	  to	  November	  2013).	  	  
	  
Participants	  
A	  total	  of	  415	  physicians	   from	  11	  European	  countries	  were	   invited	  to	  participate	   in	  the	  study.	  A	  
tutor	  for	  each	  country	  was	  identified	  from	  among	  the	  members	  of	  the	  Scientific	  Committee	  of	  the	  
Tutorial	   European	   Electronic	   Network	   on	   Acute	   Gastroenteritis	   (TEEN-­‐AGE)	   project,	   in	   order	   to	  
assist	   physicians	   in	   the	   recruitment	   process	   and	   resolve	   technical	   problems	   technical	   problems	  
related	  to	  the	  United	  European	  Gastroenterology	  (UEG)	  website.	  Each	  tutor	  was	  asked	  to	  identify	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at	   least	   25	   physicians	   from	   his/her	   country	   to	   be	   invited	   to	   participate.	   To	   obtain	   a	   randomly	  
enrolled	  sample	  from	  each	  country	  and	  to	  minimize	  selection	  bias,	  participating	  physicians	  were	  
identified	  through	  regional	  and	  national	  databases	  or	  through	  national	  scientific	  societies.	  	  
No	  specific	  inclusion	  criteria	  were	  applied	  beyond	  the	  comprehension	  of	  English	  and	  the	  ability	  to	  
use	  a	  computer.	  
	  
E-­‐learning	  course	  design	  and	  production	  
The	   e-­‐learning	   course	   included	   five	   learning	   modules	   addressing	   the	   five	   key	   areas	   of	   AGE	  
management	   based	   on	   ESPGHAN/ESPID	   guidelines:	   1)	   Introduction	   and	   definitions,	   2)	   Clinical	  
assessment	  and	  management,	  3)	  Oral	  rehydration	  and	  active	  treatment,	  4)	  Other	  treatments,	  and	  
5)	  Treatment	  of	   inpatients.	  All	  of	  the	  learning	  materials	  (video,	  slides,	  evaluation	  questionnaires,	  
figures,	  web	   references,	   checklists)	  were	   reviewed	  and	  approved	  by	   the	  Scientific	  Committee	  of	  
the	  TEEN-­‐AGE	  initiative	  for	  content	  and	  format.	  The	  course	  is	  freely	  available,	  in	  English,	  and	  only	  




After	   registering	   on	   the	   UEG	   website,	   each	   participant	   received	   a	   personal	   code	   to	   access	   the	  
section	  containing	  the	  e-­‐learning	  course	  and	  the	  patient	  data	  portal.	  	  
All	  participating	  physicians	  were	  asked	  to	  provide	  their	  personal	  profile	  information	  (age,	  country,	  
languages	  spoken,	  previous	  experience	  with	  e-­‐learning)	  and	  other	  information	  about	  their	  practice	  
(specialty,	   years	   of	   activity,	   inpatient/outpatient	   work	   setting).	   They	   completed	   a	   baseline	   and	  
post-­‐course	  questionnaire	  measuring	   their	   knowledge	  of	  AGE	  and	   its	   treatment,	  which	   included	  
questions	  from	  a	  large	  pool	  of	  calibrated	  items.	  	  
At	   baseline,	   each	   physician	   also	   reported	   on	   his/her	   case	   management	   of	   3	   to	   5	   consecutive	  
patients	  <5	  years	  of	  age	  and	  referred	  for	  AGE,	  defined	  as	  a	  decrease	  in	  the	  consistency	  of	  stools	  
(loose	   or	   liquid)	   and/or	   an	   increase	   in	   the	   frequency	   of	   evacuations	   (>3	   in	   24	   hours)	   with	   or	  
without	  fever	  or	  vomiting.	  Each	  learner	  recorded	  clinical	  case	  information	  at	  the	  end	  of	  the	  child’s	  
visit	   or,	   for	   inpatients,	   at	   the	   time	   of	   discharge.	   These	   cases	   were	   entered	   in	   an	   anonymous	  
electronic	   Case	   Report	   Form	   (CRF).	   The	   CRF	   included	   5	   domains:	   child	   and	   family	   data,	   clinical	  
features,	  home	  management,	  reasons	  for	  admission,	  and	  hospital	  management.	  Additionally,	  any	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underlying	  chronic	  conditions	  and/or	  concomitant	  acute	  illnesses	  were	  recorded	  in	  the	  CRF	  to	  aid	  
in	  the	  interpretation	  of	  outcomes	  according	  to	  case-­‐specific	  risk	  factors.	  
After	  completing	  the	  baseline	  phase,	  physicians	  had	  one	  month	  to	  view	  the	  five	  learning	  modules.	  
Subsequently,	   they	  were	  asked	   to	   load	   information	  on	  another	  3	   to	  5	  consecutive	  cases	  of	  AGE	  
using	  the	  same	  CRF.	  The	  post-­‐course	  test	  of	  knowledge	  was	  the	  final	  measure.	  
	  
Definition	  of	  inappropriate	  interventions	  	  
Inappropriate	  interventions	  in	  the	  management	  of	  AGE	  were	  identified	  by	  comparing	  the	  reported	  
medical	  interventions,	  including	  prescriptions	  and	  procedures,	  with	  the	  CPG	  recommendations	  in	  
each	  of	  the	  following	  domains:	  evaluation	  of	  the	  main	  signs/symptoms,	  concordance	  between	  the	  
objective	   assessment	   of	   dehydration	   and	   the	   physician’s	   estimate,	   nutritional	   interventions,	  
requests	   for	   blood	   tests,	   rehydration	   route,	   prescription	   of	   microbiological	   investigations,	   and	  
prescription	   of	   probiotics,	   antiemetics,	   antibiotics,	   and	   other	   anti-­‐diarrheal	   drugs.	   The	   same	  
methodology	  for	  the	  assessment	  of	  the	  appropriateness	  of	  medical	  interventions	  has	  been	  used	  in	  
a	  previous	  publication	  [6].	  
Inappropriate	   interventions	  were	  divided	   into	  major	  and	  minor	  violations.	  A	  major	  violation	  was	  
defined	   as	   a)	   an	   active	  medical	   intervention	   not	   included	   in	   CPG	   recommendations	   that	  might	  
negatively	  affect	  the	  course	  of	  the	  disease	  and/or	  might	  be	  associated	  with	  unnecessary	  costs,	  or	  
b)	   any	   violation	   to	   “high	   grade”	   recommendations	   in	   the	   guidelines	   (CPG	   recommendations	  
supported	   by	   level	   I	   or	   II	   evidence	   according	   to	   the	   Muir-­‐Gray	   score).	   A	   minor	   violation	   was	  
defined	   as	   a)	   an	   intervention	   that	   did	   not	   substantially	   change	   the	   outcome	   but	  was	   generally	  
considered	   inappropriate,	   or	   b)	   any	   violation	   to	   “low	   grade”	   recommendations	   in	   the	   referral	  
guidelines	  (level	  III,	  IV,	  and	  V	  evidence	  according	  to	  Muir-­‐Gray).	  	  
To	  produce	  a	  quantitative	  estimate	  of	  adherence	  to	  the	  AGE	  CPG	  in	  this	  study,	  any	  major	  violation	  
reduced	  the	  overall	  adherence	  by	  10%	  and	  any	  minor	  violation	  by	  5%;	  the	  final	  percentage	  score	  
was	   calculated	   by	   summing	   the	   results	   reported	   for	   each	   domain,	   with	   a	   maximum	   of	   100%.	  
Scores	  ≥90%	  were	  considered	  full	  adherence.	  	  
Primary	   outcomes	   of	   the	   e-­‐learning	   intervention	   were	   the	   proportion	   of	   participants	   whose	  
medical	   interventions	   were	   fully	   adherent	   to	   guidelines	   and	   the	   scores	   on	   the	   knowledge	  
questionnaires	   (number	  of	   correct	   answers	  out	  of	   a	   total	  of	  15	  questions).	   The	  amount	  of	   time	  
taken	   to	   complete	   the	   knowledge	   test	  was	   also	   recorded	   in	   the	   e-­‐learning	   platform	   as	   indirect	  
proof	  of	  improved	  knowledge.	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Ethical	  considerations	  
The	   study	   was	   approved	   by	   the	   Education	   Committee	   of	   ESPGHAN	   and	   conducted	   with	   the	  
technical	  partnership	  of	  the	  UEG	  as	  part	  of	  the	  TEEN-­‐AGE	  initiative.	  All	  participants	  signed	  written	  
informed	  consent	  forms.	  
	  
Statistical	  analysis	  
Statistical	   analyses	  were	  performed	   in	   the	   statistical	   computing	  environment	  R	   (version	  3.0.1;	  R	  
Foundation	   for	   Statistical	   Computing,	   Vienna,	   Austria).	   Data	   for	   continuous	   variables	   are	  
expressed	   as	   means	   ±	   SD.	   Data	   for	   categorical	   variables	   are	   presented	   as	   frequencies	   and	  
percentages.	   Pre-­‐	   and	   post-­‐course	   differences	   in	   the	   theoretical	   knowledge	   of	   CPG	  
recommendations	  and	  average	  adherence	  scores	  were	  evaluated	  using	  the	  Wilcoxon	  signed-­‐rank	  
test	   for	   paired	   samples.	   To	   examine	   the	   impact	   of	   physician-­‐	   and	   patient-­‐related	   factors	   on	  
adherence,	  a	  two-­‐level	  random	  intercept	  multilevel	  logistic	  regression	  analysis	  (MLRA)	  was	  used	  to	  
account	  for	  the	  clustering	  of	  AGE	  cases	  among	  physicians.	  MLRA	  was	  conducted	  separately	  for	  the	  
pre-­‐education	   patient	   group	   (PreEG)	   and	   post-­‐education	   patient	   group	   (PostEG)	   data	   to	  
investigate	  whether	  factors	  associated	  with	  non-­‐adherence	  to	  CPG	  prior	  to	  the	  e-­‐learning	  course	  
were	   consistent	   with	   inappropriate	   interventions	   after	   the	   course.	   Adjusted	   odds	   ratios	   and	  
corresponding	  95%	  confidence	  intervals	  were	  obtained	  using	  the	  MLR	  method.	  
All	  tests	  were	  two-­‐tailed,	  and	  p	  values	  <0.05	  were	  considered	  significant.	  
	  
	  
6.3	  Results	  of	  the	  implementation	  of	  the	  ESPGHAN	  e-­‐learning	  course	  on	  acute	  gastroenteritis	  
	  
A	   total	   of	   149	   physicians	   registered	   for	   the	   e-­‐learning	   course;	   ninety	   physicians	   (60%)	   did	   not	  
complete	  all	  the	  modules	  by	  the	  established	  deadline.	  Fifty-­‐nine	  (40%)	  of	  the	  enrolled	  physicians	  
(45	  females,	  median	  age	  40	  years,	  range	  26¬–59)	  completed	  the	  course	  (Figure	  1);	  their	  baseline	  




Figure	  6.	  1.	  Flowchart	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Participants	  were	   from	   Slovenia	   (12);	   Greece	   (11);	   the	  Netherlands	   (9);	   Portugal,	   Romania,	   and	  
Russia	   (5	   each);	   Turkey	   and	   Italy	   (3	   each);	   and	   Poland,	   Belgium,	   and	   Germany	   (2	   each).	   No	  
differences	   in	   age,	   gender,	   years	   of	   practice,	   setting	   of	   practice,	   previous	   experience	   with	   e-­‐
learning,	   or	   previous	   knowledge	  of	  CPG	  were	  observed	  between	   the	  physicians	  who	   completed	  
the	  course	  and	  those	  who	  did	  not.	  	  
	  
Table	  6.	  1.Baseline	  characteristics	  of	  the	  enrolled	  physicians	  
Characteristic	   n/N	  (%)	  
Mean	  age	  (mean	  ±	  SD)	  in	  years	   39.5	  ±	  7.57	  
M/F	   14/45	  (24%)	  













Previous	  experience	  with	  e-­‐learning	   32/59	  (54%)	  
Previous	  knowledge	  of	  guidelines	   34/59	  (57%)	  
	  
The	   data	   of	   545	   children	   with	   AGE	   (249	   females;	   median	   age	   21	   months,	   range	   1–60)	   were	  
registered	  by	  the	  participants,	  281	  before	  (PreEG,	  51%)	  and	  264	  after	  taking	  the	  course	  (PostEG,	  
49%).	  Three	  hundred	  and	  forty-­‐eight	  patients	  (64%)	  were	  managed	  in	  a	  hospital	  setting,	  and	  197	  
(36%)	  were	  treated	  in	  an	  outpatient	  setting.	  A	  total	  of	  25	  out	  of	  545	  children	  (5%)	  presented	  with	  
severe	  dehydration	  according	  to	  physician	  estimates.	  Specific	  clinical	  characteristics	  of	  the	  children	  
reported	  on	  in	  the	  PreEG	  and	  PostEG	  assessments	  are	  shown	  in	  Table	  6.2.	  
	  













Mean	  age	  ±	  SD	  (months)	  
152/129	  
23.04	  ±	  15.46	  
144/120	  
23.38	  ±	  16.24	  
1	  
0.98	  
Weight-­‐for-­‐age	  (mean	  ±	  SD)	   0.03	  ±	  0.9	   0.029	  ±	  0.092	   1	  
Inpatients	   184/281	  (65)	   164/264	  (62)	   0.423	  
Outpatients	   97/281	  (35)	   100/264	  (38)	   0.423	  
Chronic	  underlying	  disease	   20/281	  (7)	   25/264	  (9)	   0.352	  
Concomitant	  acute	  illness	   35/281	  (12)	   32/264	  (12)	   0.054	  
ORS	  at	  home	   128/281	  (46)	   148/264	  (56)	   0.0164	  
Children	  with	  severe	  dehydration	   13/281	  (5)	   12/264(5)	   0.2860	  
Pre-­‐EG	  =	  pre-­‐education	  group;	  PostEG	  =	  post-­‐education	  group;	  ORS	  =	  oral	  rehydration	  solution	  
Knowledge	  about	  the	  CPG	  on	  AGE	  treatment	  increased	  after	  the	  e-­‐learning	  course,	  based	  on	  the	  
scores	   on	   the	   15-­‐question	   knowledge	   test	   before	   (8.6	   ±	   2.7	   points)	   and	   the	   course	   (12.8	   ±	   2.1	  
points,	  P	  <0.001).	  The	  response	  time	  also	  decreased	  after	  the	  course	  (878	  ±	  503	  versus	  579	  ±	  379	  
seconds,	  P	  <0.001)	  for	  the	  59	  physicians	  who	  completed	  the	  study	  (Figure	  6.	  2).	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Figure	  6.	  2.	  Impact	  of	  e-­‐learning	  on	  knowledge	  about	  the	  management	  of	  acute	  gastroenteritis	  in	  
children	  before	  (Pre)	  and	  after	  the	  e-­‐learning	  intervention	  (Post):	  A)	  learners’	  scores,	  and	  B)	  time	  
to	  complete	  the	  15-­‐question	  evaluation	  tests	  (as	  recorded	  by	  the	  e-­‐learning	  platform).	  
	  
	  
The	  proportion	  of	  patients	  managed	   in	   full	  adherence	  with	  the	  guidelines	   (i.e.,	  no	   inappropriate	  
interventions	  or	  only	  one	  minor	  violation)	  increased	  from	  33.6	  ±	  31.7%	  to	  43.9	  ±	  36.1%	  (P	  =	  0.037).	  
Similarly,	  the	  average	  adherence	  rate	  increased	  from	  87.0	  ±	  7.7%	  to	  90.6	  ±	  7.1%	  (P	  =	  0.001)	  (Figure	  
6.	  3).	  
	  
Figure	  6.	  3.	  Adherence	   to	  clinical	  practice	  guidelines	   for	  acute	  gastroenteritis	   in	  545	  children	  <5	  
years	   managed	   before	   (Pre)	   and	   after	   (Post)	   the	   e-­‐learning	   implementation	   intervention:	   A)	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average	   adherence	   percentage	   score,	   and	   B)	   proportion	   of	   patients	  managed	   in	   full	   adherence	  
with	  the	  guidelines.	  
	  
The	  mean	  proportion	  of	  patients	  who	   received	   inappropriate	   interventions	   in	   each	  domain	  was	  
calculated.	  The	  most	  common	  violations	  to	  the	  CPG	  were	  orders	  for	  stool	  cultures	  in	  the	  absence	  
of	   appropriate	   indications.	   Unnecessary	   dietary	   changes	   and	   inconsistent	   estimates	   of	  
dehydration	  compared	  to	  objective	  parameters	  were	  also	  frequently	  observed.	  As	  shown	  in	  Figure	  
6.4,	   the	   e-­‐learning	   course	   reduced	   inappropriate	   interventions	   in	   all	   of	   these	  domains.	  We	  also	  
observed	  a	  non-­‐significant	  trend	  toward	  a	  reduction	  in	  inappropriate	  nutritional	  interventions	  (P	  =	  
0.055).	  In	  all,	  22%	  of	  patients	  were	  inappropriately	  admitted	  to	  the	  hospital	  at	  PreEG,	  compared	  to	  
15%	  at	  PostEG	  (P	  =	  0.200)	  patients.	  The	  proportion	  of	  hospitalized	  children	  with	  >5%	  weight	  gain	  
at	  discharge	  was	  only	  25%	  in	  the	  PreEG	  and	  26.5%	  in	  the	  PostEG	  (P	  =	  0.841),	  which	  indicates	  that	  
few	   children	   with	   at	   least	   a	   moderate	   degree	   of	   dehydration	   were	   hospitalized	   and	   that	   this	  
proportion	  did	  not	  change	  after	  the	  e-­‐learning	  course.	  	  
	  
	  
Figure	  6.	  4.	  Changes	   in	   inappropriate	   interventions	   for	  acute	  gastroenteritis	   in	  children	  <5	  years	  
managed	  before	  (Pre)	  and	  after	  (Post)	  e-­‐learning.	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The	  MLRA	  model	   is	   shown	   in	  Table	   6.	   3.	  We	   assessed	   the	   link	   between	   specific	   physician-­‐	   and	  
patient-­‐related	   factors	   and	   discrepancies	   with	   the	   guideline	   recommendations.	   We	   also	  
investigated	  whether	  these	  factors	  were	  still	  associated	  with	  inappropriate	  interventions	  after	  the	  
course.	  Physicians	  who	  had	  previous	  knowledge	  of	   the	  guidelines	  were	  more	   likely	   to	  adhere	  to	  
the	  CPG	  (OR	  =	  0.29;	  95%	  CI	  [0.10	  to	  0.86];	  P	  =	  0.026)	  before	  the	  course.	  However,	  the	  e-­‐learning	  
course	  bridged	  the	  gap	  between	  those	  who	  already	  knew	  the	  CPG	  and	  those	  who	  did	  not	  (OR	  =	  
1.92;	  95%	  CI	  [0.58	  to	  6.37];	  P	  =	  0.289)	  by	  the	  end	  of	  the	  course.	  In	  terms	  of	  clinical	  characteristics,	  
children	   in	   the	   PreEG	   with	   bloody	   diarrhea	   (OR	   =	   5.75	   95%	   CI	   [1.39	   to	   23.89];	   P	   =	   0.016)	   or	  
abdominal	   pain	   (OR	   =	   1.88;	   95%	   CI	   [1.1	   to	   3.24];	   P	   =	   0.02)	   were	   more	   likely	   to	   receive	  
inappropriate	   interventions	   at	   baseline	   (OR	   =	   1.9;	   95%	   CI	   [0.46	   to	   7.84],	   P	   =	   0.37),	   but	   this	  
increased	   risk	   disappeared	   after	   the	   course	   (OR	   =	   0.61;	   95%	   CI	   [0.251	   to	   0.49],	   P	   =	   0.279).	   In	  
contrast,	   frequent	   vomiting	   episodes	   (>5/day)	   remained	   associated	   with	   inappropriate	  
management	  before	  (OR	  =	  4.07;	  95%	  CI	  [1.39	  to	  11.89];	  P=0.01)	  and	  after	  the	  course	  (OR	  =	  5.22;	  
95%	  CI	  [1.64	  to	  16.69];	  P=0.005).	  Chronic	  diseases	  were	  a	  protective	  factor	  against	  non-­‐adherence	  
only	  in	  the	  PreEG	  group	  (OR	  =	  0.24;	  95%	  CI	  [0.07	  to	  0.86];	  P=0.028).	  
	  
Table	  6.	  3.	  MLRA	  model	  for	  the	  estimate	  of	  the	  risk	  of	  imperfect	  adherence	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E-­‐learning	   is	   a	   promising	   strategy	   to	   improve	   practice,	   due	   to	   its	   universal	   availability,	  
asynchronous	  accessibility,	  interactivity,	  presence	  of	  implementation	  tools	  (such	  as	  checklists,	  web	  
references,	  etc.),	  and	  the	  low	  costs	  for	  the	  learner	  [7,	  8].	  However,	  there	  is	  no	  proof	  of	  its	  efficacy	  
in	   improving	   clinical	   practice.	  Many	   studies	   used	   surrogate	   outcomes	   to	   predict	   such	   changes,	  
such	  as	  drug	  and	  test	  prescriptions	  [1],	  simulations	  of	  resuscitation	  procedures	  [2]	  and	  structured	  
clinical	  examination	  tests	  [9].	  
We	  demonstrated	  the	  efficacy	  of	  an	  e-­‐learning	  educational	  intervention	  on	  AGE	  on	  knowledge	  but	  
also	   its	   direct	   impact	   on	   clinical	   practice.	   The	   e-­‐learning	   course	   increased	   the	   theoretical	  
knowledge	  about	  appropriate	  interventions	  as	  judged	  by	  the	  questionnaire.	  This	  was	  supported	  by	  
the	  rates	  of	  correct	  answers	  but	  also	   the	  reduced	  time	  to	   fill	   it.	  Translated	   into	  clinical	  practice,	  
better	  knowledge	  is	  supposed	  to	  reduce	  the	  “time	  to	  effective	   interventions”,	  an	  added	  value	  in	  
the	  physician’s	  daily	  work.	  
The	  overall	  adherence	   to	  CPG	  also	  significantly	   improved,	  as	   judged	  by	  both	  average	  adherence	  
and	  mean	  proportion	  of	  children	  managed	  according	  to	  recommendations.	  However,	  we	  not	  only	  
investigated	  the	  specific	  gaps	  and	  the	  criticalities	  in	  the	  application	  of	  evidence-­‐based	  practice	  in	  
pediatric	   AGE,	   but	   also	   evaluated	   their	   determinants	   through	   a	   specifically	   developed	   logistic	  
regression	   model	   and	   examined	   the	   role	   of	   both	   physicians’	   and	   patients’	   features.	   Logistic	  
regression	   showed	   that	   the	   e-­‐learning	   course	   filled	   the	   gap	   between	   physicians	   who	   had	   a	  
previous	  knowledge	  of	  CPG	  and	  those	  who	  did	  not,	  which	  certainly	  is	  a	  major	  result.	  According	  to	  
this	  model,	  the	  presence	  of	  abdominal	  pain	  and	  bloody	  diarrhea	  were	  major	  determinants	  of	  non-­‐
adherence	  before	   the	   e-­‐learning	   intervention,	   but	   this	  was	   changed	   after	   the	   course,	   indicating	  
that	  the	  intervention	  reduced	  mismanagement	  triggered	  by	  clinically	  alarming	  signs.	  	  
We	  investigated	  the	  possible	  different	  domains	  of	  inappropriate	  interventions	  and	  measured	  the	  
effectiveness	  of	  the	  medical	  practice	  in	  specific	  areas.	  Notably,	  when	  comparing	  the	  PreEG	  and	  the	  
PostEG,	   a	   decrease	  of	   the	   violations	  was	  observed	   in	   all	   the	  domains.	   The	   e-­‐learning	   education	  
was	  highly	  effective	  in	  reducing	  inappropriate	  requests	  for	  microbiological	  investigations	  (i.e.	  stool	  
cultures),	  which	   in	  our	  observation	  were	  prescribed	   in	   about	  one	   fourth	  of	   the	   children,	  with	   a	  
higher	   proportion	   in	   hospitalized	   patients.	   The	   e-­‐learning	   course	   also	   reduced	   dietary	   changes,	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improved	  the	  estimate	  of	  the	  dehydration	  degree,	  decreased	  the	  use	  of	  not	  recommended	  strains	  
of	  probiotics	  and	  the	  inappropriate	  use	  of	  antiemetics	  and	  antibiotics.	  	  
However,	   selected	   clinical	   features,	   such	   as	   frequent	   vomiting,	   often	   induce	   unnecessary	  
interventions	  as	   they	  are	  perceived	  as	  worrying,	  and	  the	   intervention	  did	  not	  change	  this	   trend.	  
Although	   this	   was	   an	   exception	   with	   the	   successful	   impact	   of	   e-­‐learning,	   mismanagement	   of	  
vomiting	  associated	  with	  the	  non-­‐recommendation	  of	  antiemetics	  increased	  in	  the	  post-­‐course.	  	  
We	  found	  that	  a	  decreased	  diuresis	  was	  a	  risk	  factor	  for	  violations	  in	  the	  estimate	  of	  dehydration,	  
probably	  due	  to	  overestimation.	  This	  finding	  probably	  represents	  a	  bias,	  because	  diuresis	  was	  not	  
included	  in	  the	  parameters	  considered	  by	  the	  validated	  scoring	  systems	  (clinical	  dehydration	  scale	  
and	  Gorelick	  score)	  [10,	  11]	  but	  still	  is	  an	  important	  sign	  of	  dehydration.	  On	  the	  contrary,	  trained	  
physicians	  were	  more	   likely	   to	   correctly	   rehydrate	   a	   child	   in	   presence	  of	   reduced	  urine	   output,	  
probably	  due	  to	  a	  better	  awareness	  of	  the	  importance	  of	  this	  sign.	  	  
Our	  study	  had	  some	  limitations.	  The	  country	  distribution	  of	  participating	  physicians	  was	  scattered	  
and	   affected	   by	   the	   drop-­‐off	   of	   the	   enrolled	   trainees.	   Moreover,	   we	   did	   not	   consider	   in-­‐	   and	  
outpatients	   separately,	   but	   evaluated	   inappropriate	   interventions	   according	   to	   the	   setting	   to	  
increase	   the	   statistical	   power	   of	   the	   observations.	   In	   conclusion,	   our	   study	   provides	   the	   first	  
demonstration	  that	  e-­‐learning	  is	  effective	  not	  only	  in	  improving	  knowledge	  about	  CPG,	  but	  also	  in	  
increasing	   the	   consistency	   of	   clinical	   interventions	   with	   those	   recommended.	   These	   successful	  
results	  have	  led	  ESPGHAN	  to	  implement	  its	  e-­‐learning	  program	  and	  to	  use	  e-­‐learning	  for	  education	  
and	  training	  at	  European	  level.	  
	  
6.5	  Spreading	  the	  e-­‐learning	  initiative	  to	  developing	  countries:	  the	  FISPGHAN	  working	  group	  on	  
acute	  diarrhea	  
	  
The	  FISPGHAN	  Working	  Group	  on	  Acute	  Diarrhea	   identified	   in	  2012	  the	  top	  priorities	   in	  medical	  
intervention,	  education,	  and	   research	   that	  may	   reduce	   the	  burden	  of	  acute	  diarrhea	   in	   children	  
worldwide	   and	   published	   its	   report	   in	   JPGN	   [4].	   The	   aim	   of	   this	  WG	   is	   to	   identify,	   design	   and	  
promote	   practical	   interventions	   related	   to	   each	   of	   the	   3	   fields	   (medical	   intervention,	   education	  
and	  research)	  that	  may	  help	  to	  reach	  the	  priorities	  indicated	  in	  the	  2012	  report.	  	  
This	  WG	  will	  be	  active	  until	  the	  next	  World	  Congress	  and	  present	  what	  we	  will	  be	  able	  to	  achieve	  
in	  the	  2016	  World	  Congress.	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CHAPTER	  7	  
QUALITY	  CARE	  IMPROVEMENT	  TO	  REDUCE	  INFECTIONS	  
IN	  CHILDREN	  WITH	  LEUKEMIA	  
	  
7.1	  Introduction	  and	  rationale	  
	  
Infections	   are	   a	  major	   cause	   of	   morbidity	   and	  mortality	   in	   children	   with	   acute	   leukemia	   being	  
more	  frequent	  and	  severe	  than	  in	  other	  at-­‐risk	  populations.	  The	  threat	  to	  patient’s	  health	  and	  life	  
is	  related	  either	  to	  the	  infection	  as	  such	  or	  to	  the	  consequence	  that	  each	  episode	  may	  have	  on	  the	  
children’s’	  underlying	  condition:	  interruption	  or	  delay	  of	  chemotherapy,	  prolonged	  hospitalization,	  
risk	  of	  nosocomial	  infections	  or	  malnutrition	  (1).	  In	  turn,	  the	  risk	  of	  infection	  is	  related	  to	  patient’s	  
age	  and	  its	  main	  diagnosis,	  phase	  and	  characteristics	  of	  chemotherapy,	  absolute	  neutrophil	  count	  
and	  antibiotic	  prophylaxis	  and	  therapy	  (2,	  3,	  4,	  5,	  6).	  	  
Bloodstream	   infections	   are	   serious	   events	   and	   cause	   a	   prolongation	   of	   hospital	   stay,	   increased	  
costs	  and	  high	  risk	  of	  mortality.	  	  Central	  line-­‐associated	  blood	  stream	  infection	  (CLABSI)	  rate	  in	  at-­‐
risk	  children	  varies	  between	  0.7	  and	  7.4	  episodes	  per	  1000	  central-­‐line	  days,	  according	  to	  different	  
studies	   (7)(8)(9)(10).	  However,	   the	   risk	   of	   infection	   significantly	   changes	   in	   relation	   to	   the	  main	  
diagnosis,	   underlying	   patient	   conditions	   and	   duration	   of	   central	   line	   (7)(8).	   Children	  with	   acute	  
leukemia	  and	  children	  undergoing	  bone	  marrow	  transplantation	  show	  higher	  infection	  rates	  when	  
compared	  to	  children	  affected	  by	  other	  hematologic	  illnesses	  or	  solid	  tumors	  (8).	  	  
In	   studies	   on	   central-­‐line	   related	   complications	   in	   European	   children	   with	   acute	   leukemia,	  
infection	   rates	   ranged	   from	   1.4	   to	   5.4/1,000	   catheter	   days	   according	   to	   the	   central	   line	  
characteristics	   (11).	  Other	   factors	   that	   further	   raise	   the	   risk	  of	  CLABSI	   in	   children	  with	   leukemia	  
include	  blood	  product	  transfusion,	  parenteral	  nutrition	  and	  young	  age.	  	  
Implementation	   of	   adequate	   hygiene	   measures,	   appropriate	   management	   of	   medical	   devices	  
(central	  line),	  and	  prevention	  of	  exposure	  to	  infections	  may	  significantly	  reduce	  the	  infection	  rate	  
(10)(12)(13).	  These	  procedures	  have	  been	  reviewed	  by	  the	  Healthcare	  Infection	  Control	  Practices	  
Advisory	  Committee	  of	  the	  Center	  for	  Disease	  Control	  and	  Prevention’s	  (CDC/HIPAC)	  that	  updated	  
the	  Guidelines	  for	  the	  Prevention	  of	  Intravascular	  Catheter-­‐	  Related	  Infections	  (14).	  	  
Previous	   studies	   tested	   the	   efficacy	   of	   multifaceted	   interventions	   to	   reduce	   the	   occurrence	   of	  
infections,	   and	   particularly	   CLABSI,	   in	   at	   risk	   patients	   such	   as	   adults	   and	   children	   admitted	   to	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intensive	   care	   units	   (15)(16).	   Limited	   evidence	   supports	   effective	   approach	   to	   reduce	   the	  
incidence	  of	  CLABSI	  in	  this	  vulnerable	  population	  (7)(8).	  	  	  
	  
This	   quality	   care	   improvement	   study	  was	   aimed	   at	   reducing	   CLABSI	   rate	   in	   children	  with	   acute	  
leukemia	   through	   a	   multifaceted	   approach	   based	   on	   the	   application	   of	   best	   clinical/nursing	  
practices,	   central-­‐line	   care	   bundles	   and	   direct	   family	   involvement	   and	   training.	   	  We	   report	   the	  
results	  obtained	  in	  the	  first	  3	  years	  of	  activity,	  according	  to	  the	  Standards	  for	  Quality	  Improvement	  




Study	  design	  and	  team	  building	  	  
This	  project	  originated	   from	   the	   collaboration	  between	   the	  Pediatric	   Infectious	  Diseases	  Unit	  of	  
the	   University	   of	   Naples	   Federico	   II	   and	   the	   Pediatric	   Hemato-­‐Oncology	   Unit	   (PHO)	   of	   the	  
Santobono-­‐Pausilipon	  Children’s	  Hospital	  in	  Naples,	  Italy.	  
A	   combined	  multidisciplinary	   team	  was	   created,	   which	   included	   pediatricians	   with	   expertise	   in	  
infectious	   diseases	   and	   onco-­‐hematology,	   a	   pediatrician	  with	   specific	   knowledge	   in	   quality-­‐care	  
improvement	  methodology	  and	  microbiologists,	  surgeons	  and	  nurses.	  	  
	  
Setting	  and	  population	  
Santobono-­‐Pausilipon	   Children’s	   Hospital	   is	   the	   largest	   pediatric	   medical	   center	   located	   in	   the	  
South	  of	  Italy,	  with	  over	  35000	  pediatric	  admissions	  in	  2013.	  It	  is	  a	  major	  center	  for	  children	  with	  
leukemia,	  with	  about	  350	  children	  in	  follow-­‐up	  and	  about	  40	  new	  diagnosis	  of	  acute	  leukemia	  per	  
year.	  The	  average	  daily	  census	  is	  14	  patients	  admitted	  in	  the	  PHO	  ward	  and	  30	  patients	  under	  the	  
day	  hospital	  unit.	  
This	  quality	  improvement	  project	  started	  in	  April	  2011	  focusing	  on	  the	  pediatric	  inpatient	  and	  the	  
day-­‐hospital	   units.	   Children	   aged	   2	   months	   to	   18	   years	   admitted	   to	   the	   PHO	   unit	   with	   acute	  
leukemia	  (either	  lymphoblastic	  or	  myeloid)	  were	  considered	  for	  inclusion.	  Patients	  managed	  in	  the	  
same	   unit	   for	   other	   diseases	   or	   patients	   undergoing	   Bone	  Marrow	   Transplantation	   (BMT)	  were	  
excluded	  because	  of	  a	  different	  risk	  of	   infection	  and/or	  managed	   in	  a	  specific	  unit.	  However,	  all	  
educational	  interventions	  and	  evidence-­‐based	  procedures	  were	  disseminated	  to	  the	  entire	  health-­‐
care	  personnel	  irrespective	  of	  unit	  affiliation.	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All	  patients	  underwent	  chemotherapy	  according	  to	  the	  specific	  diagnosis	  and	  risk	  level	  according	  
to	  the	  protocols	  of	  the	  Italian	  Association	  of	  Pediatric	  Hematology	  and	  Oncology	  (AIEOP)	  (REF).	  All	  
children	   with	   fever	   were	   started	   on	   empiric	   antibiotic	   association	   of	   third-­‐generation	  
cephalosporin	  and	  amikacin	  according	   to	   the	  AIEOP	  2004	  protocol	   (18);	   if	   fever	   (and/or	  signs	  of	  
inflammation)	  persisted	  more	   than	  3	  days,	   a	   second	   line	   antibiotic	   therapy	  and/or	   antiviral	   and	  
antimycotic	   agents	   were	   introduced	   as	   additional	   empiric	   treatment	   unless	   microbiological	  
investigations	   or	   imaging	  did	   not	   yield	   a	   specific	   diagnosis.	   A	   specific	   antimicrobial	   therapy	  was	  




We	  designed	  a	   3-­‐years	   biphasic	   intervention	   study	   including	   a	   first	   retrospective	  phase	   (1	   year)	  
and	  a	  secondary	  prospective	  intervention	  phase	  (2	  years).	  
	  
Retrospective	  phase	  
The	  first	  observational	  phase	  was	  aimed	  at	  reviewing	  the	  existing	  procedures	  for	  prevention	  and	  
management	  of	  infections,	  monitoring	  nurse	  procedures	  and	  specifically	  look	  at	  the	  management	  
of	   central	   line.	   In	   this	  phase,	  we	  analyzed	   the	  baseline	   incidence	  of	   infections	   in	   the	  12	  months	  
before	  starting	  the	  implementation	  program.	  	  
The	   baseline	   infection	   rates	   were	   calculated	   by	   manual-­‐chart	   reviewing	   of	   eligible	   patients	  
admitted	   at	   the	   PHO	   between	  April	   2011	   and	  March	   2012	   because	   of	   fever	   defined	   by	   a	   body	  
temperature	   	   >38.5°C	   in	   one	   measurement	   or	   by	   body	   temperature	   >38°C	   in	   two	   consecutive	  
measurement	   within	   1	   hour.	   CLABSI	   rate	   was	   calculated	   according	   to	   the	   Center	   for	   Disease	  
Control	  definition	  (19)	  by	  using	  a	  standardized	  case	  registration	  form.	  This	  included	  patient	  data,	  
diagnosis	  and	  disease	  risk,	  presence,	  location	  and	  type	  of	  CVC,	  fever	  (and	  other	  symptoms)	  onset	  
and	   duration,	   hospital	   stay,	   blood	   tests	   at	   symptoms	   onset,	   organisms	   isolated	   from	   blood	  
cultures,	  treatment	  and	  clinical	  outcomes.	  Pre-­‐intervention	  data	  were	  used	  to	  define	  the	  baseline	  
and	  set	  up	  appropriate	  interventions	  to	  reach	  the	  goal.	  
The	   team	   members	   met	   regularly	   for	   three	   months	   to	   set	   up	   the	   study	   protocol,	   practice	  
interventions	  and	  expected	  effects	  according	  to	  the	  CDC	  and	  the	  National	  Association	  of	  Children's	  
Hospitals	  and	  Related	  Institutions	  (NACHRI)	  Quality	  Transformation	  Efforts	  (16).	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Prospective	  intervention	  phase	  
Based	   on	   the	   retrospective	   analysis,	   the	   team	   developed	   a	   SMART	   aim	   that	   was	   Specific,	  
Measureable,	  Actionable,	  Relevant,	  and	  Time-­‐bound	  (20)	  to	  reduce	  by	  at	   least	  30%	  the	  infection	  
rate	  in	  children	  with	  leukemia.	  In	  details,	  the	  intervention	  phase	  was	  aimed	  at	  identifying	  specific	  
key	  drivers	  and	  developing	  the	  interventions	  to	  reduce	  CLABSI	  in	  the	  target	  population.	  	  
Post	  intervention	  data	  were	  obtained	  through	  a	  daily	  scan	  of	  patients	  and	  manual	  chart	  review	  of	  
eligible	  patients	  admitted	  in	  two	  years	  	  (March	  2012	  and	  March	  2014).	  A	  research	  nurse	  trained	  in	  
data	   collection	   and	   interpretation,	   reviewed	   the	   list	   of	   hospital	   patients	   each	   weekday.	   On	  
Monday	  morning,	   the	   research	  nurse	  would	  also	   review	  patients	  admitted	  during	   the	  weekend.	  
Once	   a	   patient	   had	   been	   identified,	   the	   research	   nurse	   noted	   whether	   the	   patient	   met	   the	  
inclusion	  criteria	  for	  the	  QI	  project.	  	  
The	  group	  met	  regularly	  to	  discuss	   infection	  rates,	  systematically	  review	  new	  events	  and	  discuss	  
interventions	   and	   barriers	   to	   local	   implementation	   according	   to	   the	   Plan-­‐Do-­‐Study-­‐Act	   (PDSA)	  
cycle	  (20).	  	  
	  
The	   interventions	  were	  grouped	   in	  5	  different	  main	  domains	   (Table	  7.	  1)	  and	  all	  were	   tested	   in	  
two	  medical	  units	  (PHO	  ward	  and	  day-­‐hospital	  service)	  and	  adapted	  as	  needed:	  
1)	  Hygiene	  measure	  and	  management	  of	  central	  line	  
A	   bundle	   including	   interventions	   for	   maintenance	   of	   central	   venous	   catheters	   (CVC)	   was	  
introduced.	  	  Maximal	  sterile	  barrier	  precautions	  were	  reviewed	  and	  their	  application	  was	  routinely	  
checked.	  A	  dedicated	  nurse	  was	  responsible	  of	  daily	  evaluation	  of	  the	  catheter	  insertion	  site.	  Hand	  
hygiene	  measures	  were	  reviewed;	  dispensers	  with	  alcohol-­‐containing	  preparations	  were	  placed	  in	  
each	  room	  at	  patient’s	  bed.	  In	  addition,	  parents	  were	  directly	  involved	  in	  hand	  hygiene	  measure	  
control.	   Chlorhexidine	   replaced	  povidone-­‐iodine	   for	  CVC	  placement	   and	  maintenance,	   based	  on	  
strong	  evidence	  (21).	  	  
Disinfection	   products	   consumption	   was	   monitored	   monthly.	   The	   ratio	   between	   the	   number	   of	  
alcohol-­‐containing	  solutions	  and	  chlorhexidine	  and	  the	  at-­‐risk	  patients	  days,	  was	  used	  as	  process	  
measure.	  	  
2)	  Health-­‐care	  personnel	  education	  and	  training	  
A	   research	  nurse	   (RN)	  was	   specifically	   dedicated	   to	   infection	   control	   and	  procedure	   and	  events	  
monitoring.	  	  
  165 
A	  3-­‐day	  course	  was	  specifically	  organized	  for	  nurses	  focusing	  on	  the	  procedures	  for	  intravascular	  
catheters	  insertion	  and	  maintenance	  and	  on	  control	  measures	  to	  prevent	  CVC-­‐related	  infections.	  
The	  project	  was	  also	  presented	  to	  members	  of	  the	  medical	  and	  nursing	  staff	  of	  other	  units.	  	  
3)	  Family	  education	  and	  direct	  involvement	  
Since	   children	  with	   leukemia	  maintain	   a	   central	   line	   for	   about	   2	   years	   and	   spend	   at	   home	   the	  
majority	  of	  this	  time,	  we	  directly	   involved	  parents	   in	  the	  management	  of	  central	   lines.	  A	  specific	  
educational	   program	  was	   provided	   to	   the	   parents	   of	   all	   children	  with	   a	   new	  diagnosis	   of	   acute	  
leukemia	  to	  instruct	  them	  about	  the	  infection	  prevention	  measures	  and	  the	  care	  of	  central	  lines.	  A	  
training	   course	   on	   the	   management	   of	   central	   lines	   was	   delivered	   by	   a	   dedicated	   nurse	   to	   all	  
families.	  The	  training	  lasted	  about	  2	  months	  according	  to	  parent’s	  autonomy	  and	  self-­‐confidence	  
and	  included	  7	  to	  9	  practical	  sessions	  on	  both	  mannequins	  and	  children	  with	  the	  assistance	  of	  a	  
dedicated	  nurse.	  A	  video	  clip	   illustrating	  the	  procedures	   for	  asepsis	  and	  complete	  medication	  of	  
CVC	  in	  children	  was	  specifically	  produced	  and	  provided	  to	  all	   families	  taking	  part	  to	  the	  training.	  
This	   educational	   tool	   gave	   them	   the	  opportunity	   to	   view	   the	  procedures	   every	   time	   they	  want.	  
Subsequently,	  the	  training	  was	  extended	  also	  to	  all	  families	  of	  children	  already	  managed	  at	  PHO.	  
In	  addition,	  parents	  were	  specifically	   instructed	   to	  check	  health	  care	  personnel	  compliance	  with	  
standard	  of	  practice	  also	  in	  other	  settings	  throughout	  the	  hospital	  (units	  other	  than	  PHO,	  such	  as	  
radiology).	  
4)	  Feedback	  on	  Performance	  
Nurse	  performance	  was	  continuously	  monitored	  by	  the	  RN	  involved	  in	  the	  project.	  	  Determination	  
of	   CLABSI	   events	   was	   made	   by	   personnel	   independent	   from	   the	   clinical	   team.	   An	   up-­‐to-­‐date	  
infection	  rate	  was	  displayed	  graphically	  in	  the	  medical	  and	  nursing	  break	  rooms.	  Single	  infectious	  
events	  were	  discussed	  with	  infectious	  diseases	  specialists	  and	  root	  cause	  analysis	  process	  began	  as	  
soon	  as	  blood	  culture	  yielded	  positive	  results.	  
5)	  Interaction	  with	  the	  microbiology	  unit	  and	  the	  pharmacy	  
A	   revised	   protocol	   for	   blood	   culture	   sampling,	   including	   3	   blood	   cultures	   (at	   least	   one	   from	  
peripheral	  vein)	  in	  the	  first	  hour	  after	  fever	  onset	  and	  before	  starting	  antibiotic	  empiric	  treatment	  
was	  introduced	  in	  May	  2012.	  	  	  
In	   parallel	   to	   the	   family	   educational	   program,	   medical	   kits	   for	   central-­‐line	   medication	   were	  
distributed	  to	  families	  to	  care	  they	  children	  at	  home.	  
	  
Table	  7.	  1.	  Interventions	  composing	  the	  bundle	  according	  to	  the	  respective	  key-­‐drivers	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-­‐ Continuous	  education	  of	  health-­‐care	  personnel	  involved	  in	  the	  study	  -­‐ Training	  course	  for	  nurses	  -­‐ Production	  of	  local	  protocol	  for	  CVC	  management	  -­‐ Dissemination	  of	   the	   local	  protocol	   to	  other	  units	  having	  contacts	  with	  
CVC	  (eg.	  Radiology)	  -­‐ Checklist	  for	  surgical	  CVC	  placement	  	  -­‐ Registered	  nurse	  dedicated	  to	  infection	  control	  
	  
Family	  	  education	  
and	  direct	  
involvement	  




feedback	  and	  	  
performance	  
-­‐ Monitoring	  of	  nurses	  activities	  -­‐ Monitoring	  of	  antiseptic	  and	  chlorhexidine	  consumption	  -­‐ Daily	   measurement	   of	   feverish	   episodes	   and	   CLABSI	   and	   monthly	  









CLABSI	   rate/1000	   catheter	   days	   in	   children	   with	   acute	   leukemia	   were	   considered	   as	   primary	  
outcome.	  However,	  also	  the	  episodes	  of	  fever/1000	  at-­‐risk	  patient	  days	  were	  calculated	  to	  study	  
the	  impact	  of	  interventions	  on	  the	  overall	  incidence	  of	  infections.	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Central	   line	  days	  and	  patient-­‐day	  denominator	  data	  were	  obtained	  by	  measuring	  the	  number	  of	  
children	  with	  leukemia,	  with	  or	  without	  central	  line,	  present	  in	  the	  unit	  at	  the	  same	  time	  each	  day,	  
as	   recommended	   by	   the	   Center	   for	   Disease	   Control	   and	   Prevention	   recommendations	   (14)(19).	  	  
According	  to	  CDC	  recommendation	  (19),	  each	  patient	  with	  a	  central	  line	  contributed	  only	  1	  central	  
line	  day	  even	  if	  the	  patient	  had	  more	  than	  1	  central	  line.	  
The	   efficacy	   of	   family	   training	   program	  was	   specifically	   assessed	   by	  measuring	   CLABSI	   infection	  
rate	  by	  dividing	  the	  study	  population	  in	  three	  subgroups	  according	  to	  the	  level	  of	  training	  received	  
by	  the	  family	  at	  the	  date	  of	  infectious	  episode	  onset.	  	  
The	  duration	  of	  fever,	  the	  length	  of	  hospital	  stay	  and	  the	  need	  of	  a	  shift	  from	  first-­‐line	  antibiotic	  
treatment	  were	  considered	  as	  secondary	  outcomes.	  	  
	  
Statistical	  analysis	  
The	   research	  nurse	   recorded	  data	  and	  created	   run	  charts	  using	  Microsoft	  Excel®.	  Control	   charts	  
display	  data	  in	  a	  timed	  sequence	  and	  help	  detecting	  trends	  and	  their	  specific	  causes	  of	  variations	  
(20)(22).	   Data	   were	   updated	   monthly	   to	   reflect	   the	   infections	   rates.	   The	   mean	   rates	   were	  
calculated	  based	  on	  the	  first	  12	  months	  of	  observation.	  Chi-­‐square	  test	  was	  used	  to	  compare	  the	  
prevalence	   of	   infection	   in	   different	   groups.	   Continuous	   variables	   during	   the	   three	   years	   of	  
observation	  were	  analyzed	  by	  ANOVA	  test.	  Cumulative	  CLABSI	  rate	  with	  95%CI	  was	  calculated	  to	  
compare	  the	  infection	  rate	  in	  subgroups	  of	  children	  managed	  by	  families	  according	  to	  the	  level	  of	  
education.	  
	  
Human	  Subject	  Protection	  
The	  Santobono-­‐Pausilipon	  Children’s	  Hospital	  institutional	  review	  board	  reviewed	  the	  project	  and	  
considered	  it	  to	  be	  a	  local	  quality	  improvement	  initiative	  rather	  than	  a	  research	  involving	  human	  
subjects.	  Informed	  consent	  beyond	  the	  standard	  consent	  for	  treatment	  for	  all	  inpatients	  was	  not	  
required.	  
	  
7.3	  Results	  of	  the	  implementation	  program	  
	  
In	   three	   years	   of	   observation,	   118	   children	   received	   a	   diagnosis	   of	   acute	   leukemia	   at	   the	  
Santobono-­‐Pausilipon	  Children’s	  Hospital	  and	  71	  of	  them	  were	  admitted	  to	  the	  PHO	  unit	  because	  
of	  fever.	  Of	  them	  56	  patients	  (78.8	  %)	  had	  ALL,	  and	  15	  patients	  (21.2	  %)	  had	  AML.	  Of	  ALL	  patients,	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19/56	  children	  (34%)	  had	  a	  diagnosis	  of	  high	  risk	  ALL	  and	  12/56	  (21.4%)	  presented	  a	  relapse;	  all	  
these	  children	  (n=31)	  were	  grouped	  together	  and	  classified	  as	  high	  risk	  ALL	  (ALL-­‐HR).	  	  
The	  median	  age	  at	  first	  fever	  episodes	  was	  67	  months	  (IQR	  49-­‐138).	  	  
In	  the	  study	  period,	  146	  infectious	  episodes	  of	  fever	  were	  observed	  and	  their	  distribution	  was	  at	  
least	   in	  part	   affected	  by	   the	  underlying	   condition:	  29	  episodes	  occurred	   in	   the	  25	   children	  with	  
ALL,	  77	  in	  the	  31	  children	  with	  ALL-­‐HR	  and	  40	  episodes	  in	  the	  15	  children	  with	  a	  diagnosis	  of	  AML	  
(p=	  0.04).	  Fifty-­‐five	  of	  these	  146	  (37.6%)	  episodes	  were	  classified	  as	  CLABSI:	  37	  (67%)	  in	  children	  
with	  ALL	  and	  18	  (32%)	  in	  children	  with	  AML.	  
The	  characteristics	  of	  the	  study	  population	  and	  infectious	  episodes	  are	  shown	  in	  Table	  7.	  2.	  	  
	  
Table	  7.	  2.General	  characteristics	  of	  patients	  (A)	  and	  infectious	  episodes	  (B).	  
	  
	  
	   ALL	   ALL-­‐HR	   AML	   Total	   p	  
A.	  General	  characteristics	  
Number	  of	  children	   25	  (35)	   31	  (44)	   15	  (21)	   71	   NA	  
Gender	  (M/F)	   14/11	   18/13	   5/10	   37/34	   0.25	  
Age	  at	  the	  first	  episode	  (months)§	   55.5(29.7)	   91(110)	   138(141)	   69(98.2)	   0.035	  
Central	  line	  at	  first	  episode	  of	  fever	  
Hickman-­‐Broviac	  
Groshong	  


















B.	  Episodes	  of	  fever	  
Number	  of	  feverish	  episodes/patient*	   1.12±0.32	   2.48±1.83	   2.67±1.4	   2.05	   0.0001	  
Children	  presenting	  only	  1	  episode	  (%)	   22	  (58)	   12	  (31.5)	   4	  (10.5)	   38	  
0.0001	  Children	  presenting	  2	  episodes	  (%)	   3	  (20)	   10	  (66.6)	   2	  (13.3)	   15	  
Children	  presenting	  ≥3	  episodes	  (%)	   0	  (0)	   9	  (50)	   9	  (50)	   18	  
Episodes	  of	  CLABSI	  
Number	  of	  CLABSI/patient*	   0.38±0.49	   0.88±1.00	   1.13±0.99	   0.76±0.92	   0.02	  
Children	  with	  no	  CLABSI	  (%)	   16	  (45.7)	   14	  (40)	   5	  (14.3)	   35	  
0.02	  Children	  presenting	  only	  1	  CLABSI	  (%)	   9	  (37.5)	   11	  (45.8)	   4	  (16.6)	   24	  
Children	  presenting	  ≥	  2	  CLABSI	  (%)	   0	  (0)	   6	  (50)	   6	  (50)	   12	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§	  Age	  reported	  as	  median	  and	  interquartile	  range	  (IQR),	  *	  Number	  of	  infectious	  episodes	  reported	  
as	  mean±SD,	  CLABSI:	  Central-­‐line	  associated	  blood	  stream	  infection	  
	  
The	  mean	  number	  of	  episodes	  per	  patient	  was	  higher	   in	   children	  with	  ALL-­‐HR	  and	  AML	   than	   in	  
children	  with	  ALL	  (p=0.0001,	  Table	  2).	  Also	  the	  risk	  of	  presenting	  2	  or	  more	  episodes	  of	  fever	  in	  the	  
study	  period	  was	  higher	  in	  ALL-­‐HR	  and	  AML	  groups	  if	  compared	  with	  standard	  risk	  ALL	  (p=0.0001,	  
Table	  7.	  2).	  	  
The	  mean	  duration	  of	   fever	  and	  hospitalization	  was	  4.89±2.6	  and	  17.64±11.9	  days,	   respectively,	  
with	  no	  significant	  variations	  between	  the	  three	  groups	  of	  diagnosis	  and	  the	  year	  of	  observation	  
(Table	  7.	  3).	  	  
	  
Table	  7.	  3.	  Secondary	  outcome	  measures	  and	  process	  measures	  during	  the	  study	  period	  
Outcome	  and	  process	  measures	  	   1	  year	   2	  year	   3	  year	   p	  
Number	  of	  children	  undergoing	  a	  change	  
from	  first-­‐line	  antibiotic	  therapy	  (n,	  %)	  
28/54	  
(51.9)	  
10/49	  (20)	   8/43	  (18.6)	   0.01	  
Duration	  of	  hospitalization	  (mean±SD)	   19.35±12.2	   17.36±10.9	   19.9±12.4	   0.54	  
Duration	  of	  fever	  (mean±SD)	   4.1±3.1	   4.48±2.6	   5.4±7.3	   0.38	  
Mean	   number	   of	   chlorhexidine	  
bottles/month	  
13.14±7.27	   32.13±5.22	   34.50±1.77	   <0.0001	  
Mean	   number	   of	   alcohol-­‐containing	  
preparations	  
14.43±4.50	   17.88±2.23	   16.75±1.75	   0.03	  
	  
	  
Overall	  infection	  rates	  
Based	  on	   the	   rates	  observed	   in	   the	  baseline,	   the	   team	  developed	  a	  SMART	  aim	  to	   reduce	  by	  at	  
least	  30%	  the	   infection	  rate	   in	  children	  with	   leukemia.	  More	  specifically,	   the	  SMART	  aim	  was	   to	  
decrease	  the	  rate	  of	  episodes	  of	  fever	  from	  24/1000	  patient	  at-­‐risk	  days	  to	   less	  than	  15	  and	  the	  
rate	  of	  CLABSI	  from	  10/1000	  CVC	  days	  to	  6	  within	  1	  year	  after	  intervention.	  
A	   progressive	   significant	   reduction	   in	   the	   rate	   of	   fever	   episodes	  was	   obtained	   during	   the	   three	  
years	  of	  observation	  (Figure	  7.	  1).	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The	  retrospective	  analysis	   showed	  a	   rate	  of	  24.1/1000	  at-­‐risk	  patient	  days	   (95%CI	  16.3	   to	  28.0),	  
which	  decreased	  to	  17/1000	  (95%CI	  13.9	  to	  24.2,	  p=0.07)	  in	  the	  first	  year	  and	  then	  to	  14.5/1000	  
(95%CI	  10.5	  to	  19.1,	  p=0.01)	  in	  the	  second	  year	  of	  intervention.	  
	  
Figure	  7.1.	  Overall	  infection	  rate	  (grey)	  and	  CLABSI	  rate	  (black)	  over	  the	  3	  yeas	  of	  observation.	  	  
	  
	  
An	  overall	  reduction	  by	  41%	  in	  the	  rate	  of	  fever	  episodes	  was	  observed	  at	  the	  end	  of	  observation.	  
Forty-­‐six	  episodes	  of	  fever	  out	  of	  the	  146	  recorded	  (31.5%)	  needed	  an	  antimicrobial	  therapy	  shift	  
from	   the	   first	   line	   treatment.	   This	   event	   was	   differently	   distributed	   in	   the	   three	   years	   of	  
observation	  being	  more	  common	  in	  the	  baseline	  phase	  (51.9%)	  than	  in	  the	  first	  (20%)	  and	  second	  
year	  (18.6%)	  after	  intervention	  (p=0.0001)	  (Table	  7.3).	  
	  
CLABSI	  rate	  and	  etiology	  
CLABSI	  were	  more	  common	   in	  children	  with	  ALL-­‐HR	  and	  AML	   (p=0.02,	  Table	  7.	  2)	   than	   in	   those	  
with	  ALL.	  None	  of	  the	  children	  affected	  by	  standard	  risk	  ALL	  presented	  recurrence	  of	  CLABSI.	  	  
The	  occurrence	  of	  CLABSI	  was	  closely	  related	  with	  the	  duration	  of	  central-­‐line,	  being	  significantly	  
higher	  in	  children	  with	  prolonged	  dwell	  time	  (p=0.001);	  however	  no	  relation	  was	  found	  with	  CVC	  
type	   and	   place	   of	   insertion.	   Surprisingly	   the	   risk	   of	   CLABSI	   was	   not	   related	   to	   the	   duration	   of	  
neutropenia	  in	  our	  population.	  	  
A	  rate	  of	  10.2	  CLABSI	  for	  1000	  central-­‐line	  days	  was	  recorded	   in	  the	  baseline	  analysis.	  Following	  
the	   implementation	  phase,	   the	  CLABSI	   rate	   significantly	  decreased	   to	  6.6/1000	  central-­‐line	  days	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after	  the	  first	  8	  months	  of	  interventions,	  with	  a	  35.3%	  rate	  reduction	  attributable	  to	  intervention	  
alone.	  A	   further	   reduction	  of	  42.5%	  was	   recorded	   in	   the	  second	  year	  of	   intervention	   reaching	  a	  
final	  CLABSI	   rate	  of	  3.8/1000	  central-­‐line	  days.	  Figure	  7.	  2displays	   the	  control	  chart	  with	  CLABSI	  
monthly	  rates	  and	  the	  time	  of	  introduction	  of	  single	  interventions.	  	  	  
	  
Figure	  7.	  2.	  Run	  Chart	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Coagulase	  negative	  Staphylococci	  were	   the	  most	   frequent	  pathogens	   isolated	   in	  our	  population.	  
Escherichia	  coli	  was	  the	  most	  frequently	  Gram	  negative	  identified.	  	  One	  child	  had	  a	  Staphylococcus	  
haemoliticus	  bacteremia	  before	  placing	   the	  central-­‐line.	  Other	  microbial	   isolates	  are	   reported	   in	  
Table	  7.	  4.	  	  
	  
Table	  7.	  4.	  Blood	  culture	  isolates	  
PATHOGEN	  
Number	  of	  blood	  
culture	  isolates	  
Positive	  blood	  culture	  in	  patients	  with	  central-­‐line	   54	  
Positive	  blood	  culture	  in	  patients	  without	  central-­‐line	   1	  
Polimicrobic	  infections	   6	  
	   	  
GRAM	  POSITIVE	  BACTERIA	   35	  
Coagulase	  negative	  Staphylococci	   25	  
Staphylococcusepidermidis	   11	  
Staphylococcushaemoliticus	   5	  
Staphylococcushominis	   7	  
Staphylococcuscapitis	   1	  
Staphylococcuswarneri	   2	  
Streptococcusviridans	   4	  
Streptococcusmitis	   3	  
OtherStrepcocciviridans	   1	  
Micrococcusspecies	   3	  
Micrococcusluteus	   2	  
OtherMicrococci	   1	  
Enterococcusfaecium	   1	  
Other	  non-­‐specified	  Gram	  positive	  Bacilli	  	   1	  
	   	  
GRAM	  NEGATIVE	  BACTERIA	   25	  
Escherichia	  coli	   13	  
Pseudomonasaeruginosa	   8	  
Enterobactercloacae	   1	  
Klebsiellapneumoniae	   3	  
	   	  
MYCETES	   3	  
Candida	  albicans	   2	  
Aspergillusflavus	   1	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Effects	  of	  family	  educational	  intervention	  on	  infection	  rates	  
Forty-­‐three	  families	  of	  children	  with	  acute	  leukemia	  were	  specifically	  trained	  in	  18	  months.	  None	  
refused	   to	   take	  part	   to	   the	  educational	  program,	  but	  5	   families	  who	  withdrew	  during	   the	   study	  
period	  because	  of	  anxiety,	  fear	  of	  causing	  pain	  to	  their	  children	  and	  “feeling	  of	  incompetence”.	  	  
The	   risk	   of	   CLABSI	   was	   significantly	   linked	   to	   the	   level	   of	   family	   training.	   Children	  managed	   by	  
parents	  who	  completed	  the	  training	  showed	  a	  lower	  cumulative	  rate	  of	  CLABSI	  (2.71/1000)	  than	  
those	  who	  were	  not	   trained	  (14.27/1000,	  p<0.05).	  Those	  who	  were	   in	   the	  process	  of	   training	  at	  
the	   moment	   of	   infectious	   episode	   registration	   had	   an	   intermediate	   infection	   rate	   (4.57/1000).	  
Figure	   3	   reports	   the	   number	   of	   events,	   the	   cumulative	   infection	   rates	   and	   the	   relative	   95%	  
confidence	  intervals.	  
	  
Figure	  7.	  3.	  Infection	  rates	  according	  to	  the	  level	  of	  family	  education	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Monitoring	  of	  process	  measures	  
Process	   measures	   were	   used	   to	   monitor	   monthly	   activity	   to	   indirectly	   evaluate	   the	   effects	   of	  
interventions	  (Table	  3).	  Chlorhexidine	  consumption	  progressively	  increased	  from	  9	  bottles/month	  
in	  the	  first	  month	  to	  more	  than	  30	  (p<0.0001),	  reaching	  a	  plateau	  of	  32-­‐34	  bottle/month.	  When	  
related	   to	   the	  days	  of	   hospitalized	  patient	   the	   ratio	   increased	   from	  3.4	  bottles/100	  days	   at-­‐risk	  
children	   at	   the	   beginning	   of	   intervention	   to	   16.7	   at	   the	   end	   of	   the	   study.	   	   Alcohol-­‐containing	  
preparations	   also	   significantly	   increased	  during	   the	   study	  period	   (p=0.03),	   reaching	  a	  plateau	  of	  
about	  17	  bottles/month.	  
The	   compliance	   of	   health-­‐care	   personnel	   to	   hand	   hygiene	   measures	   was	   estimated	   by	   an	  
independent	   observer	   through	   random	   site	   observation.	   Compliance	   of	   healthcare	   workers	  
increased	  from	  less	  than	  50%	  in	  the	  first	  year	  of	  observation	  to	  95%.	  	  
The	  use	  of	  specific	  checklists	  for	  the	  management	  of	  central-­‐line	  progressively	  increased	  from	  20%	  
in	  the	  first	  month	  after	  introduction	  to	  80%	  at	  the	  end	  of	  the	  project.	  Checklists	  for	  surgeon	  were	  
poorly	  applied	  and	  ultimately	  were	  used	  by	  60%	  of	  surgeons.	  	  
The	   number	   of	   central-­‐line	   site	  medications	   daily	   performed	   in	   DH	   unit	   decreased	   from	   about	  
30/day	  during	  the	  observational	  phase	  to	  about	  5-­‐6	  in	  the	  third	  year,	  as	  routine	  catheter	  cleansing	  
and	  maintenance	  was	  entirely	  transferred	  to	  parents	  in	  88%	  of	  children.	  	  	  
	  
7.4	  Discussion	  	  
	  
Infections,	   mainly	   CLABSI,	   are	   a	  major	   cause	   of	  morbidity	   and	  mortality	   in	   children	   with	   acute	  
leukemia.	  We	  demonstrated	  that	  the	   implementation	  of	  evidence-­‐based	  bundle	  of	   interventions	  
into	  daily	  clinical	  practice	  reduces	  the	  overall	  risk	  of	  infections	  by	  about	  30%	  and	  the	  risk	  of	  CLABSI	  
by	  more	  than	  60%	  in	  this	  at-­‐risk	  population.	  	  
We	   found	   that	  a	   specific	   family	   training	  provided	  by	  expert	  personnel	  and	   focusing	  on	   infection	  
control	   and	  management	   of	   central	   lines,	   significantly	   reduced	   the	   risk	   of	   infections	   in	   children	  
carrying	  catheters	  with	  prolonged	  dwell	  times.	  	  
Similar	   quality	   care	   improvement	   approaches,	   focused	   on	   the	   optimization	   of	   central-­‐line	  
management	   procedures	   but	   targeting	   nurses	   and	   physicians,	   have	   significantly	   reduced	  
nosocomial	  CLABSI	  and	  improved	  patient	  safety	  in	  both	  adult	  and	  pediatric	  ICU	  settings	  (15,	  23).	  
Central-­‐line	  maintenance	  bundles	  often	  include	  a	  program	  of	  education,	  retraining	  and	  monitoring	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of	  health-­‐care	  workers	  managing	  at-­‐risk	  patients.	  However,	  differently	  from	  adults	  and	  neonate	  in	  
ICU,	  children	  with	   leukemia	  usually	   live	  for	  at	   least	  2	  years	  with	  a	  central-­‐line	  and	  spend	  a	  huge	  
amount	   of	   time	   at	   home	   or	   in	   outpatients	   settings.	   Therefore,	   caregivers	   should	   be	   actively	  
involved	   in	   prevention	   and	   care	   and	   this	   was	   the	   approach	   in	   our	   study.	   Irrespective	   of	   other	  
interventions	  that	  were	  applied	  to	  all	  enrolled	  patients,	  training	  of	  caregivers	  dramatically	  reduced	  
the	  CLABSI	   rate	  by	  more	   than	  80%	   (fully	   trained	  vs	  not	   trained).	   The	   comparative	  evaluation	  of	  
CLABSI	  rates	  in	  fully	  trained,	  in	  training	  and	  not	  trained	  caregivers	  showed	  clear	  differences	  in	  the	  
3	  populations.	   In	  addition	   to	   the	   family	   reliability,	   the	  observed	   reduction	  of	   infection	  might	  be	  
related	  also	  to	  the	  significant	  reduction	  of	  CVC	  medications	  performed	  in	  DH	  setting	  (up	  to	  80%),	  
the	  number	  of	  operators	  having	  contact	  with	  the	  patient	  and	  the	  reduced	  number	  of	  accesses	  in	  
hospital	  setting.	  	  
Similar	  to	  previous	  results,	  there	  was	  no	  association	  between	  catheter	  features	  (type,	  number	  of	  
lumens,	  and	  material)	  and	  the	  risk	  of	  developing	  CLABSI	  (8).	  	  
Over	   the	   2-­‐year	   post-­‐implementation	   period,	   CLABSI	   incidence	   was	   significantly	   reduced	   by	  
eliminating	   defects	   in	   routine	   practices	   through	   quality	   improvement	   methods.	   This	   included	  
multidisciplinary	  team-­‐based	  problem	  solving,	  iterative	  root	  cause	  analysis,	  and	  ongoing	  Plan-­‐Do-­‐
Study-­‐Act	  cycles.	  As	  recently	  reported	  by	  Rinke	  et	  al.	  (7),	  in	  our	  population	  the	  second	  year	  of	  the	  
intervention	  resulted	  in	  a	  slightly	  higher	  decline	  in	  CLABSI	  rates	  below	  baseline,	  suggesting	  that	  a	  
long	   ramp-­‐up	   period	  may	   be	   necessary	   to	   achieve	   effective	   permanent	   change.	   The	   significant	  
reduction	  of	  infections	  requires	  day-­‐to-­‐day	  adherence	  to	  evidence-­‐based	  guidelines	  and	  continued	  
re-­‐evaluation	   of	   catheter	   care	   practices.	   In	   consistency	   with	   published	   data	   (15,	   23,	   24),	   the	  
reduction	  of	   infections	  occurred	  without	  hiring	  additional	  staff	  or	  significantly	   increasing	  nursing	  
workload,	  and	  did	  not	  need	  the	  application	  of	  novel	  and	  expensive	  tools	  or	  methods	  of	  care.	  
In	   addition	   to	   the	   reduction	   of	   CLABSI	   rate,	   other	   interesting	   results	  were	   observed	   during	   the	  
study.	  An	  increase	  in	  infection	  rate	  was	  observed	  during	  the	  summer	  months	  (June	  -­‐	  August)	  in	  all	  
3	  years	  of	  study,	  other	  nurses,	  usually	  working	  in	  different	  units,	  and	  therefore	  less	  trained	  in	  the	  
management	   of	   those	   children,	   are	   called	   to	   replace	   the	   standard	   nurses	   working	   at	   PHO.	   A	  
similar,	  but	  less	  evident	  evidence,	  was	  observed	  in	  December-­‐January,	  during	  Christmas	  holidays.	  	  
According	   to	   the	   national	   protocol	   for	   the	  management	   of	   feverish	   neutropenia,	   children	   who	  
failed	   on	   first-­‐line	   antibiotic	   therapy	   were	   started	   on	   a	   second-­‐line	   empiric	   treatment	   with	  
antibiotics	   and	   the	   adjunct	   of	   antimycotic	   and	   antiviral	   agents	   (18).	   During	   the	  QI	   initiative	  we	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recorded	   a	   reduction	   in	   the	   prescription	   of	   second-­‐line	   empiric	   treatments	   that	   reflects	   a	  
substantial	  change	  in	  clinical	  practice	  and	  may	  result	  in	  substantial	  cost	  savings.	  
	  
Our	  study	  has	  some	  limitations.	  One	  of	  the	  main	  barrier	  to	  local	  implementation	  of	  best	  evidence-­‐
based	   practice	   was	   the	   limited	   collaboration	   and	   commitment	   of	   pediatric	   surgeons	   who	   are	  
usually	  in	  charge	  of	  CVC	  insertion.	  Routine	  use	  of	  chlorhexidine	  for	  CVC	  placement,	  routine	  use	  of	  
surgery	  checklist	   for	  CVC	   insertion	  and	  progressive	   introduction	  of	  ultrasound	  guidance	   to	  place	  
CVC	  were	  the	  intervention	  planned	  in	  this	  area.	  The	  chlorhexidine	  was	  progressively	  introduced	  in	  
the	   routine	   practice.	   However,	   the	   specific	   checklists,	   although	   reviewed	   and	   modified	   in	  
agreement	  with	  surgeons,	  were	  only	  partially	  filled	  in	  the	  first	  semester	  after	  introduction	  (71%),	  
and	  were	   progressively	   dismissed	   in	   the	   second	   year	   of	   intervention	   (21%	   and	   33%	   completed	  
checklists	  in	  the	  past	  2	  semesters).	  
A	  specific	  training	  for	  ultrasound-­‐assisted	  CVC	  placing	  was	  eventually	  provided	  this	  was	  not	  done.	  
This	   technique	  may	   reduce	   the	   number	   of	   cannulation	   attempts	   and	  mechanical	   complications	  
and	  is	  currently	  recommended	  by	  guidelines	  as	  the	  standard	  for	  long	  term	  central-­‐line	  placement	  
(19).	  However,	   other	   quality	   improvement	   studies	   reached	   significant	   results	   following	   catheter	  
maintenance	  procedures	  rather	  than	  addressing	  insertion	  procedures	  that	  usually	  require	  specific	  
quality	  improvement	  strategies	  (7).	  	  
	  
In	  conclusion,	  a	  continuous	  education	  program	  offered	  to	  families	  and	  health-­‐care	  personnel	  and	  
coupled	   to	   routine	   application	   of	   stringent	   standard	   hygiene	   procedures	   and	  maintenance	   CVC	  
care	   bundles,	   was	   effective	   in	   reducing	   the	   overall	   risk	   of	   infections	   and	   the	   risk	   of	   CLABSI	   in	  
children	  with	  leukemia.	  The	  implementation	  of	  evidence-­‐based	  practices	  and	  in	  particular	  training	  
of	   caregivers	  may	   result	   in	   a	   dramatic	   improvement	   of	  management	   and	   eventually	   of	   survival	  
without	  significant	  additional	  health-­‐care	  costs	  or	  increase	  in	  nursing	  workload.	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Clinical	   practice	   guidelines	   currently	   represent	   the	   standard	   of	   care	   and	   a	   support	   for	   medical	  
practitioners	  in	  the	  management	  of	  acute	  and	  chronic	  conditions	  in	  all	  periods	  of	  life,	  from	  infancy	  
to	   elderly.	   The	   primary	   aim	   of	   guidelines	   in	   pediatrics	   is	   to	   provide	   appropriate	   health	   care	   in	  
specific	  clinical	  circumstances	  and	  improve	  the	  health	  of	  infants	  and	  children	  by	  ensuring	  that	  they	  
receive	  up-­‐to-­‐date,	  evidence-­‐based	  care.	  
As	  this	  thesis	  showed,	  the	  process	  that	  goes	  from	  the	  identification	  of	  a	  relevant	  clinical	  problem	  
to	   its	  resolution	   is	  complex	  and	  time-­‐consuming,	  and	  the	  delivery	  of	  standard	  care	  to	  the	  target	  
population	  needs	  time	  and	  efforts.	  	  
Each	  one	  of	  the	  steps	  depicted	  in	  the	  thesis,	  from	  the	  development	  of	  clinical	  recommendations	  to	  
their	   dissemination	   and	   local	   implementation,	   may	   potentially	   represent	   a	   barrier	   to	   local	  
application	  of	  evidence-­‐based	  recommendations.	  
As	  we	  showed	  above,	  the	  production	  of	  a	  high	  quality	  guideline,	  based	  on	  a	  rigorous	  methodology,	  
with	   the	  participation	  of	   relevant	   stakeholders	   and	   target	  users,	   is	   the	   first,	   essential	   step	   for	   a	  
correct	   and	   effective	   evidence-­‐based	   path.	   However,	   despite	   the	   continuous	   production	   and	  
update	  of	  referral	  documents,	   for	  many	  health	  conditions,	  there	   is	  a	  gap	  between	  what	  medical	  
science	   has	   shown	   to	   be	   effective	   in	   practice	   and	   what	   is	   actually	   done.	   Although	   guidelines	  
represent	  a	  major	  tool	  to	  improve	  quality	  of	  care,	  in	  most	  cases,	  the	  development	  of	  a	  guideline	  is	  
not	   enough	   to	   change	   clinical	   practice.	   Further	   steps	   are	   always	   necessary	   and	   should	   include:	  
pilot	  testing,	  capillary	  dissemination	  and	  implementation,	  local	  tailoring,	  and	  quality	  improvement.	  	  
All	  these	  interventions	  need	  to	  be	  accurately	  planned,	  applied	  and	  monitored	  by	  expert	  personnel.	  
	  
This	   thesis	   reported	   the	   efficacy	   and	   effectiveness	   of	   different	   interventions	   in	   the	   field	   of	  
pediatric	  infectious	  diseases.	  	  
Infectious	   diseases	   are	   the	   most	   common	   illnesses	   in	   infants	   and	   children.	   Respiratory	   and	  
gastrointestinal	   infections	   represent	   worldwide	   the	   major	   indication	   to	   medical	   visit,	   access	   to	  
emergency	   department	   and	   hospital	   admission	   in	   pediatric	   age.	   In	   most	   cases,	   infections	   are	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curable	  diseases	  if	  an	  appropriate	  management	  is	  rapidly	  provided.	  However,	  the	  high	  frequency	  
and	  worldwide	  spreading	  result	  in	  high	  social	  and	  economic	  burden.	  
A	  routine	  and	  appropriate	  application	  of	  evidence-­‐based	  recommendations	  may	  have	  a	  dramatic	  
impact	   on	   the	   burden	   of	   all	   infections	   in	   pediatric	   age,	   improving	   child	   health	   and	   reducing	  
inappropriate	  interventions,	  adverse	  effects	  and	  health-­‐care	  expenses.	  
For	  all	   these	  reasons,	  and	  from	  a	  methodological	  point	  of	  view,	   infectious	  diseases	  represent	  an	  
ideal	  setting	  to	  test	  the	  efficacy	  and	  applicability	  of	  guidelines.	  
	  
In	   the	   field	  of	  acute	   intestinal	   infections,	  we	  observed	  a	   significant	   inappropriateness	   in	   current	  
practice	   in	   Italy	   [1],	   as	  previously	   reported	   in	  other	   countries	   [2].	   The	  gap	  between	   standard	  of	  
care	  and	  local	  practice	  may	  be	  resolved	  by	  using	  different	  approaches	  that	  improve	  practitioners’	  
knowledge	  and	  significantly	  change	  their	  practice	  with	  consequential	   impact	  of	  child	  health.	  We	  
previously	  demonstrated	  that	  a	  brief	  educational	  course	  (2	  hours)	  addressed	  to	  pediatricians	  and	  
based	   on	   updated	   guidelines	   for	   the	   management	   of	   acute	   gastroenteritis,	   may	   significantly	  
reduce	   inappropriate	   prescriptions	   and	   improve	   physicians’	   knowledge	   and	   clinical	   outcomes	  
(duration	   of	   diarrhea)	   [3].	   A	   similar	   approach	   has	   been	   proposed	   with	   the	   collaboration	   of	  
ESPGHAN	  and	  the	  United	  European	  Gastroenterology	  by	  using	  an	  e-­‐learning	  course	  directed	  to	  all	  
European	  physicians	  managing	  children	  with	  acute	  intestinal	  infections.	  We	  demonstrated	  a	  good	  
applicability	   of	   this	   approach	   and	   its	   efficacy	   in	   changing	   clinical	   practice	   and	   adherence	   to	  
guidelines	  in	  11	  European	  countries.	  
E-­‐learning	   is	  a	  useful	  tool	   for	  the	  dissemination	  of	  guidelines	  recommendations	  on	  a	   large	  scale,	  
and	  this	  is	  particularly	  helpful	  for	  student	  education,	  rapid	  and	  continuous	  update	  of	  evidence	  and	  
continuous	  medical	  training.	  However,	  some	  interventions	  need	  to	  be	  tested	  in	  a	  local	  setting,	  and	  
barriers	  to	  local	   implementation	  may	  significantly	  differ	  between	  different	  countries,	  health-­‐care	  
settings	   and	   organizations.	   For	   all	   those	   reasons,	   evidence-­‐based	   recommendations	   should	   be	  
tested	  in	  daily	  practice	  by	  using	  small	  tests	  of	  the	  changes	  that	  may	  lead	  to	  improvement	  over	  a	  
short	  period	  of	  time,	  barriers	  should	  be	  identified	  and	  a	  continuous	  monitoring	  should	  be	  set	  up.	  
Once	   these	   small	   tests	   are	   refined	   and	   successfully	   implemented	   in	   the	   given	   context	   we	   can	  
broaden	   the	   testing,	   scale	   up	   the	   changes	   and	   measure	   their	   effects.	   All	   this	   methodology	   is	  
usually	  called	  “quality	  improvement”	  in	  health	  care	  and	  represents	  today	  the	  ideal	  way	  to	  put	  best	  
scientific	  evidence	  in	  practice.	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We	  applied	  a	  rapid	  cycle	  of	  improvement	  to	  increase	  prescription	  of	  evidence-­‐based	  interventions	  
(probiotics)	   in	   children	   hospitalized	   for	   acute	   gastroenteritis	   in	   a	   tertiary-­‐care	   hospital	   [4].	   In	  
addition,	  we	   used	   a	   similar	  methodology	   to	   set	   up	   effective	   interventions	   to	   reduce	   infections’	  
rate	   in	   children	   with	   acute	   leukemia,	   and	   demonstrated	   that	   moving	   central-­‐line	   management	  
from	  physicians	  and	  nurse	  to	  caregivers,	  by	  using	  a	  specific	  training,	   is	  one	  of	  the	  most	  effective	  
interventions	  to	  reduce	  the	  rate	  of	  blood	  stream	  infections.	  	  
	  
Based	  on	  the	  data	  we	  obtained	  in	  this	  field,	  the	  message	  we	  can	  drive	  to	  health	  care	  authorities	  is	  
to	   invest	   in	   translational	   medicine	   sciences	   and	   move	   part	   of	   health-­‐care	   resources	   from	  
production	  of	  evidence	  to	  their	  implementation.	  
The	   continuous	   investment	   in	   basic	   science	   research,	   a	   rapid	   translation	   of	   evidence	   in	   clinical	  
practice	  and	  a	   specific	   training	   in	  evidence-­‐based	  medicine	  and	  quality	   improvement,	   represent	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